Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABLIM2 KIAA1808 ENSG00000163995 "Actin binding LIM protein family member 2" Q6H8Q1 4 7965310-8158832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skeletal muscle: 204.8;tongue: 73.5" "Group enriched" "Detected in many" 4 "Excitatory neurons: 93.2;Inhibitory neurons: 67.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 13.8;SiHa: 5.9;U-2197: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035808 Uncertain Uncertain Nucleoplasm,Mitochondria NA NA "Cluster 32: T-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Mitochondria Nucleoplasm "HPA035808: AB_10601962" "unprognostic (7.57e-2)" "unprognostic (3.24e-3)" "unprognostic (7.78e-2)" "unprognostic (3.33e-1)" "unprognostic (2.86e-2)" "unprognostic (6.09e-2)" "unprognostic (1.49e-2)" "unprognostic (5.54e-2)" "unprognostic (1.46e-1)" "unprognostic (5.01e-3)" "unprognostic (2.04e-2)" "unprognostic (3.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.32e-2)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.45e-2)" 7.3 4.0 2.7 1.6 11.0 0.1 5.1 0.0 9.9 2.5 0.0 2.3 0.5 1.2 0.7 13.1 1.8 1.3 7.1 2.7 10.4 7.0 0.9 3.3 1.0 1.4 0.0 0.6 3.4 1.3 6.8 0.6 1.1 1.5 1.7 5.0 5.4 0.5 204.8 6.9 1.6 1.9 0.0 20.5 1.4 1.0 1.4 1.7 3.0 73.5 2.2 1.9 4.1 0.0 1.1 0.0 0.2 1.6 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 1.5 3.1 0.3 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.4 0.0 1.3 0.0 0.7 0.0 0.0 0.1 1.1 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.7 2.1 0.1 0.0 1.2 2.9 0.9 0.2 1.0 0.7 0.2 0.0 13.8 1.0 5.9 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.4 20.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.6 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 2.7 11.0 0.0 9.9 2.7 10.4 1.4 0.0 1.1 0.0 1.4 0.0 4.4 0.0 1.1 9.4 0.5 2.5 0.1 0.1 0.6 6.4 0.4 0.3 4.7 1.5 0.3 3.7 0.0 0.0 0.6 7.9 0.0 3.5 2.2 5.2 0.7 3.5 10.7 0.0 93.2 4.3 0.6 0.9 2.6 0.2 2.5 0.5 0.7 0.4 0.1 11.8 67.6 3.8 0.0 0.6 0.7 5.1 0.0 0.3 0.0 2.8 0.0 3.1 0.0 16.1 17.6 3.5 5.1 3.8 0.1 0.3 14.3 0.6 1.7 3.2 6.6 7.0 3.5 0.2 2.0 2.0 6.3 0.0 0.7 4.0 5.8 0.3 AC008764.4 ENSG00000268790 "Novel protein" 19 16577642-16660115 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "T-47d: 3.3;THP-1: 3.2" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 6: T47d - Mammary gland" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (3.52e-1)" "unprognostic (2.20e-1)" "unprognostic (2.65e-1)" "unprognostic (2.41e-1)" "unprognostic (1.26e-1)" "unprognostic (6.04e-2)" "unprognostic (2.33e-1)" "unprognostic (3.03e-1)" "unprognostic (7.19e-2)" "unprognostic (1.64e-2)" "unprognostic (1.47e-1)" "unprognostic (5.83e-2)" "unprognostic (7.27e-3)" "unprognostic (5.09e-3)" "unprognostic (4.17e-2)" "unprognostic (2.09e-1)" "unprognostic (2.28e-1)" 0.2 0.4 0.1 0.0 0.2 0.1 0.1 0.1 0.5 0.0 0.1 0.3 0.4 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.7 0.4 0.2 0.1 0.3 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.2 0.8 0.3 1.8 0.5 0.3 0.2 0.2 0.6 0.4 0.4 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.3 1.6 1.2 0.0 0.2 0.8 0.9 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.0 1.2 2.5 0.0 0.0 0.0 1.4 0.0 0.9 0.2 0.0 1.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.7 0.9 1.2 0.0 0.0 0.6 1.7 0.0 1.7 0.2 0.1 3.3 3.2 0.0 0.0 0.5 2.2 1.9 1.4 0.0 1.7 0.4 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.3 0.2 0.1 0.2 0.2 0.2 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012531.3 ENSG00000273049 "Novel protein, readthrough between HOXC10 and HOXC5" 12 53985845-54034888 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "skeletal muscle: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 8.0;fHDF/TERT166: 2.0;HDLM-2: 3.0" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 2.4 0.2 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 8.0 0.6 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.7 0.0 0.1 2.0 0.1 0.9 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.2 0.4 0.1 1.5 0.0 0.0 0.3 1.1 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTA1 "ACTA, NEM3" ENSG00000143632 "Actin alpha 1, skeletal muscle" P68133 1 229431245-229434098 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 133409.0" "Group enriched" "Detected in some" 36 "Cardiomyocytes: 1901.9;Skeletal myocytes: 1541.2" "Group enriched" "Detected in many" 18 "head and neck cancer: 133.1;prostate cancer: 34.7" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 22 "BEWO: 469.2" "Low region specificity" "Detected in all" "CAB000045, HPA041264, HPA041271" Enhanced NA NA 2800000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 37: Myocytes - Muscle contraction" "CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (5.59e-2)" "unprognostic (1.60e-2)" "unprognostic (1.77e-1)" "unprognostic (3.07e-4)" "unprognostic (5.75e-3)" "unprognostic (3.84e-3)" "unprognostic (1.86e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (2.64e-3)" "unprognostic (2.50e-1)" "unprognostic (1.56e-3)" "unprognostic (9.40e-4)" "unprognostic (2.61e-1)" "unprognostic (1.58e-2)" "unprognostic (1.01e-1)" 15.3 3.8 1.2 1.6 1.2 0.3 19.8 1.8 2.8 1.2 0.4 8.8 0.3 3.0 0.0 604.6 0.6 1.6 6656.6 1.2 3.5 2.6 7.3 7.6 2.2 0.9 1.1 4.6 7.3 0.0 4.7 1.2 0.8 164.8 0.0 0.1 591.0 0.7 133409.0 36.0 5.3 66.3 0.7 3.0 5.1 2.5 1.4 3.1 14.5 20867.7 0.9 3.0 5.4 1.0 0.2 0.2 0.1 0.4 0.0 0.1 469.2 0.0 0.0 0.3 0.1 0.5 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 1.4 0.2 0.5 21.5 0.0 0.5 0.7 20.8 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.5 0.2 0.0 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.5 0.2 4.3 0.1 0.0 0.3 0.4 0.6 0.3 0.2 0.5 0.5 0.6 1.0 0.3 0.3 0.6 0.3 18.3 16.5 34.2 11.5 25.4 8.4 6.7 9.4 11.2 23.6 6.4 7.2 11.5 18.8 8.2 24.1 7.5 15.7 45.4 1.2 1.2 1.8 2.8 1.2 3.5 0.9 1.1 0.8 0.7 1.4 1.0 0.2 0.0 0.0 0.3 0.1 0.5 0.4 0.8 0.0 0.8 0.3 2.2 1901.9 0.0 0.1 0.0 4.2 1.7 0.0 0.0 0.0 1.9 0.4 0.1 0.4 38.1 0.0 0.0 0.6 0.0 3.3 43.6 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 2.1 0.3 0.0 9.7 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1541.2 46.6 1.1 0.2 0.7 0.4 0.3 8.2 0.1 0.1 0.2 ACTN3 ENSG00000248746 "Actinin alpha 3" Q08043 11 66546395-66563334 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 72 "skeletal muscle: 1670.4" "Group enriched" "Detected in some" 6 "Early spermatids: 6.3;Late spermatids: 16.2;Skeletal myocytes: 15.2" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "HDLM-2: 13.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA006035 Uncertain Uncertain "Actin filaments" NA NA 11000000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Actin filaments" "HPA006035: AB_1078095" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (6.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.35e-4)" "unprognostic (1.40e-3)" "unprognostic (5.37e-3)" "unprognostic (5.09e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "unprognostic (6.71e-9)" "unprognostic (2.06e-1)" "unprognostic (6.98e-2)" "unprognostic (5.16e-2)" "unprognostic (2.48e-1)" 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.1 0.2 0.0 0.2 0.0 0.1 0.0 1.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.1 1670.4 0.1 0.1 0.0 0.0 0.1 0.1 4.0 0.0 0.0 0.3 23.3 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.3 0.0 0.0 0.2 1.8 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.2 1.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ADRM1 "ARM1, GP110, Rpn13" ENSG00000130706 "Adhesion regulating molecule 1" Q16186 20 62302093-62308862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 369.5" "Cell type enhanced" "Detected in all" "Late spermatids: 1655.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 727.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042266 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 28000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Plasma membrane, Cytosol" "HPA042266: AB_10794044" "unprognostic (5.49e-2)" "unprognostic (5.14e-3)" "unprognostic (7.34e-2)" "unprognostic (6.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-3)" "unprognostic (2.14e-2)" "unprognostic (3.56e-2)" "unprognostic (2.13e-3)" "unprognostic (8.98e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (4.15e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.47e-2)" 76.9 92.7 44.9 53.4 45.6 78.0 68.3 48.7 63.7 57.8 38.1 78.7 52.0 80.6 14.6 99.0 58.4 33.5 109.0 44.0 48.4 65.1 119.5 67.3 54.2 52.0 45.7 44.5 83.2 23.5 52.6 39.6 51.0 59.5 16.1 11.9 61.3 35.1 369.5 93.9 63.4 23.3 44.4 83.2 68.6 128.5 47.3 38.9 51.7 66.9 29.7 73.0 64.4 46.4 219.9 241.8 66.8 142.6 62.5 45.8 178.1 138.9 95.4 260.1 104.0 727.1 227.8 117.4 250.3 82.1 148.3 243.6 84.3 209.9 79.8 136.7 170.1 284.4 177.4 392.0 105.6 149.3 261.1 57.0 126.3 170.9 67.7 43.4 101.4 113.0 211.4 125.6 61.7 296.1 187.5 290.8 225.1 106.6 354.0 149.2 115.5 186.7 71.3 163.9 118.5 146.5 151.5 241.7 174.0 44.9 168.1 163.3 149.4 258.5 274.4 252.4 289.1 261.5 223.4 158.6 272.6 148.7 192.3 195.4 208.7 233.5 200.4 262.1 179.9 260.2 180.8 192.9 219.2 265.2 132.4 151.4 200.2 184.8 227.8 205.6 265.8 260.8 44.9 45.6 48.7 63.7 44.0 48.4 52.0 45.7 51.0 44.4 47.3 46.4 91.4 35.3 25.2 7.5 91.3 148.2 115.6 275.4 98.4 34.7 62.0 62.0 19.4 52.9 119.3 66.2 18.8 230.4 83.3 156.4 115.4 186.9 359.1 61.7 43.9 105.6 57.8 74.3 5.2 211.3 173.6 73.3 51.0 56.9 42.5 55.8 87.1 101.7 150.2 33.7 4.9 87.1 156.6 77.6 154.2 1655.0 72.4 89.8 97.8 3.7 126.5 73.0 83.4 4.0 8.5 247.5 129.7 86.9 118.2 145.7 118.6 139.0 96.2 31.7 65.7 49.9 177.0 135.2 204.2 108.0 148.0 423.0 86.1 57.5 95.2 144.6 ADSS1 "ADSSL1, FLJ38602" ENSG00000185100 "Adenylosuccinate synthase 1" Q8N142 14 104724229-104747325 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 1273.1;tongue: 609.8" "Cell type enriched" "Detected in some" 20 "Cardiomyocytes: 137.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 15.2;MCF7: 14.2;OE19: 23.2;SiHa: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052621 Enhanced NA NA 290000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 21: OE19 - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA052621: " "unprognostic (2.23e-2)" "unprognostic (3.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.14e-2)" "unprognostic (2.81e-3)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (2.26e-1)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (2.33e-1)" "unprognostic (2.35e-1)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" 8.1 5.1 3.8 1.0 6.8 0.9 4.4 6.6 5.6 4.1 7.6 3.0 2.7 3.3 4.5 18.5 6.5 5.7 100.2 3.7 6.7 14.8 28.8 3.1 1.1 6.0 6.0 2.7 7.9 7.3 10.0 7.3 6.1 7.6 1.4 10.1 10.7 4.0 1273.1 5.5 2.8 2.3 5.2 2.0 6.5 18.5 5.5 1.0 7.4 609.8 0.8 6.5 5.4 7.7 0.1 3.2 2.4 7.1 1.7 1.1 0.8 0.9 1.3 0.2 0.7 0.2 2.5 0.0 15.2 0.8 0.5 1.3 0.2 0.5 0.6 1.0 0.5 0.1 7.9 1.1 1.8 0.0 6.0 3.2 2.3 0.0 2.6 2.7 0.4 0.3 2.9 0.1 1.2 14.2 0.0 0.7 2.1 23.2 1.3 0.2 0.3 0.9 0.5 1.7 2.0 4.2 23.1 1.0 3.3 1.8 7.1 2.1 0.8 0.1 0.6 1.6 0.1 4.4 3.5 0.0 2.2 1.0 1.5 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.8 6.8 6.6 5.6 3.7 6.7 6.0 6.0 6.1 5.2 5.5 7.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.4 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 ALDOA ENSG00000149925 "Aldolase, fructose-bisphosphate A" P04075 16 30064164-30070457 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease variant, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "skeletal muscle: 26754.8;tongue: 9180.4" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 3267.9;Extravillous trophoblasts: 2322.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004177, CAB006252" Supported Approved Cytosol NA NA 640000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "CAB006252: AB_437007, HPA004177: AB_1078128" "unprognostic (2.63e-2)" "unprognostic (3.22e-2)" "unprognostic (6.80e-2)" "unprognostic (1.33e-1)" "unprognostic (6.74e-3)" "unprognostic (4.28e-3)" "prognostic unfavorable (5.79e-5)" "prognostic unfavorable (7.32e-5)" "unprognostic (1.68e-1)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "unprognostic (1.57e-1)" "unprognostic (1.81e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.19e-3)" "unprognostic (4.48e-2)" 569.3 696.4 616.8 443.1 697.4 732.5 512.6 617.3 719.7 566.0 617.0 774.1 517.9 533.7 201.0 1302.0 449.7 420.5 2286.1 731.9 652.0 709.0 217.1 425.6 358.2 762.3 654.0 510.4 390.5 943.1 525.1 351.4 763.9 457.7 400.1 465.2 904.9 597.6 26754.8 643.4 488.3 465.2 545.5 417.5 595.0 138.7 657.8 280.9 454.5 9180.4 478.3 761.8 740.3 558.7 2206.1 1620.4 477.9 1542.8 714.6 808.5 1520.8 1297.9 1336.2 1291.6 1603.0 1158.1 1643.6 1487.6 2072.2 1318.6 708.6 1632.6 966.8 2829.1 939.3 658.5 1272.9 1219.3 1202.7 2591.1 1112.5 1793.8 1251.3 1115.7 979.6 1455.4 968.9 2119.7 965.4 686.9 1070.0 951.1 1393.4 3136.7 1100.2 1477.0 1192.8 848.1 1346.6 1613.9 765.2 3353.2 1629.4 1230.5 950.7 668.5 808.6 3368.5 1213.9 591.2 1433.0 1194.7 1162.5 1892.3 750.3 1046.7 1430.0 1861.5 1387.3 1369.3 3524.5 1715.9 1532.9 2050.6 2694.7 2081.7 1008.7 2466.5 1138.1 908.5 1091.7 1047.0 2182.7 877.9 1027.4 996.9 2531.7 819.9 2780.2 824.0 1476.3 4372.2 616.8 697.4 617.3 719.7 731.9 652.0 762.3 654.0 763.9 545.5 657.8 558.7 17.0 12.8 32.4 83.2 281.2 792.0 716.4 3267.9 784.8 387.4 34.4 21.6 1968.4 273.1 1385.1 42.3 118.9 1194.1 107.9 1834.8 111.6 120.9 258.8 15.8 11.8 261.1 323.9 215.8 66.2 76.2 2322.1 329.7 513.3 16.1 196.5 18.7 289.5 102.0 1181.9 733.6 70.0 755.1 1265.4 632.2 715.4 1152.4 380.8 388.8 924.9 50.6 417.7 662.1 328.5 40.2 60.8 126.2 1497.1 405.1 409.4 676.9 1755.7 75.8 700.9 298.9 486.4 680.9 572.9 25.8 123.6 1174.6 684.5 1361.3 294.3 15.2 937.7 1146.2 AMPD1 "MAD, MADA" ENSG00000116748 "Adenosine monophosphate deaminase 1" P23109 1 114673090-114695618 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "skeletal muscle: 559.2;tongue: 211.4" "Group enriched" "Detected in some" 6 "Plasma cells: 43.8;Skeletal myocytes: 13.3" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "U-266/70: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026478, HPA028080" Enhanced "Intracellular and membrane" NA NA 38000 "Cluster 37: B-cells - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 37: Myocytes - Muscle contraction" "HPA026478: AB_10599969, HPA028080: AB_10600776" "unprognostic (1.98e-3)" "unprognostic (1.43e-3)" "unprognostic (8.75e-3)" "unprognostic (8.03e-2)" "unprognostic (1.95e-2)" "unprognostic (5.61e-3)" "unprognostic (8.21e-2)" "unprognostic (4.29e-3)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.36e-5)" "unprognostic (1.68e-1)" "unprognostic (3.70e-1)" "unprognostic (3.36e-1)" "unprognostic (4.02e-1)" 0.1 0.1 0.0 0.5 0.0 0.3 3.0 0.0 0.0 0.2 0.0 5.6 16.4 0.2 0.0 5.8 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.0 0.1 0.3 0.0 0.0 0.0 3.5 5.5 0.0 4.4 0.9 559.2 0.0 7.5 0.1 0.0 1.6 3.7 0.1 0.0 0.4 0.1 211.4 2.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.8 1.9 0.0 0.0 0.0 3.0 4.2 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 39 "skeletal muscle: 1438.6;tongue: 448.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 5.0;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 5.2;Skeletal myocytes: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Karpas-707: 38.5" "Low region specificity" "Detected in many" HPA036201 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 2: Karpas-707 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Cytosol" "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.8 0.9 1.6 0.4 2.1 0.7 1.2 2.2 2.1 1.4 0.6 1.3 0.8 1.8 0.0 6.0 2.5 0.2 24.2 1.5 1.4 0.7 2.2 1.0 0.6 2.5 1.6 1.7 1.6 0.3 10.4 0.2 1.8 5.3 0.1 0.1 18.5 0.3 1438.6 2.5 1.3 0.2 1.5 2.3 0.7 0.7 1.9 0.6 1.1 448.6 0.4 1.2 1.1 2.3 0.5 0.7 0.4 0.8 0.0 0.2 1.1 0.3 0.1 0.2 0.1 0.1 0.2 0.4 0.2 0.1 0.3 0.3 0.3 0.3 0.2 1.1 1.0 0.5 0.8 0.2 0.1 0.8 1.8 0.3 0.3 0.6 0.0 0.2 0.1 1.5 0.9 38.5 0.3 0.9 0.5 0.8 0.4 0.1 0.3 1.4 0.0 5.0 0.2 0.9 1.4 0.2 0.3 0.7 0.0 0.2 1.1 0.0 0.3 0.5 0.6 0.7 0.1 1.7 0.7 0.3 0.4 1.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 2.1 2.2 2.1 1.5 1.4 2.5 1.6 1.8 1.5 1.9 2.3 1.1 0.0 1.1 2.0 0.5 0.8 0.5 0.4 0.6 2.6 0.8 2.3 5.0 0.0 1.5 0.0 2.1 0.4 2.1 0.9 0.0 0.3 3.3 1.3 1.9 0.8 0.0 0.4 2.8 1.1 0.2 1.3 0.5 0.7 1.3 1.1 1.4 1.2 0.2 1.7 2.7 1.0 0.0 0.6 0.3 1.8 1.5 0.6 0.0 1.0 0.2 1.1 1.0 0.5 2.9 0.1 0.3 3.0 0.4 0.3 0.6 0.2 7.4 5.2 0.0 6.1 1.6 1.3 0.4 0.4 1.3 0.3 1.1 0.7 0.9 0.2 ASB16 FLJ30165 ENSG00000161664 "Ankyrin repeat and SOCS box containing 16" Q96NS5 17 44170447-44179084 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 67.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.4;Horizontal cells: 1.7;Inhibitory neurons: 1.6;NK-cells: 2.1;Oligodendrocyte precursor cells: 1.5;Rod photoreceptor cells: 2.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 9.8" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066834 Approved Approved "Focal adhesion sites" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 37: Myocytes - Muscle contraction" "Focal adhesion sites" "HPA066834: AB_2685732" "unprognostic (2.72e-2)" "unprognostic (8.47e-3)" "unprognostic (4.24e-2)" "unprognostic (1.46e-1)" "unprognostic (1.12e-1)" "unprognostic (5.95e-2)" "unprognostic (2.45e-2)" "unprognostic (2.31e-3)" "unprognostic (1.03e-2)" "unprognostic (6.13e-2)" "unprognostic (7.23e-4)" "unprognostic (5.84e-2)" "unprognostic (3.97e-2)" "unprognostic (8.53e-3)" "unprognostic (7.33e-2)" "unprognostic (2.20e-1)" "unprognostic (1.07e-3)" 0.8 1.0 0.8 2.3 0.9 2.2 0.6 9.8 1.2 1.1 0.0 1.5 2.1 1.9 0.0 1.0 1.4 1.1 4.6 0.5 0.3 1.1 0.6 1.1 3.3 1.5 1.8 1.7 3.6 1.6 1.9 0.6 1.6 1.6 0.0 2.3 2.0 0.2 67.7 3.2 2.1 0.6 0.1 3.1 2.0 1.0 1.1 0.0 1.2 13.1 0.0 1.2 0.8 1.6 2.1 3.9 4.6 4.2 0.0 0.0 3.7 4.2 0.0 0.0 0.0 3.0 2.3 3.2 2.5 0.0 1.0 4.9 0.0 0.0 0.0 5.0 6.8 2.0 8.0 3.4 0.0 2.1 6.2 0.0 0.0 0.0 0.0 1.2 0.0 4.7 3.7 7.6 0.0 3.5 2.6 4.0 1.3 0.7 4.5 8.0 4.4 4.8 0.0 3.1 4.6 2.6 2.0 0.6 0.7 1.3 6.0 2.0 2.1 5.7 5.1 3.5 2.7 11.8 6.2 2.9 1.3 3.0 3.8 2.3 1.3 5.8 1.7 1.2 2.0 2.5 1.8 1.6 0.7 1.9 2.3 1.5 4.1 2.6 1.1 1.6 1.9 1.6 0.8 0.9 9.8 1.2 0.5 0.3 1.5 1.8 1.6 0.1 1.1 1.6 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 1.4 0.2 0.1 0.1 0.0 0.2 0.0 0.2 0.7 0.0 0.1 1.7 1.6 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 1.0 0.0 0.7 2.1 1.5 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.6 0.2 0.3 0.4 0.3 0.0 0.0 0.2 0.3 0.1 0.1 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 217.2;tongue: 67.0" "Cell type enhanced" "Detected in some" "Early spermatids: 52.7;Late spermatids: 293.6;Skeletal myocytes: 79.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.5;prostate cancer: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 1184.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 31: Spermatids - Spermatogenesis" "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 0.1 0.0 0.4 0.9 0.5 0.0 0.0 1.3 1.0 1.0 0.2 11.1 0.3 0.6 0.1 10.5 0.1 1.2 3.9 0.5 0.4 0.7 0.0 0.2 0.0 0.9 1.5 0.0 0.0 0.1 0.4 0.0 0.8 12.9 3.3 0.0 23.9 0.3 217.2 0.2 1.2 2.5 0.8 0.0 4.7 7.3 0.5 0.1 0.0 67.0 0.0 19.2 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 29.1 0.0 25.9 54.7 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 61.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1184.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.3 1.0 0.5 0.4 0.9 1.5 0.8 0.8 0.5 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.7 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 293.6 1.2 0.3 0.0 0.0 0.0 0.0 0.0 11.6 0.8 0.0 0.0 1.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 79.6 0.6 0.9 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 ATP1B4 ENSG00000101892 "ATPase Na+/K+ transporting family member beta 4" Q9UN42 X 120362085-120383249 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "skeletal muscle: 55.7;tongue: 21.6" "Group enriched" "Detected in some" 32 "Cardiomyocytes: 1.7;Skeletal myocytes: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (2.59e-2)" "unprognostic (6.02e-4)" "unprognostic (5.78e-1)" "unprognostic (5.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 55.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ATP2A1 "ATP2A, SERCA1" ENSG00000196296 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1" O14983 16 28878405-28904466 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Translocase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 85 "skeletal muscle: 8241.7;tongue: 3199.6" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 65.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 30.0" "Region enriched" "Detected in some" 8 "thalamus: 13.1" "Group enriched" "Detected in some" 6 "basal ganglia: 1.3;cerebral cortex: 1.4;hippocampal formation: 1.2" "CAB002310, CAB032706" Enhanced Approved "Endoplasmic reticulum" NA NA 2800000 "Cluster 15: NK-cells - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 37: Myocytes - Muscle contraction" "Endoplasmic reticulum" "CAB002310: AB_564139, CAB032706: AB_2061286" "unprognostic (2.37e-1)" "unprognostic (6.81e-2)" "unprognostic (2.23e-5)" "unprognostic (5.35e-2)" "unprognostic (2.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.87e-1)" "unprognostic (5.22e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-4)" "unprognostic (1.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-2)" 1.5 1.1 0.7 1.6 0.8 1.9 1.8 0.9 2.6 1.0 0.1 1.4 1.6 1.5 0.4 27.7 1.4 0.5 1.2 0.6 0.8 1.3 3.1 1.2 2.9 1.1 0.7 1.6 1.0 0.5 3.2 0.7 1.5 9.5 0.4 7.9 67.2 3.5 8241.7 2.4 2.2 0.4 0.7 1.5 1.1 10.7 1.1 1.5 2.2 3199.6 0.4 1.2 1.2 1.4 7.7 8.0 14.4 8.7 0.7 2.3 13.3 3.5 2.0 0.6 0.6 4.5 6.7 11.9 4.1 0.6 4.8 7.9 3.6 0.2 1.0 5.9 30.0 4.2 19.0 14.4 0.3 1.8 3.8 5.9 1.6 0.9 0.7 7.3 0.4 21.8 8.2 9.8 0.4 15.2 17.3 9.5 14.4 2.8 11.2 26.4 10.2 9.1 0.1 0.9 9.2 7.3 5.0 6.8 5.2 5.2 5.1 4.2 3.1 4.5 9.4 8.5 4.5 14.2 9.5 12.0 8.7 23.4 4.4 0.0 0.0 0.2 0.3 0.0 0.4 0.5 0.3 0.3 0.0 0.2 0.4 0.4 0.0 1.6 0.0 1.0 0.5 0.2 0.7 0.8 0.9 2.6 0.6 0.8 1.1 0.7 1.5 0.7 1.1 1.4 0.3 0.0 0.0 0.7 0.2 0.1 0.0 0.3 0.6 2.1 0.5 0.5 0.5 0.0 0.2 0.0 14.6 0.4 0.0 0.6 0.0 0.1 1.3 0.4 0.4 0.3 0.0 0.0 2.3 0.2 0.2 0.5 1.5 0.7 0.0 0.7 0.0 0.6 0.1 0.0 2.3 0.3 0.0 0.6 0.0 3.9 0.3 0.3 0.0 1.0 0.0 0.3 0.0 0.5 2.3 0.2 1.2 0.0 0.1 0.2 0.7 0.1 0.4 4.7 0.0 65.2 0.6 5.7 3.4 0.3 0.1 0.7 0.4 0.7 0.6 0.1 C10orf71 FLJ45913 ENSG00000177354 "Chromosome 10 open reading frame 71" Q711Q0 10 49299170-49327492 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 280.2;tongue: 81.9" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 56.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "K-562: 6.9;RH-30: 9.9" "Not detected" "Not detected" HPA057556 Approved Nucleoplasm,Mitochondria NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Mitochondria "HPA057556: AB_2683467" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (4.16e-2)" "unprognostic (5.58e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 44.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.3 21.9 0.0 0.0 0.1 1.3 0.0 0.0 1.2 0.0 280.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 C1orf127 FLJ37118 ENSG00000175262 "Chromosome 1 open reading frame 127" 1 10946471-10982037 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 4.4;skeletal muscle: 16.5" "Cell type enriched" "Detected in some" 9 "Enteroendocrine cells: 20.4" "Cancer enriched" "Detected in single" 9 "pancreatic cancer: 2.8" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.3" "Lineage enhanced" "Detected in single" "dendritic cells: 1.3" "Cell line enriched" "Detected in single" 4 "THP-1: 2.6" "Not detected" "Not detected" HPA027654 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 43: THP-1 - Innate immune response" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nuclear speckles, Cytosol" "HPA027654: AB_10611814" "unprognostic (1.82e-2)" "unprognostic (8.57e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-2)" "unprognostic (9.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-2)" "unprognostic (8.47e-2)" "unprognostic (1.59e-2)" "unprognostic (3.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.04e-1)" "unprognostic (4.03e-1)" 0.2 0.6 0.3 0.1 0.3 0.1 0.1 1.2 0.7 0.1 0.2 0.3 0.7 0.0 0.1 0.6 0.0 0.3 0.6 0.2 0.3 0.0 0.2 0.4 0.6 0.2 0.5 0.0 4.4 0.1 0.2 0.2 0.3 0.1 0.6 0.0 0.2 0.0 16.5 0.0 0.3 0.0 0.2 0.6 1.9 0.5 0.7 0.1 0.2 3.7 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 1.2 0.7 0.2 0.3 0.2 0.5 0.3 0.2 0.7 0.3 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.8 0.0 0.8 0.6 0.1 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4orf54 "FOPV, LOC285556" ENSG00000248713 "Chromosome 4 open reading frame 54" D6RIA3 4 99636529-99654648 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 72.7" "Cell type enriched" "Detected in single" 17 "Endometrial ciliated cells: 14.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 1.6;SK-BR-3: 1.1" "Low region specificity" "Detected in single" HPA079091 Approved "Nuclear bodies,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear bodies" Cytosol "HPA079091: " "unprognostic (3.91e-2)" "unprognostic (3.76e-1)" "unprognostic (4.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.76e-2)" "unprognostic (4.00e-3)" "unprognostic (2.31e-3)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (2.20e-1)" "unprognostic (2.42e-3)" "unprognostic (1.89e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 6.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 72.7 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.7 0.0 14.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CA3 "CAIII, Car3" ENSG00000164879 "Carbonic anhydrase 3" P07451 8 85373436-85449040 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 5273.7" "Group enriched" "Detected in many" 8 "Erythroid cells: 221.3;Skeletal myocytes: 304.0" "Group enriched" "Detected in many" 7 "glioma: 23.1;prostate cancer: 9.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 47.3;RH-30: 78.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004967, HPA021775, HPA026700" Enhanced NA NA 53000000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991" "prognostic favorable (4.24e-6)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (2.22e-3)" "unprognostic (4.71e-2)" "unprognostic (8.43e-3)" "unprognostic (3.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.11e-1)" "unprognostic (3.68e-1)" "unprognostic (4.71e-2)" "unprognostic (3.54e-1)" "unprognostic (3.19e-2)" "unprognostic (1.18e-1)" "unprognostic (9.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.19e-1)" 43.4 3.8 2.4 0.3 2.3 9.9 6.4 2.7 3.7 5.1 1.4 1.7 1.8 8.3 2.1 64.8 9.8 2.2 19.5 2.3 2.8 3.7 2.4 24.6 0.4 2.9 2.3 1.4 1.3 1.0 3.8 0.3 2.0 89.5 1.1 5.5 15.4 2.7 5273.7 5.2 4.4 19.1 2.5 0.8 4.1 2.9 2.5 1.4 3.0 1018.8 0.6 1.5 5.5 2.8 2.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.1 0.0 0.1 0.2 0.3 0.3 0.0 0.5 0.2 47.3 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 78.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 2.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 2.4 2.3 2.7 3.7 2.3 2.8 2.9 2.3 2.0 2.5 2.5 2.8 0.3 3.2 4.2 2.3 0.1 0.5 1.7 0.6 1.2 0.0 14.5 0.6 1.0 5.7 0.6 0.0 6.2 1.1 0.4 0.4 0.0 0.6 24.1 0.4 0.2 2.2 0.0 221.3 2.2 0.2 0.2 9.1 0.0 0.7 0.0 0.2 2.5 0.3 0.4 0.0 2.5 0.4 0.0 0.3 0.4 7.0 0.3 2.5 0.0 0.0 0.0 29.6 0.0 1.5 0.7 0.2 1.7 0.0 0.0 0.5 8.5 0.6 1.0 1.6 0.0 304.0 5.1 0.6 1.3 0.2 1.0 1.6 1.4 0.3 0.9 0.3 CACNG1 CACNLG ENSG00000108878 "Calcium voltage-gated channel auxiliary subunit gamma 1" Q06432 17 67044554-67056797 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 55 "skeletal muscle: 327.7;tongue: 121.8" "Cell type enriched" "Detected in single" 27 "Skeletal myocytes: 8.1" "Cancer enhanced" "Detected in some" "breast cancer: 1.6;head and neck cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 2.9" "Region enriched" "Detected in single" 6 "basal ganglia: 3.4" "Not detected" "Not detected" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (1.76e-1)" "unprognostic (9.83e-3)" "unprognostic (1.75e-5)" "unprognostic (2.60e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.84e-3)" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.94e-1)" 0.0 1.6 0.6 0.0 0.7 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 3.3 0.0 327.7 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.6 0.0 121.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.1 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53991637-54012666 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skeletal muscle: 90.7;tongue: 29.9" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 8.3;Horizontal cells: 1.7;Respiratory ciliated cells: 9.1;Skeletal myocytes: 2.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 107 "basophil: 13.3;eosinophil: 8.0" "Lineage enriched" "Detected in single" 133 "granulocytes: 13.3" "Cell line enhanced" "Detected in some" "A549: 12.7;EFO-21: 23.6;HHSteC: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center" Cytosol "HPA056615: AB_2683192" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.1 0.9 0.3 0.2 0.1 0.2 0.2 0.0 0.3 8.8 0.0 0.0 0.6 0.6 0.0 0.0 2.2 0.0 1.0 2.0 0.0 0.0 2.9 1.9 0.0 0.8 0.4 0.0 0.1 1.0 0.0 90.7 0.0 0.2 0.0 1.0 0.1 0.3 2.3 0.4 0.0 0.0 29.9 0.1 0.0 0.0 0.5 0.0 12.7 0.2 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 23.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.6 0.0 0.1 0.1 0.0 0.0 0.0 1.9 3.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.1 1.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.2 0.0 2.8 0.0 0.0 0.0 3.5 0.1 0.2 0.0 0.0 13.3 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.9 0.6 0.6 1.0 2.0 0.8 1.0 0.4 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.1 0.0 0.0 2.3 0.1 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CASQ1 "CASQ, PDIB1" ENSG00000143318 "Calsequestrin 1" P31415 1 160190575-160201886 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 64 "skeletal muscle: 4442.6;tongue: 1892.7" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 17.6;Rod photoreceptor cells: 25.2;Skeletal myocytes: 20.6" "Cancer enhanced" "Detected in many" "glioma: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 19.3;HDLM-2: 38.5;RT4: 67.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007845, CAB015170, HPA026823" Enhanced Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA 270000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Mitochondria" "CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557" "unprognostic (1.87e-2)" "unprognostic (3.97e-3)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (6.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.65e-3)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (2.87e-2)" "unprognostic (3.01e-2)" "unprognostic (3.21e-3)" "unprognostic (9.04e-4)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "prognostic favorable (8.93e-5)" 0.9 0.4 5.1 0.8 6.0 1.5 1.4 4.9 10.0 0.5 3.3 3.3 0.5 1.7 0.3 43.1 1.9 1.2 44.9 6.5 3.1 0.3 0.4 0.7 3.0 3.7 3.9 0.4 0.3 0.2 1.0 6.2 3.2 16.2 0.5 49.7 16.7 5.0 4442.6 1.0 1.9 7.4 3.1 1.3 0.8 5.7 3.6 0.5 0.6 1892.7 1.0 5.7 0.9 6.2 0.0 0.0 0.5 0.0 0.2 0.0 19.3 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 38.5 0.4 0.1 0.0 0.0 0.1 0.6 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.7 0.4 0.1 0.0 0.2 0.3 0.2 0.0 67.4 0.0 0.1 0.3 0.2 0.0 3.5 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.7 0.8 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.1 6.0 4.9 10.0 6.5 3.1 3.7 3.9 3.2 3.1 3.6 6.2 0.1 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 1.9 0.7 0.9 17.6 0.0 0.0 0.0 2.1 3.0 0.1 0.0 0.0 0.1 3.0 0.1 0.1 0.2 0.0 0.0 2.0 0.0 4.9 0.3 0.0 0.1 3.8 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.3 0.6 0.6 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 25.2 0.0 20.6 0.6 1.2 1.9 0.0 0.0 4.5 0.1 0.1 0.0 0.3 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234200-26278808 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.9;tongue: 65.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 29.0;Oligodendrocytes: 28.8;Spermatocytes: 40.9;Spermatogonia: 34.2;Syncytiotrophoblasts: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.8 3.5 3.9 5.3 8.3 20.8 3.8 5.6 6.7 4.1 3.7 5.4 3.4 3.2 3.2 8.6 2.7 2.7 25.5 4.3 5.9 6.0 5.8 4.7 6.9 7.1 6.8 3.3 5.0 8.8 6.1 3.2 8.9 2.9 6.0 14.1 5.3 2.4 132.9 9.8 5.2 3.7 3.7 6.3 4.7 31.1 7.1 13.6 7.8 65.9 7.8 3.2 6.2 14.3 29.6 12.5 30.2 22.6 7.3 8.9 52.5 18.8 11.5 31.9 28.5 17.4 28.2 34.3 20.1 9.2 14.6 25.5 41.0 14.4 29.9 23.5 20.9 49.7 31.9 19.4 6.6 46.2 43.8 3.8 13.7 24.9 16.4 12.8 14.5 47.7 57.4 39.9 19.2 9.8 38.7 35.2 23.0 17.4 20.8 39.8 31.3 29.7 10.4 5.5 41.4 16.7 24.5 19.8 15.7 21.5 14.5 26.4 14.3 17.1 26.7 19.3 24.7 30.0 48.4 38.9 9.8 65.2 27.5 5.0 6.4 19.2 3.5 6.1 2.8 2.6 2.6 2.7 4.9 1.8 2.2 3.5 0.6 2.3 7.4 2.1 3.6 3.6 3.9 8.3 5.6 6.7 4.3 5.9 7.1 6.8 8.9 3.7 7.1 14.3 1.0 0.0 2.2 3.6 2.7 6.9 4.0 2.5 6.2 11.2 3.7 2.9 29.0 1.5 3.7 5.5 12.5 3.4 5.1 6.9 7.9 1.7 1.0 3.4 2.3 2.0 1.8 16.8 12.8 1.3 3.9 2.3 3.6 4.9 2.5 9.1 1.4 3.1 4.8 0.0 9.9 3.7 2.0 5.0 3.7 2.9 1.5 4.3 1.8 4.7 4.0 1.8 2.1 3.0 28.8 2.7 3.4 0.4 4.4 2.5 2.3 1.1 2.0 11.1 0.0 2.4 2.3 40.9 34.2 8.6 6.1 41.7 3.4 2.3 4.5 4.5 CHMP1B "C18orf2, CHMP1.5, Vps46B" ENSG00000255112 "Charged multivesicular body protein 1B" Q7LBR1 18 11851413-11854444 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 361.4" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 514.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061997, HPA062896" Supported Approved Nucleoplasm,Midbody Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" Midbody Nucleoplasm "HPA061997: AB_2684653, HPA062896: AB_2684898" "unprognostic (6.73e-2)" "unprognostic (5.35e-2)" "unprognostic (1.09e-2)" "unprognostic (6.74e-3)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" "unprognostic (1.44e-1)" "unprognostic (8.44e-3)" "unprognostic (1.90e-1)" "unprognostic (9.44e-3)" "unprognostic (2.37e-3)" "unprognostic (9.20e-2)" "prognostic favorable (7.37e-8)" "unprognostic (1.88e-2)" "unprognostic (1.59e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-1)" 43.3 35.7 24.5 36.2 25.9 61.2 29.0 19.6 25.4 25.6 30.0 39.1 38.7 28.3 26.2 39.1 24.8 39.3 40.7 25.9 25.6 33.1 31.1 29.7 29.9 21.9 23.2 29.6 24.8 39.9 29.3 27.8 22.6 27.8 37.5 17.6 29.5 35.0 361.4 40.4 48.8 23.6 20.3 30.2 30.5 14.0 24.0 46.0 52.2 53.2 24.8 49.5 23.8 23.6 30.0 28.8 36.5 31.1 46.9 32.7 52.9 31.4 52.6 21.0 27.9 37.5 29.4 18.5 45.9 34.2 35.0 25.0 16.8 43.7 18.5 17.2 20.8 13.5 43.6 31.1 34.6 51.7 22.3 47.7 92.5 23.5 53.9 46.8 30.7 41.6 23.1 23.4 33.3 37.3 36.1 39.6 15.3 94.9 14.3 18.4 18.8 32.1 56.5 40.5 35.5 35.5 53.1 24.7 50.5 33.9 20.2 47.2 45.2 46.7 24.5 37.3 34.0 27.8 34.3 23.5 43.3 23.8 22.7 32.5 38.8 66.7 15.4 35.7 14.3 14.7 14.3 18.5 30.2 14.7 17.6 16.4 77.9 18.3 36.6 26.7 21.5 29.2 24.5 25.9 19.6 25.4 25.9 25.6 21.9 23.2 22.6 20.3 24.0 23.6 71.2 67.3 47.0 0.0 152.9 419.6 141.8 291.8 216.9 30.5 71.3 59.4 21.7 52.9 157.7 132.4 8.4 135.9 171.0 281.4 60.7 123.0 80.4 146.6 110.2 69.9 143.8 40.4 0.0 80.3 144.4 99.3 70.8 298.3 149.9 38.4 52.8 44.1 118.0 28.6 0.0 104.6 111.9 139.9 440.8 42.6 37.9 354.5 158.3 0.0 102.1 32.2 78.2 0.0 0.0 134.0 393.7 37.2 21.8 93.9 179.2 139.1 84.8 16.8 78.9 61.2 94.5 16.0 21.1 177.1 514.7 253.2 135.5 43.9 96.8 252.2 CHRNA1 CHRNA ENSG00000138435 "Cholinergic receptor nicotinic alpha 1 subunit" P02708 2 174747592-174787935 "Disease related genes, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 170.1" "Cell type enriched" "Detected in some" 48 "Skeletal myocytes: 193.5" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Group enriched" "Detected in some" 13 "cerebral cortex: 12.8;hippocampal formation: 5.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "LHCN-M2: 445.4;RH-30: 360.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071554 Enhanced Supported "Plasma membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "HPA071554: AB_2686416" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.22e-3)" "unprognostic (2.28e-2)" "unprognostic (2.96e-1)" "unprognostic (8.55e-3)" "unprognostic (5.34e-2)" "unprognostic (5.29e-3)" "unprognostic (9.59e-2)" "unprognostic (9.64e-2)" "unprognostic (9.66e-2)" "unprognostic (6.37e-2)" "unprognostic (4.18e-4)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-2)" 0.2 0.0 0.2 0.2 0.4 0.0 0.5 0.1 12.8 0.6 0.2 1.5 0.2 0.0 0.2 0.6 0.0 0.0 0.3 5.5 0.2 0.0 0.2 0.6 0.8 0.5 0.2 0.0 0.0 0.0 3.3 0.2 0.5 2.0 0.9 0.0 3.2 0.0 170.1 0.5 0.0 0.0 0.3 0.0 0.0 0.4 0.3 1.1 0.0 20.4 1.2 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 21.5 0.0 0.2 0.0 0.0 1.4 0.0 0.1 0.2 445.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 360.2 0.0 0.0 0.3 2.9 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.1 12.8 5.5 0.2 0.5 0.2 0.5 0.3 0.3 0.7 0.1 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 4.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.5 0.0 0.6 0.4 1.7 0.3 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 193.5 0.3 0.1 0.2 0.0 0.0 0.0 1.8 0.0 0.2 0.0 CHRNA10 ENSG00000129749 "Cholinergic receptor nicotinic alpha 10 subunit" Q9GZZ6 11 3665587-3671384 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "skeletal muscle: 47.8" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 4.4;Ionocytes: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Region enriched" "Detected in some" 6 "olfactory bulb: 7.2" "Not detected" "Not detected" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (4.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.50e-1)" "unprognostic (3.79e-2)" "unprognostic (2.74e-1)" "unprognostic (6.90e-5)" "unprognostic (4.35e-2)" "unprognostic (1.06e-5)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (2.32e-1)" "unprognostic (4.39e-3)" 0.8 0.7 1.1 0.5 0.9 0.3 0.4 1.3 1.4 0.9 1.1 0.8 0.5 0.6 0.3 0.7 0.8 0.1 1.1 1.0 1.0 2.1 1.5 0.8 0.4 1.0 0.9 0.8 0.7 0.1 1.4 0.2 1.0 1.5 0.1 0.7 0.8 0.1 47.8 0.5 0.9 0.1 0.7 1.9 0.8 1.1 0.9 0.4 1.1 0.1 0.2 0.6 0.4 0.8 0.5 0.5 0.7 1.0 0.3 0.1 0.5 0.6 0.1 0.4 0.4 0.4 0.9 0.9 0.3 0.3 0.3 1.1 0.5 0.3 0.3 0.6 1.8 0.2 1.7 0.1 0.4 0.2 0.9 0.3 0.3 0.3 0.1 0.2 0.2 1.1 0.7 0.2 0.3 0.1 0.5 1.5 1.0 0.9 0.7 1.0 0.3 0.1 0.3 0.7 0.6 0.3 0.3 0.3 0.5 0.6 0.2 1.1 0.2 0.6 0.8 0.4 0.7 0.2 0.6 0.5 0.3 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.1 0.9 1.3 1.4 1.0 1.0 1.0 0.9 1.0 0.7 0.9 0.8 1.5 0.0 0.5 1.3 0.5 1.8 0.6 0.5 0.0 1.6 2.2 3.6 1.3 0.0 0.4 0.0 0.0 0.4 0.4 0.9 0.0 0.2 1.4 2.1 0.9 0.9 0.0 0.0 1.3 0.4 0.3 0.4 2.0 4.4 0.0 0.8 1.1 1.2 0.6 1.7 1.3 0.9 4.1 0.6 0.7 0.8 0.3 1.1 1.8 2.8 0.6 1.2 0.0 1.0 0.6 0.4 0.2 0.4 0.4 0.8 0.6 0.0 2.1 0.8 0.0 3.1 0.9 0.4 0.5 0.1 1.1 0.3 0.6 0.7 0.8 0.7 CHRNB1 CHRNB ENSG00000170175 "Cholinergic receptor nicotinic beta 1 subunit" P11230 17 7445061-7457710 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 158.4;tongue: 57.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 39.0;Skeletal myocytes: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 34.6;RH-30: 71.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA005822, CAB011200" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 47: Cytotrophoblasts - Unknown function" "CAB011200: AB_262151, HPA005822: AB_1079484" "unprognostic (2.89e-2)" "unprognostic (3.43e-1)" "unprognostic (1.08e-1)" "unprognostic (2.67e-2)" "unprognostic (4.19e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "unprognostic (3.56e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" "unprognostic (2.49e-1)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" 7.0 30.6 6.9 2.4 7.8 9.1 6.7 7.3 7.5 7.5 8.8 6.3 2.9 6.6 5.1 7.0 5.4 1.9 11.5 6.9 6.9 10.7 16.5 5.1 3.6 7.5 7.0 5.4 16.5 9.1 6.7 6.7 7.3 5.1 2.5 3.2 10.7 3.0 158.4 8.1 5.5 3.2 7.3 7.9 5.2 3.2 7.1 6.5 13.0 57.7 3.9 5.5 7.2 8.1 1.6 2.2 3.8 4.5 6.0 4.0 8.6 1.1 3.8 5.6 4.6 1.3 2.0 6.2 4.0 2.5 2.0 13.6 1.4 25.1 2.0 7.6 4.8 3.5 2.3 8.1 2.6 2.2 8.6 8.8 6.8 3.4 11.0 9.3 3.8 12.0 4.6 3.4 34.6 1.0 6.7 4.1 2.7 1.5 1.1 4.4 71.0 15.8 15.3 1.2 0.6 11.1 2.4 4.0 4.7 5.9 3.9 3.0 3.6 2.3 6.4 1.7 5.0 8.1 9.6 1.7 2.1 4.9 2.1 9.9 5.4 13.6 7.9 6.3 6.1 6.7 8.7 8.0 7.0 7.0 7.0 9.2 1.7 11.0 10.4 5.2 7.9 6.1 6.9 7.8 7.3 7.5 6.9 6.9 7.5 7.0 7.3 7.3 7.1 8.1 8.8 0.0 4.8 4.6 8.9 6.4 3.8 12.6 6.2 3.9 9.3 11.2 9.8 4.3 7.2 9.2 2.1 39.0 17.7 5.2 23.5 16.1 2.2 5.1 7.1 10.1 2.4 3.4 1.4 13.4 9.4 8.1 3.6 7.1 13.3 5.8 10.4 10.8 12.6 15.2 1.5 4.8 14.2 7.2 8.7 2.1 21.8 7.9 12.4 1.0 17.0 14.0 29.9 1.0 5.6 17.3 4.9 17.0 5.8 4.1 10.2 15.5 9.5 7.1 0.0 47.3 8.1 2.8 2.8 6.1 6.5 30.4 11.2 12.1 5.9 3.8 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 57.6" "Group enriched" "Detected in some" 10 "Muller glia cells: 4.0;Skeletal myocytes: 4.4" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 49 "RH-30: 99.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: AB_2732603, HPA065404: AB_2732734" "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 6.3 0.7 0.0 57.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 99.4 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CHRNG ACHRG ENSG00000196811 "Cholinergic receptor nicotinic gamma subunit" P07510 2 232539692-232548115 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "skeletal muscle: 32.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "HSkMC: 2.7;RH-30: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (2.26e-1)" "unprognostic (8.97e-2)" "unprognostic (5.61e-2)" "unprognostic (1.92e-2)" "unprognostic (4.38e-1)" "unprognostic (4.86e-3)" "unprognostic (2.32e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (4.18e-2)" "unprognostic (4.32e-1)" "unprognostic (4.19e-6)" "unprognostic (6.13e-2)" "unprognostic (8.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.24e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.1 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CKM CKMM ENSG00000104879 "Creatine kinase, M-type" P06732 19 45306413-45322875 "Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "skeletal muscle: 73556.4;tongue: 26058.9" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 5353.0" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 64.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 68.8" "Region enriched" "Detected in single" 15 "olfactory bulb: 1.5" "Low region specificity" "Detected in many" HPA047859 Enhanced NA NA 170000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA047859: AB_2680186" "unprognostic (3.51e-1)" "unprognostic (7.63e-2)" "unprognostic (2.61e-2)" "unprognostic (4.14e-1)" "unprognostic (7.68e-3)" "unprognostic (4.04e-3)" "unprognostic (1.85e-2)" "unprognostic (4.23e-2)" "unprognostic (5.19e-2)" "unprognostic (1.81e-1)" "unprognostic (5.00e-1)" "unprognostic (9.46e-3)" "unprognostic (9.67e-8)" "unprognostic (3.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.33e-1)" "unprognostic (1.95e-1)" 8.5 2.7 0.1 0.0 0.3 0.7 12.4 0.2 0.3 0.9 0.0 6.6 0.1 1.8 0.0 512.5 0.4 0.2 4618.8 0.0 0.0 2.1 5.2 8.7 0.4 0.1 0.0 2.8 5.3 0.0 2.1 0.3 0.2 134.8 0.1 0.2 340.9 2.1 73556.4 23.4 4.3 2.4 0.0 2.5 23.5 9.9 0.0 2.5 8.5 26058.9 0.4 1.5 3.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 5.8 0.0 0.3 16.3 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.0 0.0 0.0 0.0 6.3 0.2 0.2 0.0 0.0 68.8 0.0 0.0 0.1 0.1 0.0 0.1 16.3 0.1 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 5353.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 11.7 0.1 15.3 0.8 0.9 51.2 0.0 0.0 0.4 0.0 0.7 141.8 0.0 0.1 1.3 0.4 0.4 0.0 6.6 0.0 0.5 0.0 0.0 0.9 0.3 53.2 1.5 3.2 0.0 0.0 0.9 0.0 0.0 0.5 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.8 0.0 0.0 639.9 47.3 16.5 1.6 0.0 0.1 0.3 2.6 3.6 0.0 0.1 CLCN1 "ClC-1, CLC1" ENSG00000188037 "Chloride voltage-gated channel 1" P35523 7 143316111-143352083 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 65.9" "Cell type enriched" "Detected in some" 4 "Late spermatids: 149.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "HSkMC: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (5.16e-2)" "unprognostic (4.99e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" "unprognostic (9.53e-2)" "unprognostic (8.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.56e-4)" "unprognostic (8.71e-3)" "unprognostic (2.35e-1)" "unprognostic (2.90e-3)" "unprognostic (3.12e-1)" "unprognostic (2.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.47e-1)" "unprognostic (3.55e-3)" "unprognostic (3.57e-2)" 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 65.9 0.0 1.0 0.0 0.0 0.1 0.2 1.0 0.0 0.2 0.0 15.9 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.1 0.8 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 32.9 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.8 149.6 0.0 0.7 0.0 1.0 0.6 0.0 0.0 0.0 0.7 5.7 15.0 0.0 0.0 0.2 0.4 0.1 0.3 0.0 0.0 1.4 0.3 0.1 2.2 0.7 0.1 0.0 0.1 0.1 0.2 2.1 CLTCL1 "CHC22, CLH22, CLTCL, CLTD" ENSG00000070371 "Clathrin heavy chain like 1" P53675 22 19179473-19291719 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 187.4;testis: 47.2;tongue: 61.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 11.3;Cone photoreceptor cells: 14.6;Early spermatids: 19.3;Late spermatids: 17.0;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.5;Spermatocytes: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 2.1;neutrophil: 5.2" "Group enriched" "Detected in many" 20 "granulocytes: 5.2;monocytes: 2.1" "Cell line enhanced" "Detected in many" "HMC-1: 64.8;K-562: 31.8" "HPA075327, HPA075795" Enhanced Approved Vesicles NA NA 2300000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA075327: , HPA075795: AB_2686764" "unprognostic (1.29e-2)" "unprognostic (3.13e-2)" "unprognostic (1.93e-2)" "unprognostic (3.16e-3)" "unprognostic (8.20e-2)" "unprognostic (6.93e-3)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (4.42e-2)" "unprognostic (2.93e-3)" "unprognostic (3.14e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" "unprognostic (8.71e-4)" "unprognostic (1.61e-1)" "unprognostic (2.10e-2)" "unprognostic (1.06e-1)" 6.8 16.0 5.4 0.8 6.1 15.6 4.8 6.2 6.5 5.0 5.0 2.4 0.5 3.1 1.6 3.6 3.8 1.2 14.8 5.2 7.8 3.2 6.5 3.0 0.7 7.4 8.6 3.6 2.5 2.1 13.4 1.5 8.5 5.2 1.0 2.0 3.9 0.8 187.4 4.1 1.8 1.7 5.7 3.5 2.8 47.2 9.1 3.9 8.0 61.3 0.5 2.8 3.7 6.9 4.5 4.6 3.0 4.9 10.8 5.9 1.4 3.1 3.3 4.2 6.3 1.7 1.4 1.9 0.4 7.0 3.3 1.5 4.7 8.5 3.5 0.3 4.6 0.2 4.4 5.3 5.5 6.5 64.8 25.0 7.0 7.8 10.9 12.5 2.7 2.4 31.8 1.7 10.0 3.6 0.6 22.4 3.8 18.1 2.8 2.4 24.2 0.1 3.4 1.8 6.9 1.2 6.6 4.1 0.4 3.6 8.9 27.1 0.8 7.6 15.5 4.2 5.2 3.1 8.4 0.8 4.5 17.4 1.6 0.0 2.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.4 5.4 6.1 6.2 6.5 5.2 7.8 7.4 8.6 8.5 5.7 9.1 6.9 1.4 3.2 0.5 9.4 0.1 0.6 0.5 1.0 1.2 2.4 0.7 0.3 11.3 1.5 1.8 0.0 14.6 0.4 0.2 1.2 0.0 0.8 19.3 1.2 1.9 0.9 0.0 0.8 4.5 0.0 0.2 1.4 1.5 1.4 0.0 3.5 1.1 2.4 0.3 0.0 8.9 1.3 6.1 1.0 0.7 17.0 2.5 0.5 0.0 4.7 1.3 1.5 0.0 12.5 12.5 1.2 0.8 4.1 0.1 1.3 0.2 1.3 1.0 2.0 0.0 2.6 4.5 14.5 4.7 1.0 0.9 1.1 0.1 6.2 0.9 0.0 COQ8A "ADCK3, CABC1, COQ8, SCAR9" ENSG00000163050 "Coenzyme Q8A" Q8NI60 1 226940286-226987544 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Kinase, Transferase" "Disease variant, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skeletal muscle: 1165.1;tongue: 484.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 21.9;Collecting duct cells: 33.1;Ductal cells: 21.2;Exocrine glandular cells: 32.7;Proximal tubular cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 82.0;RPMI-8226: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061662 Supported Mitochondria NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA061662: AB_2684578" "unprognostic (6.37e-3)" "unprognostic (2.09e-2)" "unprognostic (2.29e-1)" "unprognostic (9.06e-2)" "unprognostic (8.94e-2)" "unprognostic (2.49e-1)" "unprognostic (4.42e-2)" "unprognostic (3.50e-3)" "unprognostic (1.81e-1)" "unprognostic (4.02e-1)" "unprognostic (4.15e-3)" "unprognostic (8.67e-2)" "unprognostic (2.40e-2)" "unprognostic (9.24e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (2.62e-1)" 63.9 123.8 7.1 10.3 8.0 26.1 35.8 17.3 8.1 16.5 16.1 30.8 29.9 15.9 0.5 32.2 24.6 19.7 123.5 7.1 5.6 14.4 35.7 9.6 12.7 8.9 5.4 34.1 93.8 6.4 5.3 6.5 9.8 18.5 6.4 1.3 32.7 11.7 1165.1 25.1 18.5 7.2 5.9 14.4 52.8 6.7 5.9 8.6 9.4 484.7 4.3 40.8 13.4 11.5 8.0 14.4 3.3 10.3 11.4 7.3 57.7 3.6 2.9 5.2 6.9 23.0 12.8 24.5 17.9 2.4 2.6 9.2 6.9 8.2 0.8 25.5 82.0 16.7 11.2 38.8 2.5 25.8 9.3 14.2 12.2 4.0 5.4 4.9 2.5 24.7 29.4 19.4 0.7 11.0 15.2 37.3 15.5 62.8 29.5 14.9 17.1 78.6 1.6 5.9 59.9 24.2 7.3 28.7 20.6 3.4 15.1 34.8 2.5 5.9 5.3 8.2 13.3 43.0 40.5 13.1 5.3 29.3 6.0 47.7 23.5 68.4 15.8 17.1 15.3 22.2 15.8 14.6 18.6 26.8 21.5 17.0 43.1 21.2 13.6 8.1 21.5 26.0 7.1 8.0 17.3 8.1 7.1 5.6 8.9 5.4 9.8 5.9 5.9 11.5 11.4 3.2 21.9 0.0 5.8 0.0 0.0 0.0 0.0 0.0 18.1 17.1 0.0 0.0 4.3 33.1 0.0 12.2 10.2 0.0 15.6 21.2 0.0 12.3 8.9 5.4 0.0 0.0 0.0 32.7 10.0 6.3 0.0 9.6 13.9 9.8 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 11.4 0.0 0.0 0.0 0.0 10.8 0.0 0.0 3.2 0.0 0.0 24.8 2.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 7.7 5.2 16.0 0.0 0.0 DDIT4L "REDD2, Rtp801L" ENSG00000145358 "DNA damage inducible transcript 4 like" Q96D03 4 100185870-100190782 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 323.5;tongue: 106.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 22.0;Distal tubular cells: 21.5;Extravillous trophoblasts: 18.5;Granulosa cells: 23.5;Sertoli cells: 19.7" "Cancer enhanced" "Detected in many" "testis cancer: 19.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 19.3;BJ: 29.6;fHDF/TERT166: 16.2;HSkMC: 14.7;hTERT-RPE1: 32.8;RPTEC TERT1: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050903 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA050903: " "unprognostic (2.21e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.77e-4)" "unprognostic (1.66e-3)" "unprognostic (5.92e-2)" "unprognostic (2.72e-2)" "unprognostic (3.12e-1)" "unprognostic (3.21e-1)" "unprognostic (7.18e-2)" "unprognostic (2.59e-1)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (4.82e-3)" "unprognostic (2.09e-2)" "unprognostic (7.53e-5)" "unprognostic (4.99e-3)" 3.1 1.0 7.0 0.6 21.1 0.4 2.2 8.5 11.0 23.0 7.7 2.0 0.3 1.5 1.7 7.7 2.1 0.6 2.3 10.2 7.6 21.8 0.4 0.8 0.5 11.8 8.8 7.7 0.4 0.6 2.0 3.7 11.1 11.2 0.9 1.2 17.4 6.9 323.5 1.1 0.7 1.6 9.1 1.2 0.5 3.0 8.7 1.2 1.1 106.9 0.4 1.2 2.6 8.9 0.0 2.2 8.5 0.0 3.7 19.3 1.2 29.6 2.5 0.5 0.1 0.1 0.9 0.0 0.7 16.2 0.7 0.0 6.2 0.5 0.5 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.0 14.7 0.1 0.3 1.5 32.8 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 9.7 0.0 0.0 0.6 0.0 0.0 20.5 0.1 0.1 0.1 0.6 1.2 4.0 2.0 0.0 0.1 0.1 0.0 0.0 0.0 2.3 3.9 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 7.0 21.1 8.5 11.0 10.2 7.6 11.8 8.8 11.1 9.1 8.7 8.9 3.8 0.0 0.0 6.2 0.0 2.7 0.2 4.2 1.8 0.1 1.0 0.9 7.3 0.0 1.3 22.0 0.0 1.9 0.4 0.2 21.5 0.1 0.8 0.5 0.3 3.6 0.0 0.0 0.0 0.0 18.5 5.1 1.5 0.9 0.0 23.5 0.0 0.0 12.0 0.0 0.5 0.3 0.0 0.0 3.0 0.4 0.9 0.3 7.2 0.0 0.0 8.6 0.0 0.5 0.0 0.5 0.0 2.2 0.2 1.1 0.0 2.2 0.1 0.2 19.7 7.3 11.9 4.7 0.8 0.9 1.4 4.0 0.6 8.3 0.4 0.3 DUSP13 "BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP" ENSG00000079393 "Dual specificity phosphatase 13" "Q6B8I1, Q9UII6" 10 75094432-75109221 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 247.2;testis: 53.7;tongue: 122.5" "Cell type enriched" "Detected in some" 4 "Early spermatids: 428.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.0" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 10 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "BEWO: 4.3;EFO-21: 5.0;Hep G2: 11.0;K-562: 4.3;LHCN-M2: 9.5;RH-30: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.79e-1)" "unprognostic (2.39e-2)" "unprognostic (2.39e-1)" "unprognostic (7.07e-2)" "unprognostic (1.66e-3)" "unprognostic (2.47e-3)" "unprognostic (8.63e-2)" "unprognostic (1.97e-1)" "unprognostic (2.63e-2)" "unprognostic (1.27e-1)" "unprognostic (3.92e-1)" "unprognostic (2.22e-7)" "unprognostic (1.93e-2)" "unprognostic (1.54e-1)" "unprognostic (4.81e-1)" "unprognostic (2.09e-2)" 0.1 0.0 0.1 0.0 0.1 5.8 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.3 3.7 0.1 0.0 17.3 0.1 0.5 0.1 0.1 0.3 0.0 0.2 0.7 0.0 0.0 0.2 0.1 0.0 1.3 1.0 0.0 0.0 3.5 0.0 247.2 0.5 0.0 0.0 0.1 0.5 0.0 53.7 0.1 0.2 0.1 122.5 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 11.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 4.3 0.0 9.5 0.5 0.0 0.0 0.6 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.5 0.2 0.7 1.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 1.1 3.4 0.0 0.0 0.1 12.2 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 428.1 0.0 0.0 0.6 0.0 0.0 0.1 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 94.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.1 0.1 0.0 0.0 0.2 0.0 0.0 21.7 0.6 10.4 3.3 6.3 2.0 3.0 0.1 0.0 0.0 0.2 DUSP29 "DUPD1, DUSP27" ENSG00000188716 "Dual specificity phosphatase 29" Q68J44 10 75037836-75058514 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 71.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042964 Uncertain NA NA "Cluster 33: Striated muscle - Muscle contraction" "HPA042964: AB_10795764" "unprognostic (1.05e-2)" "unprognostic (1.77e-1)" "unprognostic (2.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.9 0.0 71.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYRK1B MIRK ENSG00000105204 "Dual specificity tyrosine phosphorylation regulated kinase 1B" Q9Y463 19 39825350-39834201 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 131.3;testis: 83.8" "Group enriched" "Detected in many" 12 "Early spermatids: 179.4;Late spermatids: 580.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028522, HPA028786" Uncertain Supported "Nucleoplasm,Mitotic chromosome" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Mitotic chromosome" "HPA028522: AB_2672656, HPA028786: AB_10670831" "unprognostic (2.22e-2)" "unprognostic (9.86e-2)" "unprognostic (4.55e-2)" "unprognostic (3.45e-3)" "unprognostic (1.96e-1)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (2.39e-1)" "unprognostic (6.02e-2)" "unprognostic (3.67e-2)" "unprognostic (8.93e-2)" "unprognostic (4.22e-2)" "prognostic favorable (8.83e-4)" "unprognostic (9.73e-2)" "unprognostic (1.12e-1)" "unprognostic (2.53e-2)" "unprognostic (3.88e-2)" 9.5 19.6 4.8 2.7 4.8 4.7 10.9 4.1 6.2 12.5 4.8 12.4 5.3 11.9 7.8 11.7 13.8 3.3 20.0 4.7 3.6 16.2 7.5 8.8 4.6 3.5 3.4 11.6 10.3 6.5 31.5 2.7 3.6 13.0 2.1 4.1 14.3 3.3 131.3 14.8 10.2 2.6 1.2 14.0 12.1 83.8 3.6 5.2 16.5 49.9 2.5 11.4 10.5 3.0 0.4 9.3 8.8 6.2 4.9 4.6 0.7 2.9 1.8 2.6 2.3 0.9 3.6 1.4 11.0 3.4 0.1 3.2 1.3 2.0 2.3 5.4 7.8 0.6 5.9 0.9 4.1 0.3 1.9 6.2 1.2 0.8 2.9 8.6 0.6 3.5 1.5 2.0 0.4 4.7 2.1 0.8 2.2 2.7 2.1 1.0 0.2 0.6 5.7 2.2 12.7 14.5 4.5 4.4 0.2 4.6 4.4 0.5 4.5 1.1 2.0 1.0 0.9 3.2 1.1 1.0 7.4 0.9 0.4 0.7 1.6 1.8 3.0 1.7 3.6 2.4 2.0 3.1 1.9 1.6 1.0 1.7 2.5 3.3 1.6 4.5 2.2 1.7 4.8 4.8 4.1 6.2 4.7 3.6 3.5 3.4 3.6 1.2 3.6 3.0 6.0 0.0 0.6 6.2 10.9 3.4 3.8 8.4 10.2 15.2 9.0 6.1 6.1 7.2 3.4 16.5 20.9 2.1 21.7 10.3 9.8 13.1 179.4 15.4 6.7 7.3 20.4 19.8 4.6 4.3 1.7 5.1 7.7 10.1 1.3 11.9 12.1 3.9 5.9 10.1 6.3 9.8 10.2 8.2 3.0 580.2 7.2 4.7 5.4 7.5 5.7 8.3 10.3 5.0 3.2 9.7 9.7 5.3 5.0 4.8 11.5 17.4 10.7 13.0 0.0 11.1 4.8 30.1 13.4 6.1 2.8 1.4 10.8 20.2 7.4 3.6 FBXO32 "ATROGIN1, Fbx32, MAFbx" ENSG00000156804 "F-box protein 32" Q969P5 8 123497889-123541206 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 649.5" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 247.5;Cardiomyocytes: 286.5;Prostatic glandular cells: 225.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 2.9;gdT-cell: 2.5;MAIT T-cell: 2.5;memory CD4 T-cell: 3.6;memory CD8 T-cell: 3.8;naive CD4 T-cell: 4.2;naive CD8 T-cell: 5.4;NK-cell: 3.2;T-reg: 3.8" "Group enriched" "Detected in many" 8 "granulocytes: 2.9;NK-cells: 3.2;T-cells: 5.4" "Cell line enhanced" "Detected in many" "GAMG: 49.3;HDLM-2: 176.1;hTERT-RPE1: 58.3;U-251 MG: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058955, HPA065209" Enhanced Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "HPA058955: , HPA065209: AB_2685433" "unprognostic (2.55e-1)" "unprognostic (3.62e-1)" "unprognostic (1.80e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (8.58e-3)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (7.97e-3)" 10.9 2.7 13.2 13.9 19.6 2.2 29.2 20.0 15.5 15.0 41.4 136.6 6.7 86.9 14.9 16.2 59.5 32.5 77.9 10.6 15.1 2.7 1.1 3.8 6.0 27.4 20.3 24.9 4.6 11.7 8.9 7.7 28.8 25.8 20.7 17.9 23.0 43.8 649.5 12.9 23.5 94.9 21.5 3.9 31.8 1.7 15.9 9.2 24.3 105.6 5.1 73.3 13.8 28.6 5.3 0.9 0.2 0.0 10.6 2.5 1.9 1.0 11.4 0.6 1.1 0.0 2.9 0.0 3.1 8.5 49.3 0.3 0.2 1.0 0.9 176.1 4.0 0.0 6.3 0.0 14.5 0.1 0.7 21.1 7.4 2.6 3.2 58.3 0.8 2.5 0.3 1.5 0.8 1.3 0.7 0.1 0.1 2.1 0.9 0.0 0.2 1.1 1.9 1.7 0.3 1.1 1.2 19.2 21.5 1.1 18.9 0.4 0.7 3.1 0.8 1.1 51.9 17.4 2.6 0.4 12.7 0.2 2.5 2.9 0.2 0.0 2.5 0.1 2.5 0.4 3.6 3.8 0.2 0.4 4.2 5.4 0.1 3.2 0.2 0.1 3.8 1.1 13.2 19.6 20.0 15.5 10.6 15.1 27.4 20.3 28.8 21.5 15.9 28.6 6.8 0.0 3.7 7.5 6.1 11.5 184.8 113.3 64.9 17.7 44.9 247.5 286.5 4.3 63.6 7.3 35.5 17.8 27.9 153.0 9.8 14.4 4.7 22.2 88.2 13.0 102.4 8.0 52.2 30.7 17.5 28.9 14.8 76.0 0.0 30.3 2.2 2.9 5.3 21.9 30.9 63.6 111.9 5.9 3.4 3.5 39.7 5.6 44.4 14.0 2.4 58.6 25.7 9.5 117.2 51.7 189.5 61.3 38.3 225.2 36.9 5.2 19.9 100.1 19.7 75.2 61.3 15.9 2.9 49.9 6.3 109.2 32.5 3.7 21.1 90.8 FEM1A ENSG00000141965 "Fem-1 homolog A" Q9BSK4 19 4791734-4801273 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "skeletal muscle: 273.6;tongue: 121.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016565, HPA063622" Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Golgi apparatus" Cytosol "HPA016565: AB_1848489, HPA063622: AB_2685063" "unprognostic (4.62e-2)" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" "unprognostic (3.60e-1)" "unprognostic (2.42e-3)" "unprognostic (2.04e-1)" "unprognostic (6.74e-2)" "unprognostic (1.25e-2)" "unprognostic (9.21e-2)" "unprognostic (2.28e-3)" "unprognostic (6.25e-2)" "unprognostic (6.18e-5)" "unprognostic (3.72e-3)" "unprognostic (1.25e-1)" "unprognostic (1.91e-1)" "unprognostic (4.70e-2)" 4.3 3.7 8.0 4.0 7.8 7.5 4.4 8.1 8.0 3.2 6.8 3.8 3.7 3.0 3.6 8.4 3.4 2.7 17.8 8.2 6.1 3.8 4.4 4.2 4.7 7.9 7.5 3.5 8.5 9.6 0.9 4.2 7.3 4.9 3.3 3.0 5.9 3.3 273.6 8.5 3.3 3.9 7.1 4.3 3.9 2.4 7.8 4.8 3.5 121.2 4.6 4.1 1.0 8.5 9.2 6.2 5.7 12.4 6.2 3.6 8.3 5.4 4.4 8.5 6.0 9.7 4.1 10.4 5.4 6.7 4.6 9.3 10.1 8.9 5.5 12.4 11.6 10.1 4.9 7.4 9.4 17.0 12.4 5.3 13.6 6.6 9.4 4.0 6.2 13.9 15.1 19.3 5.9 9.3 14.3 6.2 17.7 5.7 15.0 13.1 7.4 11.0 7.7 11.6 18.5 13.1 7.1 13.2 10.4 4.3 10.2 14.5 8.7 7.7 5.6 12.1 14.4 22.3 20.0 8.8 7.9 12.1 11.1 4.7 2.8 2.8 2.5 3.2 2.1 1.9 2.0 2.3 2.6 2.5 1.7 2.0 2.4 2.6 3.0 2.6 1.5 1.8 8.0 7.8 8.1 8.0 8.2 6.1 7.9 7.5 7.3 7.1 7.8 8.5 7.9 25.6 32.8 1.6 16.6 20.1 14.9 7.7 12.5 16.8 20.8 16.4 6.5 18.6 15.5 1.8 16.7 21.2 16.1 16.7 13.7 10.3 5.3 8.7 11.6 12.3 13.1 28.6 2.7 11.8 13.8 9.2 6.1 19.1 22.8 7.5 15.4 18.7 12.3 11.8 3.2 15.5 4.1 15.4 8.7 3.5 9.0 13.1 3.6 2.8 17.2 12.1 32.0 2.5 2.3 12.4 9.4 8.2 9.9 15.5 10.9 10.1 11.3 19.8 6.6 27.1 9.3 12.7 6.2 18.3 29.5 27.1 14.3 16.8 18.0 17.7 FGF8 AIGF ENSG00000107831 "Fibroblast growth factor 8" P55075 10 101770130-101780369 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "skeletal muscle: 48.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.1;testis cancer: 3.3" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 17 "RH-30: 37.8" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (1.56e-1)" "unprognostic (3.90e-3)" "unprognostic (1.12e-2)" "unprognostic (4.88e-1)" "unprognostic (2.47e-2)" "unprognostic (9.09e-2)" "unprognostic (8.75e-3)" "unprognostic (8.12e-2)" "unprognostic (1.75e-1)" "unprognostic (2.95e-2)" "unprognostic (1.17e-2)" "unprognostic (2.35e-9)" "unprognostic (6.17e-3)" "unprognostic (9.01e-2)" "unprognostic (1.97e-1)" 0.5 0.0 0.7 0.0 0.7 0.2 0.2 0.6 1.2 0.1 0.8 0.2 0.3 0.2 0.2 0.9 0.1 0.3 0.3 0.9 1.1 0.1 0.1 0.3 0.3 0.5 0.7 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.1 0.5 0.0 0.1 48.7 0.2 0.0 0.0 0.4 0.6 0.1 1.1 0.7 0.0 0.2 0.0 0.0 0.2 0.0 1.0 0.6 0.1 0.3 1.4 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.6 0.7 0.4 0.6 0.0 0.0 0.5 0.3 0.0 0.0 1.1 1.0 0.4 0.3 0.5 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.0 1.0 0.3 0.9 0.0 0.4 0.6 2.2 0.2 0.0 0.1 0.6 37.8 0.8 0.0 0.2 0.9 0.9 0.0 0.6 0.5 0.0 0.6 0.1 0.6 0.6 1.1 0.8 0.2 0.2 0.8 1.3 0.8 0.7 0.8 1.9 0.4 0.5 0.3 0.5 0.6 0.4 0.4 0.4 0.4 0.5 0.6 0.5 1.1 0.7 0.9 0.4 0.5 0.3 0.7 0.7 0.6 1.2 0.9 1.1 0.5 0.7 0.6 0.4 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 FHL3 SLIM2 ENSG00000183386 "Four and a half LIM domains 3" Q13643 1 37996770-38005606 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 26 "skeletal muscle: 1603.0;tongue: 805.6" "Cell type enhanced" "Detected in many" "granulocytes: 73.1;NK-cells: 52.5;Skeletal myocytes: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "eosinophil: 336.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 336.1" "Cell line enhanced" "Detected in many" "HEL: 72.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045723 Approved Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "HPA045723: AB_10966278" "prognostic favorable (5.62e-4)" "unprognostic (1.12e-1)" "unprognostic (3.02e-3)" "unprognostic (6.97e-2)" "unprognostic (2.26e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.02e-3)" "unprognostic (1.80e-1)" "unprognostic (1.36e-1)" "unprognostic (9.05e-2)" "unprognostic (5.05e-2)" "prognostic unfavorable (4.20e-11)" "unprognostic (8.88e-3)" "unprognostic (2.38e-1)" "unprognostic (4.94e-2)" "unprognostic (2.77e-2)" 14.8 11.4 7.3 16.7 7.6 21.4 12.7 7.4 7.5 30.8 5.9 45.3 3.5 46.8 7.9 36.7 29.8 14.7 16.0 6.6 7.5 14.6 6.0 19.1 5.6 8.8 7.5 20.8 10.2 6.6 5.6 9.6 8.9 16.6 6.0 0.5 23.7 16.5 1603.0 15.5 11.4 29.6 8.8 13.0 15.5 7.2 8.1 3.7 8.1 805.6 5.3 40.8 16.0 8.0 15.4 5.6 14.3 14.4 13.3 52.9 9.3 12.0 23.1 22.1 16.3 12.2 11.8 0.1 19.7 26.8 10.3 5.8 9.5 14.2 10.8 5.8 17.2 72.0 12.5 14.2 51.7 5.6 49.8 47.4 15.8 24.9 14.2 46.3 30.9 7.2 61.7 0.3 41.6 8.1 1.9 23.5 18.5 1.1 3.7 9.5 12.2 1.0 14.1 2.8 1.8 7.4 10.9 1.0 17.1 27.0 4.3 4.9 21.6 9.2 21.6 2.7 11.1 3.9 14.5 1.7 4.4 33.0 9.9 6.0 28.7 336.1 14.1 18.2 15.1 0.3 3.5 7.2 18.0 0.6 2.6 3.4 34.5 14.3 12.0 0.8 8.1 13.8 7.3 7.6 7.4 7.5 6.6 7.5 8.8 7.5 8.9 8.8 8.1 8.0 11.6 0.0 3.0 3.3 2.0 20.9 20.9 4.5 23.3 1.5 12.1 29.3 5.1 5.7 3.5 7.3 0.0 9.2 18.0 0.2 1.9 19.8 0.8 2.4 27.4 20.8 0.0 9.4 1.3 28.1 29.1 25.6 0.5 3.2 73.1 2.7 12.1 1.0 26.1 0.0 0.4 0.2 12.2 21.7 33.1 1.4 22.4 23.5 5.4 9.4 20.3 2.9 52.5 0.5 0.1 34.5 0.0 32.0 1.3 8.9 0.0 3.6 0.2 0.5 26.3 54.4 38.1 1.1 16.6 8.6 16.2 9.7 12.6 14.9 0.2 11.6 GADL1 ENSG00000144644 "Glutamate decarboxylase like 1" Q6ZQY3 3 30726200-30894765 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skeletal muscle: 25.8;tongue: 11.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.4;Club cells: 1.3;Collecting duct cells: 1.8;Fibroblasts: 5.9;Late spermatids: 1.8;Skeletal myocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.7;TIME: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039160, HPA040229" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 2: Karpas-707 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane, Cytosol" "HPA039160: AB_10796222, HPA040229: AB_10796118" "unprognostic (4.96e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.60e-2)" "unprognostic (7.32e-2)" "unprognostic (5.05e-3)" "unprognostic (8.37e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-3)" "unprognostic (1.63e-1)" "unprognostic (1.98e-5)" "unprognostic (8.81e-2)" "unprognostic (4.54e-2)" "unprognostic (4.39e-1)" "unprognostic (1.06e-1)" 0.3 0.4 2.2 0.4 2.1 1.2 0.4 2.6 2.5 0.1 0.1 0.2 0.2 0.3 0.6 0.6 0.2 0.3 0.6 1.8 0.8 0.7 0.3 0.3 0.4 0.9 0.5 0.6 0.4 0.2 0.2 0.3 0.9 0.6 0.2 1.7 0.4 0.1 25.8 0.9 0.2 0.2 0.1 0.6 0.3 0.5 1.0 0.1 0.9 11.3 0.3 0.2 0.0 2.3 0.4 0.0 0.2 0.4 0.3 0.1 0.5 0.2 0.1 0.0 0.0 0.5 0.5 0.4 0.2 0.0 0.2 0.3 4.7 0.1 0.1 0.6 0.1 0.5 0.8 0.2 0.0 0.3 1.3 0.1 0.1 0.2 0.1 0.4 0.1 0.3 0.5 1.7 0.2 0.3 0.2 0.5 0.5 0.1 0.1 0.7 0.9 0.4 0.2 0.6 0.5 0.3 0.2 0.3 1.3 0.3 0.4 0.3 2.4 0.6 0.5 0.8 0.2 0.6 0.3 0.3 0.2 0.2 0.6 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 2.2 2.1 2.6 2.5 1.8 0.8 0.9 0.5 0.9 0.1 1.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.0 1.3 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 1.8 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 GNPAT "DAP-AT, DAPAT, DHAPAT" ENSG00000116906 "Glyceronephosphate O-acyltransferase" O15228 1 231241207-231277973 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (8.87e-2)" "unprognostic (3.28e-2)" "unprognostic (3.36e-2)" "unprognostic (2.56e-2)" "unprognostic (5.25e-3)" "unprognostic (1.91e-1)" "unprognostic (5.07e-2)" "unprognostic (6.72e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.29e-6)" "unprognostic (5.69e-2)" "unprognostic (1.66e-1)" "unprognostic (4.48e-2)" "unprognostic (2.68e-1)" 22.4 26.9 21.6 20.5 24.0 17.3 21.7 23.9 28.2 18.3 25.2 30.0 30.0 20.3 23.7 22.1 27.9 18.2 44.9 22.0 23.5 25.7 30.9 18.7 23.6 24.1 22.5 22.5 29.5 22.6 17.9 19.4 23.3 22.8 24.8 17.0 26.4 20.9 101.9 23.6 28.1 26.4 23.6 18.5 26.9 32.0 23.2 27.5 20.8 84.1 25.8 21.5 17.0 26.1 39.8 43.6 60.4 46.1 48.7 71.4 40.7 32.9 37.1 34.1 39.1 56.1 48.3 57.0 40.4 49.5 35.9 41.9 40.6 44.7 50.0 64.8 37.2 41.2 41.4 81.7 49.4 70.9 31.4 50.1 53.8 35.5 39.6 44.5 81.2 56.0 61.1 53.3 71.7 13.1 63.6 41.0 97.1 112.0 49.5 68.7 81.0 66.9 42.7 29.2 40.0 57.1 55.2 30.7 49.1 23.8 53.7 110.7 42.8 34.5 32.1 50.5 83.3 68.2 93.6 65.1 49.8 58.8 65.3 34.1 36.4 37.3 23.7 37.1 27.2 35.1 30.6 31.3 36.4 37.7 26.4 24.4 14.3 26.9 50.3 17.2 37.9 29.8 21.6 24.0 23.9 28.2 22.0 23.5 24.1 22.5 23.3 23.6 23.2 26.1 17.7 25.6 20.8 19.9 32.3 13.5 19.5 23.1 16.5 23.3 14.9 12.6 55.8 30.0 21.2 27.6 39.6 25.3 20.1 16.4 17.6 41.5 70.3 21.5 19.4 21.4 28.2 13.2 18.9 43.4 19.2 19.5 21.4 14.1 11.4 30.1 19.2 26.9 27.4 11.8 18.6 21.0 22.4 24.8 18.3 119.2 25.4 21.8 12.4 15.9 38.7 22.7 26.8 17.1 29.2 40.2 30.3 26.7 30.1 24.9 41.7 28.0 30.8 24.2 19.7 16.5 22.4 50.9 31.5 18.8 13.9 12.4 24.5 19.7 30.1 19.0 HOXC10 HOX3I ENSG00000180818 "Homeobox C10" Q9NYD6 12 53985065-53990279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 113.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 21.2;Collecting duct cells: 16.5;Distal tubular cells: 62.6;Proximal tubular cells: 100.4;Skeletal myocytes: 22.4;Suprabasal keratinocytes: 19.2" "Cancer enhanced" "Detected in many" "renal cancer: 20.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 291.5;ASC diff: 82.5;ASC TERT1: 75.6;fHDF/TERT166: 67.6;T-47d: 99.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 319 "spinal cord: 31.8" HPA053919 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear bodies" Nucleoplasm "HPA053919: AB_2682308" "unprognostic (1.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.56e-4)" "unprognostic (1.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (1.23e-1)" "unprognostic (9.60e-3)" "unprognostic (3.96e-2)" "unprognostic (7.37e-3)" "unprognostic (2.25e-2)" "unprognostic (3.56e-2)" "unprognostic (5.07e-2)" "unprognostic (5.24e-3)" "unprognostic (1.91e-1)" 13.1 1.1 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.7 0.0 0.2 0.0 1.5 0.0 0.1 8.8 0.0 0.0 0.0 0.0 22.5 0.0 0.0 1.6 0.0 0.0 1.8 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.5 113.5 16.4 2.1 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.1 0.7 3.3 0.0 291.5 82.5 75.6 0.5 10.1 24.4 13.6 12.6 0.6 0.9 0.5 2.7 67.6 1.9 31.4 4.1 0.0 6.5 15.2 5.6 3.0 36.2 0.0 0.4 0.0 3.7 36.0 0.5 1.0 0.0 0.0 0.1 8.5 2.3 0.0 9.4 1.8 0.1 7.5 0.1 36.4 1.1 0.0 0.4 0.0 30.6 0.0 0.0 3.9 6.9 10.0 15.7 0.4 99.4 2.2 0.0 8.0 10.2 0.2 13.3 1.3 0.2 0.1 0.1 1.7 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 1.0 21.2 0.0 0.0 0.0 0.0 4.8 7.9 0.3 0.0 0.0 16.5 0.0 0.0 0.1 0.0 62.6 0.0 0.2 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 0.4 0.6 0.9 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 100.4 0.0 0.0 0.0 22.4 5.2 3.6 4.4 0.0 19.2 0.1 0.4 0.0 0.0 0.0 HOXC9 "HOX3, HOX3B" ENSG00000180806 "Homeobox C9" P31274 12 53994895-54003337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 11.0;skeletal muscle: 25.9" "Cell type enhanced" "Detected in some" "Distal tubular cells: 41.1;Fibroblasts: 20.1;Granulosa cells: 26.7;Melanocytes: 39.2;Proximal tubular cells: 22.0;Skeletal myocytes: 28.3;Smooth muscle cells: 19.6;Spermatogonia: 21.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 21.5;HDLM-2: 28.4;HEK 293: 33.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "spinal cord: 7.7" "HPA063965, HPA072160" Enhanced Nucleoplasm NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA063965: AB_2685162, HPA072160: AB_2686491" "unprognostic (2.38e-1)" "unprognostic (1.03e-1)" "unprognostic (3.19e-5)" "unprognostic (1.23e-1)" "unprognostic (4.09e-3)" "unprognostic (7.12e-2)" "unprognostic (6.92e-3)" "unprognostic (1.06e-3)" "unprognostic (4.32e-1)" "unprognostic (1.58e-2)" "unprognostic (7.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.01e-1)" "unprognostic (2.74e-2)" "unprognostic (1.53e-1)" 11.0 1.7 0.0 0.3 0.0 0.0 6.1 0.0 0.0 0.3 0.0 0.3 0.0 1.0 1.3 0.4 8.1 0.0 0.0 0.0 0.0 9.8 0.0 0.1 1.0 0.0 0.0 2.7 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 25.9 7.8 6.2 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.5 0.5 0.0 0.8 3.3 0.0 21.5 8.5 7.0 1.5 2.3 2.0 2.8 1.8 0.9 3.3 0.0 1.7 8.8 0.5 3.9 0.5 2.3 2.4 28.4 33.7 0.7 5.9 0.9 0.9 0.1 5.1 7.9 3.6 4.2 1.9 0.0 2.7 0.1 7.1 0.0 5.8 2.5 0.0 2.0 0.0 1.7 0.3 0.4 4.1 0.0 6.5 2.1 0.0 6.2 7.9 4.1 9.5 0.5 6.5 0.3 0.0 5.1 9.0 1.5 2.7 0.0 0.0 0.0 0.1 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 9.6 0.0 0.0 1.8 0.0 6.5 7.9 0.5 0.0 0.0 1.8 0.0 0.3 0.2 0.0 41.1 0.0 3.7 0.1 0.2 2.1 0.0 0.0 0.0 0.4 11.5 20.1 0.0 0.0 0.0 26.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.9 4.1 4.7 0.5 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.9 0.0 0.1 0.6 22.0 0.0 0.0 6.6 28.3 19.6 9.3 21.2 0.7 9.5 0.4 0.5 7.2 0.1 0.0 IDI2 IPPI2 ENSG00000148377 "Isopentenyl-diphosphate delta isomerase 2" Q9BXS1 10 1018910-1025859 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "skeletal muscle: 273.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Glandular and luminal cells: 1.1;Horizontal cells: 1.7;Skeletal myocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041254 Uncertain Vesicles NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Vesicles "HPA041254: AB_10794270" "unprognostic (6.69e-3)" "unprognostic (4.05e-2)" "unprognostic (1.64e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 1.2 0.0 0.0 273.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.0 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.4 0.3 0.0 0.1 0.2 0.2 0.0 0.6 0.3 0.5 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.9 0.5 0.4 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 IGFN1 "DKFZp434B1231, EEF1A2BP1" ENSG00000163395 "Immunoglobulin like and fibronectin type III domain containing 1" Q86VF2 1 201190824-201228952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skeletal muscle: 186.3" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 103.8" "Cancer enriched" "Detected in some" 4 "thyroid cancer: 8.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "HeLa: 76.6" "Group enriched" "Detected in many" 7 "amygdala: 3.3;basal ganglia: 1.2;cerebral cortex: 2.9;hippocampal formation: 1.9" "Low region specificity" "Detected in some" HPA050415 Enhanced Approved "Midbody ring" Yes NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 50: Fibroblasts - ECM organization" "Midbody ring" "HPA050415: AB_2681120" "unprognostic (2.09e-1)" "unprognostic (1.63e-3)" "unprognostic (1.82e-2)" "unprognostic (3.25e-1)" "unprognostic (1.02e-2)" "unprognostic (2.00e-2)" "unprognostic (9.80e-3)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (1.27e-8)" "unprognostic (3.55e-4)" "unprognostic (6.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" 0.6 0.1 0.3 0.1 0.1 0.0 0.2 0.0 0.3 0.9 0.6 0.1 0.0 10.4 15.1 0.0 0.9 0.2 0.3 1.2 0.6 0.1 0.1 0.5 0.1 0.1 0.2 0.2 7.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.3 186.3 0.3 0.0 0.8 0.0 0.0 0.1 2.5 0.4 0.0 14.6 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 76.6 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 4.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.2 0.6 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.1 0.0 0.0 0.1 1.5 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 22.1 0.4 1.8 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 103.8 0.7 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ITIH6 "ITIH5L, UNQ6369" ENSG00000102313 "Inter-alpha-trypsin inhibitor heavy chain family member 6" Q6UXX5 X 54748918-54798255 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.5" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 7 "melanoma: 10.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "WM-115: 50.7" HPA000506 Uncertain "Secreted to blood" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 17: WM-115 - Nervous system development" "Cluster 35: Glandular cells - Unknown function" "HPA000506: AB_2666007" "unprognostic (3.40e-1)" "unprognostic (1.04e-1)" "unprognostic (9.73e-3)" "unprognostic (7.24e-2)" "unprognostic (2.83e-1)" "unprognostic (5.38e-3)" "unprognostic (9.81e-2)" "unprognostic (2.66e-1)" "unprognostic (1.02e-1)" "unprognostic (6.33e-2)" "unprognostic (4.14e-4)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321540 "Human disease related genes, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "skeletal muscle: 237.4;tongue: 106.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 0.3 0.2 2.9 0.5 7.5 0.0 0.7 7.6 5.3 0.7 13.2 3.3 0.7 3.2 0.8 2.8 0.3 0.3 8.4 5.9 1.5 0.8 0.4 3.7 0.1 3.0 1.5 0.1 6.5 0.8 0.5 1.4 2.4 2.8 5.0 0.4 2.8 0.5 237.4 0.6 1.0 1.9 1.9 0.1 0.9 1.0 1.9 3.2 1.4 106.0 1.1 2.3 1.4 3.6 1.1 0.0 0.4 0.0 0.0 0.0 0.1 0.1 1.1 1.1 0.5 0.2 4.4 0.0 1.5 0.0 1.0 6.4 5.6 4.3 1.4 0.0 8.3 0.0 5.2 0.0 0.7 2.9 0.3 0.8 3.7 0.0 4.0 0.0 0.0 10.9 0.8 0.0 0.4 4.1 15.1 0.0 9.7 17.7 2.9 7.6 5.4 0.0 0.2 12.7 7.3 1.0 0.1 34.4 1.8 1.6 24.2 0.2 0.0 1.6 2.3 0.6 1.4 0.0 0.0 0.0 2.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.5 7.6 5.3 5.9 1.5 3.0 1.5 2.4 1.9 1.9 3.6 1.1 38.5 12.9 3.9 0.2 2.8 32.8 3.0 6.2 0.4 2.4 1.5 35.7 0.0 10.8 1.8 6.2 0.0 0.1 7.1 0.0 0.3 2.4 2.9 8.9 1.7 12.6 0.0 82.2 1.4 0.0 2.6 7.7 3.7 0.0 0.0 0.0 0.0 0.1 0.0 50.3 9.9 2.0 0.0 0.4 0.5 0.9 0.4 1.8 3.7 0.0 0.4 0.0 14.1 4.6 3.4 6.2 0.0 0.0 32.8 0.0 1.0 6.2 0.1 0.0 25.0 1.4 0.1 4.3 7.4 2.0 0.0 0.2 0.1 6.7 25.6 JSRP1 "FLJ32416, JP-45" ENSG00000167476 "Junctional sarcoplasmic reticulum protein 1" Q96MG2 19 2252252-2269759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "skeletal muscle: 335.4" "Cell type enhanced" "Detected in many" "B-cells: 31.7;Melanocytes: 46.2;Plasma cells: 139.4;Skeletal myocytes: 132.6" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 11.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "naive B-cell: 2.6" "Lineage enriched" "Detected in single" 10 "B-cells: 2.6" "Cell line enhanced" "Detected in some" "Karpas-707: 164.1;RPMI-8226: 109.8;U-266/70: 444.1;U-266/84: 57.8" "Group enriched" "Detected in many" 6 "amygdala: 8.4;basal ganglia: 11.6;cerebral cortex: 9.9;hippocampal formation: 4.4;white matter: 5.1" "Not detected" "Not detected" HPA044741 Enhanced Approved "Endoplasmic reticulum" NA NA 13000 "Cluster 24: B-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA044741: AB_10794295" "unprognostic (9.41e-3)" "unprognostic (1.52e-2)" "unprognostic (1.39e-1)" "unprognostic (5.85e-2)" "unprognostic (2.15e-1)" "unprognostic (9.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.80e-2)" "unprognostic (2.44e-2)" "unprognostic (1.87e-2)" "unprognostic (8.64e-5)" "unprognostic (3.63e-1)" "unprognostic (4.43e-1)" "unprognostic (2.07e-1)" "unprognostic (2.71e-1)" 0.2 0.1 0.4 0.9 0.4 0.4 0.4 0.4 0.4 0.3 0.2 1.5 2.9 0.1 0.0 0.3 0.3 0.1 0.0 0.3 0.4 0.6 0.3 0.7 0.5 0.3 0.3 0.1 0.5 0.0 0.3 0.0 0.3 1.9 0.1 0.0 8.9 0.0 335.4 0.3 1.4 0.0 0.3 5.4 1.7 1.9 0.5 0.1 0.6 18.6 0.6 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 26.8 0.0 0.0 0.2 0.0 0.0 0.0 46.6 0.1 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.1 7.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 26.7 109.8 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 444.1 57.8 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.5 0.3 0.1 0.0 5.3 0.0 31.7 0.5 0.3 0.2 0.6 0.8 0.6 0.4 0.6 1.5 0.1 0.0 2.1 0.2 0.7 1.7 0.0 1.8 19.0 0.7 0.3 0.3 5.4 1.3 0.2 1.0 0.6 1.1 1.5 1.1 6.3 2.9 0.7 0.6 0.5 0.0 0.1 2.3 2.0 1.3 2.2 18.2 0.6 1.1 46.2 0.0 0.0 0.5 1.0 0.0 0.1 1.0 0.3 0.0 139.4 0.3 0.6 0.4 1.7 0.5 0.0 132.6 0.6 7.6 1.9 0.2 1.0 0.3 5.0 0.5 0.7 0.2 KBTBD13 "hCG_1645727, NEM6" ENSG00000234438 "Kelch repeat and BTB domain containing 13" C9JR72 15 65076746-65079948 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062737 Uncertain NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 48: Smooth muscle cells - ECM organization" "HPA062737: AB_2684856" "unprognostic (1.18e-1)" "unprognostic (7.88e-2)" "unprognostic (6.07e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.2 0.5 0.1 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA7 "HAK6, Kv1.7" ENSG00000104848 "Potassium voltage-gated channel subfamily A member 7" Q96RP8 19 49067418-49072941 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 51 "skeletal muscle: 75.7;tongue: 19.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 16.9;Cone photoreceptor cells: 6.2;granulocytes: 3.8;Pancreatic endocrine cells: 3.8;Skeletal myocytes: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-251 MG: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (2.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (1.68e-1)" "unprognostic (4.31e-2)" "unprognostic (3.17e-2)" "unprognostic (6.97e-2)" "unprognostic (2.94e-2)" "unprognostic (1.26e-1)" "unprognostic (2.21e-8)" "unprognostic (1.70e-1)" "unprognostic (2.62e-1)" "unprognostic (5.80e-2)" "unprognostic (5.29e-2)" 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.4 0.0 75.7 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 19.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.3 0.1 0.1 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.1 0.3 0.2 0.3 0.0 0.2 0.5 0.2 6.4 16.9 0.0 0.1 0.4 1.2 0.1 0.0 0.4 0.3 0.1 3.4 0.0 3.2 0.0 6.2 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.9 0.8 0.0 0.0 0.1 0.2 0.2 1.8 0.0 0.9 3.8 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.7 0.0 0.2 0.9 1.4 0.0 4.7 0.6 0.2 0.6 0.0 0.3 1.1 1.5 0.0 0.0 0.5 KLHL30 FLJ43374 ENSG00000168427 "Kelch like family member 30" Q0D2K2 2 238138668-238152947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "skeletal muscle: 149.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 13.5;Skeletal myocytes: 9.8;Smooth muscle cells: 3.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;CAPAN-2: 1.6;EFO-21: 1.5;REH: 1.4;RH-30: 4.5;THP-1: 2.3" "Region enriched" "Detected in single" 35 "olfactory bulb: 9.4" "Not detected" "Not detected" HPA062095 Approved "Centriolar satellite" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "Centriolar satellite" "HPA062095: AB_2684680" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (2.07e-4)" "unprognostic (6.02e-5)" "unprognostic (1.29e-1)" "unprognostic (1.22e-2)" "unprognostic (1.31e-1)" "unprognostic (4.54e-3)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (5.57e-3)" "unprognostic (2.24e-1)" "unprognostic (1.93e-1)" "unprognostic (8.17e-4)" "unprognostic (2.75e-2)" "unprognostic (2.30e-1)" "unprognostic (2.06e-1)" 3.8 0.1 0.2 0.1 0.2 0.0 1.4 0.5 0.2 2.2 0.2 1.0 0.2 1.2 0.0 1.0 1.3 0.5 14.3 0.1 0.4 1.0 0.1 0.9 0.0 0.9 0.8 0.4 0.1 0.0 0.1 0.3 0.3 1.0 0.1 0.1 1.0 0.8 149.1 0.8 0.7 0.7 0.1 0.2 0.5 0.1 0.2 0.0 0.6 15.2 0.0 1.6 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.1 0.1 0.0 0.0 1.4 4.5 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.2 0.1 0.4 0.9 0.8 0.3 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 9.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL33 ENSG00000185271 "Kelch like family member 33" A6NCF5 14 20425852-20436166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 29 "skeletal muscle: 73.3;tongue: 20.2" "Cell type enriched" "Detected in some" 19 "Cardiomyocytes: 27.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 21 "plasmacytoid DC: 5.8" "Lineage enriched" "Detected in single" 21 "dendritic cells: 5.8" "Cell line enriched" "Detected in single" 9 "REH: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049985, HPA056560" Enhanced NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 14: REH - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA049985: , HPA056560: AB_2683174" "unprognostic (6.92e-2)" "unprognostic (6.39e-2)" "unprognostic (2.07e-1)" "unprognostic (4.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.26e-1)" "unprognostic (2.38e-3)" "unprognostic (1.60e-1)" "unprognostic (9.77e-2)" "unprognostic (1.25e-1)" "unprognostic (7.39e-2)" "unprognostic (4.15e-2)" "unprognostic (4.60e-2)" "unprognostic (7.43e-3)" "unprognostic (4.88e-3)" "unprognostic (3.32e-5)" "unprognostic (2.32e-1)" 0.9 0.3 0.5 0.2 0.5 0.2 0.6 1.5 0.6 1.2 0.3 0.8 0.3 1.4 1.0 0.9 0.8 0.8 1.0 0.4 0.5 0.5 0.1 0.4 0.6 0.4 0.6 1.2 0.2 0.5 0.2 0.2 0.4 1.0 0.3 0.3 0.5 1.0 73.3 0.1 0.5 0.5 0.1 0.6 0.3 0.4 0.6 1.0 0.4 20.2 0.6 0.5 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 5.8 0.0 0.1 0.5 0.5 1.5 0.6 0.4 0.5 0.4 0.6 0.4 0.1 0.6 0.7 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 KLHL34 "FLJ34960, RP11-450P7.3" ENSG00000185915 "Kelch like family member 34" Q8N239 X 21654690-21658330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 25.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.7;Cardiomyocytes: 7.9;Cone photoreceptor cells: 14.6;Horizontal cells: 16.8;Rod photoreceptor cells: 66.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA060287 Uncertain NA NA "Cluster 32: T-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA060287: AB_2684243" "unprognostic (2.00e-2)" "unprognostic (8.73e-2)" "unprognostic (1.79e-1)" "unprognostic (3.02e-1)" "unprognostic (3.14e-2)" "unprognostic (8.68e-2)" "unprognostic (9.17e-2)" "unprognostic (3.24e-1)" "unprognostic (3.40e-2)" "unprognostic (3.74e-1)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (8.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (3.29e-1)" 0.0 0.0 1.9 0.1 0.6 0.0 0.0 1.7 2.5 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 1.8 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.2 0.1 0.0 25.6 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.6 1.7 2.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.0 0.0 7.7 0.1 0.0 7.9 0.0 0.0 0.0 14.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.8 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.1 4.1 0.1 0.0 66.6 0.0 0.8 0.1 0.2 0.9 0.0 0.0 0.0 0.2 0.0 1.1 0.0 KLHL40 "KBTBD5, NEM8, SRYP" ENSG00000157119 "Kelch like family member 40" Q2TBA0 3 42685537-42692544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "skeletal muscle: 431.2;tongue: 162.3" "Group enriched" "Detected in some" 17 "Early spermatids: 5.0;Late spermatids: 10.7;Skeletal myocytes: 16.3" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024463, HPA052201" Enhanced NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "HPA024463: AB_1852095, HPA052201: AB_2681759" "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (2.50e-1)" "unprognostic (4.04e-1)" 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 4.7 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.1 4.2 0.0 431.2 0.7 0.0 0.0 0.1 0.0 0.0 1.7 0.3 0.0 0.1 162.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 0.2 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.3 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC30 ENSG00000206422 "Leucine rich repeat containing 30" A6NM36 18 7231125-7232047 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "skeletal muscle: 16.2;tongue: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041039 Uncertain NA NA "Cluster 33: Striated muscle - Muscle contraction" "HPA041039: AB_2677270" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LSMEM1 "C7orf53, FLJ39575" ENSG00000181016 "Leucine rich single-pass membrane protein 1" Q8N8F7 7 112480853-112491062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 81.6" "Cell type enhanced" "Detected in many" "Early spermatids: 49.2;Glandular and luminal cells: 27.7;Late spermatids: 67.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HeLa: 8.7" "Group enriched" "Detected in many" 4 "amygdala: 1.4;basal ganglia: 1.0;cerebellum: 4.0;olfactory bulb: 3.3" "Low region specificity" "Detected in many" "HPA013753, HPA047988" Uncertain Supported Vesicles,Cytosol NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Cytosol Vesicles "HPA013753: AB_1848926, HPA047988: AB_2680229" "unprognostic (6.87e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-2)" "unprognostic (2.77e-2)" "unprognostic (1.38e-1)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (6.68e-2)" "unprognostic (3.54e-2)" "unprognostic (2.80e-3)" "unprognostic (1.47e-6)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.25e-2)" "unprognostic (3.42e-2)" 2.2 2.1 1.2 0.2 1.7 0.3 1.5 2.1 2.5 1.7 1.1 2.0 0.5 1.0 1.0 2.0 1.6 0.1 2.9 1.2 1.7 4.0 7.2 4.3 0.1 1.2 1.1 1.7 5.5 0.0 2.3 0.2 1.1 2.5 0.3 0.8 1.7 0.3 81.6 1.4 2.2 0.1 0.8 4.2 2.7 2.9 1.3 0.1 2.2 17.0 0.0 1.8 2.2 1.5 0.0 0.1 0.1 0.6 0.5 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.2 8.7 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.9 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.7 1.3 0.0 0.2 0.4 0.1 0.0 0.2 0.5 0.3 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 2.1 2.5 1.2 1.7 1.2 1.1 1.1 0.8 1.3 1.5 16.8 0.0 2.8 5.9 5.1 5.5 2.7 1.3 9.6 2.1 12.8 23.4 9.9 2.8 2.2 1.8 2.1 1.3 9.5 17.5 0.0 0.8 49.2 12.7 18.4 5.3 3.0 0.0 8.5 0.9 1.1 7.2 7.7 27.7 0.0 0.5 1.1 1.0 4.0 0.0 7.6 5.7 0.0 1.2 4.8 67.8 0.9 13.6 1.8 3.7 1.8 0.6 0.0 1.5 5.0 0.8 7.1 0.4 4.2 6.1 5.2 0.5 1.4 3.2 0.0 22.3 8.1 0.5 0.5 9.5 4.7 1.9 6.3 2.2 5.4 3.6 MAFA "hMafA, RIPE3b1" ENSG00000182759 "MAF bZIP transcription factor A" Q8NHW3 8 143419182-143430732 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 25.6" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 42.7;Skeletal myocytes: 12.8" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "spinal cord: 2.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;MCF7: 1.9;RH-30: 1.2;SCLC-21H: 2.8;T-47d: 2.6;U-2 OS: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 6: T47d - Mammary gland" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (5.92e-3)" "unprognostic (9.89e-3)" "unprognostic (2.81e-3)" "unprognostic (1.42e-8)" "unprognostic (1.75e-2)" "unprognostic (8.67e-2)" "unprognostic (6.08e-2)" "unprognostic (5.67e-2)" "unprognostic (4.41e-1)" "unprognostic (3.71e-1)" "unprognostic (1.37e-1)" "unprognostic (1.21e-1)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.00e-1)" "unprognostic (3.36e-1)" "unprognostic (3.38e-2)" 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.2 0.0 0.0 0.0 0.9 0.5 0.0 2.4 0.5 0.5 0.3 0.4 0.1 0.0 0.1 0.4 0.0 25.6 0.2 0.0 0.0 2.8 0.1 0.1 3.9 0.5 0.0 0.2 1.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.9 0.0 0.3 0.3 0.0 0.1 0.3 1.2 0.2 0.0 0.0 2.8 0.1 0.7 0.0 0.0 0.4 2.6 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.2 0.4 0.2 0.9 0.5 0.4 2.8 0.5 0.3 6.8 0.0 0.0 0.0 3.9 0.5 0.5 0.0 2.8 2.7 2.3 1.9 6.0 0.0 0.0 3.7 2.1 0.3 4.0 6.5 0.0 0.0 0.5 1.8 0.5 0.9 42.7 0.0 0.0 0.0 0.1 0.8 5.1 2.3 0.0 0.4 0.4 0.0 0.1 0.0 0.0 4.0 0.0 0.0 1.0 0.2 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 3.5 0.0 1.0 0.4 1.0 0.0 0.0 3.9 0.0 12.8 3.3 0.8 2.9 2.9 1.1 0.3 1.8 0.0 2.8 0.3 MAMSTR "FLJ36070, MASTR" ENSG00000176909 "MEF2 activating motif and SAP domain containing transcriptional regulator" Q6ZN01 19 48712725-48719725 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 32.4;skeletal muscle: 88.9;tongue: 22.6" "Cell type enhanced" "Detected in many" "Theca cells: 10.1" "Cancer enhanced" "Detected in all" "ovarian cancer: 7.0" "Region enhanced" "Detected in many" "cerebellum: 7.9" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 7.2;RH-30: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049765 Approved "Nuclear speckles" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "Nuclear speckles" "HPA049765: AB_2680870" "unprognostic (6.00e-2)" "unprognostic (3.20e-2)" "unprognostic (5.98e-2)" "unprognostic (6.07e-2)" "unprognostic (1.65e-1)" "unprognostic (6.50e-3)" "unprognostic (4.34e-4)" "unprognostic (2.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (4.65e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (2.79e-1)" "unprognostic (4.84e-2)" "unprognostic (1.39e-2)" 4.6 32.4 1.7 0.8 2.0 0.3 1.8 7.9 3.7 6.2 0.0 2.5 0.6 8.0 1.4 3.5 8.0 1.0 4.0 2.0 0.2 2.4 0.4 1.4 0.6 0.6 0.8 8.7 1.9 3.0 3.8 1.6 0.9 2.4 0.7 0.5 2.9 1.9 88.9 2.1 1.2 4.6 0.2 6.1 1.6 9.2 0.6 0.5 1.2 22.6 0.6 2.0 4.6 1.2 0.5 1.3 1.4 3.5 2.7 4.5 1.3 4.8 3.8 2.3 3.6 1.4 0.9 0.7 0.2 4.4 1.3 1.0 0.1 0.8 0.9 0.5 1.6 0.3 0.6 7.2 1.4 0.1 0.9 2.8 0.9 3.2 0.4 3.1 0.8 1.3 0.3 0.9 1.5 0.6 1.1 0.5 0.1 1.1 1.0 1.3 16.6 0.4 0.2 0.3 1.5 2.8 0.7 0.3 0.3 0.3 0.5 0.0 0.3 4.7 0.8 3.8 0.6 1.0 0.6 0.5 1.7 0.5 0.9 0.0 0.2 0.5 1.6 0.4 1.0 1.3 1.7 1.6 0.4 2.1 1.6 1.5 0.2 0.3 0.4 1.3 0.8 0.3 1.7 2.0 7.9 3.7 2.0 0.2 0.6 0.8 0.9 0.2 0.6 1.2 2.4 0.0 0.0 2.6 1.3 0.9 1.8 1.5 4.6 1.8 1.4 2.2 2.9 0.0 2.3 1.8 2.1 0.8 0.5 0.6 5.9 1.7 0.8 0.8 3.5 3.8 0.0 1.3 2.9 1.0 2.9 4.9 1.1 1.6 0.0 6.1 4.6 0.3 1.1 0.0 2.0 0.7 2.0 0.3 2.2 1.7 5.6 1.6 7.2 0.0 1.2 5.3 2.1 1.5 1.2 0.5 0.0 6.0 1.5 0.6 1.1 0.6 0.4 2.9 0.0 5.1 4.7 0.7 1.6 2.4 0.9 1.0 1.8 10.1 0.8 1.6 MINAR2 KIAA1024L ENSG00000186367 "Membrane integral NOTCH2 associated receptor 2" P59773 5 129748094-129766732 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 22 "skeletal muscle: 35.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA013760 Uncertain NA NA "Cluster 17: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" "HPA013760: AB_1852363" "unprognostic (1.77e-1)" "unprognostic (5.13e-1)" 0.2 0.1 1.1 0.0 1.0 0.1 0.2 1.1 1.4 0.1 0.6 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 1.0 1.2 0.0 0.1 0.2 0.1 1.1 1.0 0.0 0.1 0.0 0.0 0.4 1.0 0.1 0.0 0.2 0.0 0.1 35.9 0.1 0.0 0.1 0.7 0.4 0.1 0.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.3 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.4 0.1 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.4 0.5 0.3 0.0 0.4 0.1 0.1 0.1 0.0 0.2 0.2 1.4 0.0 0.9 0.2 0.0 0.3 0.1 0.0 0.5 0.3 0.2 0.1 0.0 0.2 0.1 0.3 0.0 0.7 1.3 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.2 0.6 0.1 0.2 0.8 0.1 0.0 1.1 1.0 1.1 1.4 1.0 1.2 1.1 1.0 1.0 0.7 1.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 261.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.3;Excitatory neurons: 11.9;Inhibitory neurons: 9.7;Oligodendrocyte precursor cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 1.9 1.5 1.5 1.5 1.8 1.6 1.7 4.3 2.0 3.2 1.6 2.3 1.2 2.1 1.7 1.4 2.2 1.2 10.9 1.5 0.6 1.7 1.6 2.2 1.8 0.2 0.3 3.0 1.9 56.2 2.3 0.6 0.2 2.5 1.3 2.5 1.7 0.8 261.3 3.7 2.7 1.1 0.0 3.9 1.8 1.4 0.7 1.5 1.5 5.9 1.5 2.2 2.2 1.3 0.9 0.6 1.5 2.7 2.1 2.8 1.2 0.7 0.5 0.3 0.6 0.3 0.7 2.1 0.2 0.7 0.1 1.1 1.0 0.2 0.8 1.1 0.9 1.7 1.3 0.5 0.7 1.1 1.7 2.4 0.7 0.6 1.7 2.1 0.2 0.8 0.6 1.0 1.2 0.2 0.9 1.6 0.4 0.5 0.7 0.5 4.1 0.1 0.8 0.9 0.3 0.8 0.5 1.0 0.9 1.4 0.9 0.9 1.3 1.2 0.7 0.4 1.7 0.6 2.1 1.1 0.5 1.9 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.8 4.3 2.0 1.5 0.6 0.2 0.3 0.2 0.0 0.7 1.3 0.9 0.0 3.6 4.6 1.0 0.5 0.1 0.6 0.0 1.4 0.4 0.5 5.3 0.0 0.2 0.0 0.0 0.3 0.4 0.4 0.0 0.4 0.3 0.4 0.7 1.2 0.0 1.3 11.9 0.4 0.2 0.8 1.1 0.8 5.1 1.8 1.4 0.2 0.2 0.0 9.7 0.4 0.0 0.8 0.6 0.3 3.1 0.5 0.0 4.7 1.1 0.5 1.0 6.0 3.4 0.2 3.9 1.5 0.4 0.5 0.6 0.2 0.3 1.2 0.0 4.0 0.6 0.7 0.3 0.0 0.0 0.1 1.1 1.4 0.6 0.2 MYADML2 LOC255275 ENSG00000185105 "Myeloid associated differentiation marker like 2" A6NDP7 17 81939645-81947233 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 84.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.0;Cardiomyocytes: 4.2;Early spermatids: 1.5;Excitatory neurons: 1.5;Horizontal cells: 1.7;Inhibitory neurons: 2.4;Skeletal myocytes: 1.0;Undifferentiated cells: 1.0" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041856, HPA048476" Uncertain NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 37: Myocytes - Muscle contraction" "HPA041856: AB_2677709, HPA048476: AB_2680410" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (7.07e-2)" "unprognostic (2.90e-4)" "unprognostic (2.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.44e-2)" "unprognostic (3.37e-2)" "unprognostic (4.16e-7)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-2)" 0.0 0.0 1.2 0.0 1.6 0.0 0.0 1.0 2.5 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 3.6 0.8 1.5 0.0 0.0 0.0 0.0 2.0 1.1 0.0 0.2 0.0 0.2 0.0 2.2 0.6 0.0 0.4 1.0 0.0 84.0 0.0 0.3 0.0 0.2 0.0 0.1 0.8 1.8 0.0 0.0 16.8 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.4 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 1.0 2.5 0.8 1.5 2.0 1.1 2.2 0.2 1.8 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 MYBPC1 ssMyBP-C ENSG00000196091 "Myosin binding protein C1" Q00872 12 101568353-101686028 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 87 "skeletal muscle: 11290.5;tongue: 5207.7" "Cell type enhanced" "Detected in some" "Astrocytes: 34.6;Breast glandular cells: 102.4;Breast myoepithelial cells: 81.4;Cardiomyocytes: 64.7;Skeletal myocytes: 184.6" "Cancer enhanced" "Detected in many" "prostate cancer: 33.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "HAP1: 6.8" "Group enriched" "Detected in many" 9 "cerebellum: 39.6;olfactory bulb: 10.6" "Region enhanced" "Detected in many" "thalamus: 6.9" "HPA021004, HPA027614" Enhanced NA NA 240000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 37: Myocytes - Muscle contraction" "HPA021004: AB_1854232, HPA027614: AB_10602711" "prognostic favorable (4.76e-5)" "unprognostic (7.72e-2)" "unprognostic (1.09e-1)" "unprognostic (1.81e-2)" "unprognostic (3.33e-2)" "unprognostic (4.63e-2)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (9.98e-3)" "unprognostic (2.56e-1)" "unprognostic (2.55e-1)" "unprognostic (1.19e-2)" "unprognostic (4.10e-2)" "unprognostic (7.96e-2)" "unprognostic (6.13e-2)" "unprognostic (5.55e-3)" 1.5 0.3 55.5 0.1 66.5 0.0 63.7 60.4 71.6 1.9 36.3 4.5 0.1 0.2 1.1 94.7 0.8 0.3 1.8 50.1 59.5 0.3 0.7 0.7 0.0 52.3 64.5 0.5 1.1 0.0 0.3 0.0 55.0 83.5 0.8 0.0 48.4 0.3 11290.5 6.1 7.4 0.0 49.4 0.4 1.3 3.4 68.4 2.6 1.2 5207.7 4.0 0.3 0.7 49.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 66.5 60.4 71.6 50.1 59.5 52.3 64.5 55.0 49.4 68.4 49.9 1.3 0.0 0.0 34.6 0.3 0.0 2.2 0.0 0.0 0.0 102.4 81.4 64.7 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.0 16.5 0.1 0.1 1.2 0.0 0.0 5.3 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.2 0.0 0.8 0.3 23.7 0.6 1.2 1.8 1.0 0.0 0.0 0.0 0.5 0.5 0.1 1.6 0.4 0.0 16.3 0.3 0.1 0.0 0.0 0.0 184.6 2.7 1.4 1.4 0.0 0.0 0.0 0.7 0.0 0.3 2.9 MYBPC2 "fsMyBP-C, MGC163408, MYBPCF" ENSG00000086967 "Myosin binding protein C2" Q14324 19 50432892-50466321 "Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "skeletal muscle: 4338.8;tongue: 1199.2" "Cell type enriched" "Detected in some" 29 "Skeletal myocytes: 56.9" "Cancer enriched" "Detected in some" 9 "head and neck cancer: 9.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HDLM-2: 58.7;Karpas-707: 143.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042991 Enhanced NA NA 420000 "Cluster 37: B-cells - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 2: Karpas-707 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "HPA042991: AB_2678257" "unprognostic (6.48e-3)" "unprognostic (2.65e-3)" "unprognostic (6.25e-2)" "unprognostic (3.26e-3)" "unprognostic (1.91e-3)" "unprognostic (2.15e-2)" "unprognostic (6.22e-3)" "unprognostic (2.46e-1)" "unprognostic (5.38e-2)" "unprognostic (9.65e-2)" "unprognostic (1.05e-1)" "unprognostic (1.30e-1)" "unprognostic (2.19e-8)" "unprognostic (1.85e-1)" "unprognostic (5.74e-2)" "unprognostic (2.73e-3)" "unprognostic (2.73e-1)" 0.3 0.0 0.2 1.1 0.2 0.3 0.4 0.2 0.4 0.0 0.1 0.4 0.0 0.0 0.0 4.2 0.1 0.0 0.3 0.2 0.4 0.3 0.1 0.2 1.1 0.4 0.4 0.1 0.3 212.6 0.2 0.0 0.5 6.7 0.2 0.0 12.5 0.0 4338.8 0.8 0.4 0.0 0.2 0.3 0.2 0.3 0.3 1.4 1.0 1199.2 1.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.2 0.4 0.4 0.4 0.5 0.2 0.3 0.1 0.0 0.0 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 56.9 0.5 0.2 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175826 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "salivary gland: 16.2;skeletal muscle: 74.2;tongue: 19.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.3;Hofbauer cells: 1.0;Microglial cells: 1.0;Skeletal myocytes: 2.5" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 2.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.5" "Group enriched" "Detected in some" 5 "CACO-2: 30.6;HSkMC: 56.7;THP-1: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria NA NA 9700 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: AB_2684497" "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.2 0.0 0.7 0.5 1.3 0.2 0.5 0.7 2.0 0.1 0.9 0.0 0.0 0.2 0.0 1.1 0.2 0.0 0.1 0.9 0.7 1.9 3.4 0.3 0.1 1.7 1.3 0.0 0.0 0.0 1.3 0.1 3.3 3.3 0.0 0.1 16.2 0.0 74.2 0.5 0.0 0.0 0.0 1.0 0.0 0.0 2.8 1.8 0.1 19.6 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 7.3 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 56.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.9 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.7 1.3 0.7 2.0 0.9 0.7 1.7 1.3 3.3 0.0 2.8 1.0 0.0 0.0 1.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 MYF6 "bHLHc4, MRF4" ENSG00000111046 "Myogenic factor 6" P23409 12 80707634-80709474 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "skeletal muscle: 440.0;tongue: 207.6" "Cell type enriched" "Detected in some" 39 "Skeletal myocytes: 146.1" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "LHCN-M2: 26.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (2.20e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.88e-2)" "unprognostic (6.64e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 7.7 0.0 440.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 207.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 146.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYH1 "MGC133384, MYHa, MyHC-2X/D, MYHSA1" ENSG00000109061 "Myosin heavy chain 1" P12882 17 10492307-10518542 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 137 "skeletal muscle: 7882.0" "Cell type enriched" "Detected in some" 10 "Skeletal myocytes: 77.4" "Cancer enriched" "Detected in single" 45 "head and neck cancer: 8.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001349, CAB010759" Enhanced Uncertain "Focal adhesion sites" NA NA 98000000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "Focal adhesion sites" "CAB010759: AB_477248, HPA001349: AB_1079437" "unprognostic (2.87e-2)" "unprognostic (3.27e-3)" "unprognostic (1.91e-1)" "unprognostic (8.95e-3)" "unprognostic (4.49e-2)" "unprognostic (7.31e-2)" "unprognostic (5.63e-3)" "unprognostic (9.85e-4)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" 2.6 0.1 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 3.5 0.1 0.1 0.6 0.3 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 1.3 0.0 0.0 9.1 0.1 7882.0 0.7 0.2 0.1 0.0 0.1 0.2 1.8 0.0 0.0 0.5 57.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.4 0.6 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 MYH13 MyHC-eo ENSG00000006788 "Myosin heavy chain 13" Q9UKX3 17 10300865-10373130 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 1.5;stomach 1: 1.6" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-2 OS: 2.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA 29000000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 9: U-2 OS - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (8.86e-2)" "unprognostic (2.45e-2)" "unprognostic (7.81e-2)" "unprognostic (3.95e-1)" "unprognostic (8.35e-2)" "unprognostic (1.42e-2)" "unprognostic (7.50e-3)" "unprognostic (3.15e-2)" "unprognostic (1.08e-1)" "unprognostic (8.74e-2)" "unprognostic (3.40e-9)" "unprognostic (2.44e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH2 "IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2" ENSG00000125414 "Myosin heavy chain 2" Q9UKX2 17 10521148-10549700 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 84 "skeletal muscle: 12790.2;tongue: 6140.2" "Cell type enriched" "Detected in some" 18 "Skeletal myocytes: 129.6" "Cancer enriched" "Detected in single" 60 "head and neck cancer: 27.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 4.0;HSkMC: 1.9;NTERA-2: 8.3;SuSa: 1.7" "HPA001349, CAB010760" Enhanced Uncertain "Focal adhesion sites" NA NA 81000000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 5: NTERA-2 - Transcription" "Cluster 37: Myocytes - Muscle contraction" "Focal adhesion sites" "CAB010760: AB_477190, HPA001349: AB_1079437" "unprognostic (6.50e-2)" "unprognostic (1.86e-2)" "unprognostic (4.76e-2)" "unprognostic (1.92e-2)" "unprognostic (1.05e-4)" "unprognostic (2.89e-1)" "unprognostic (9.51e-2)" "unprognostic (2.03e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" 0.5 0.1 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 46.5 0.3 0.0 0.5 0.4 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 21.5 0.0 0.0 113.1 1.0 12790.2 1.1 0.2 0.4 0.0 0.1 0.2 0.2 0.0 0.3 0.9 6140.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.6 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MYH4 "MYH2B, MyHC-2B, MyHC-IIb" ENSG00000264424 "Myosin heavy chain 4" Q9Y623 17 10443290-10469559 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "skeletal muscle: 10.6" "Cell type enriched" "Detected in single" 5 "Cardiomyocytes: 3.3" "Cancer enriched" "Detected in single" 115 "liver cancer: 9.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 25 "OE19: 9.0" HPA001349 Supported Uncertain "Focal adhesion sites" NA NA 86000000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 21: OE19 - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "Focal adhesion sites" "HPA001349: AB_1079437" "unprognostic (3.27e-2)" "unprognostic (2.94e-2)" "unprognostic (4.94e-2)" "unprognostic (1.69e-2)" "unprognostic (4.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.32e-2)" "unprognostic (1.21e-3)" "unprognostic (3.52e-4)" "unprognostic (9.97e-2)" 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 MYLK2 "KMLC, MLCK2, skMLCK" ENSG00000101306 "Myosin light chain kinase 2" Q9H1R3 20 31819308-31834689 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skeletal muscle: 732.0" "Cell type enriched" "Detected in some" 5 "Skeletal myocytes: 15.9" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.1;RH-30: 10.5;RPMI-8226: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA059704, HPA059890" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Endoplasmic reticulum" "HPA059704: AB_2684108, HPA059890: AB_2684153" "unprognostic (1.74e-2)" "unprognostic (1.87e-1)" "unprognostic (8.84e-2)" "unprognostic (5.27e-2)" "prognostic favorable (4.00e-4)" "unprognostic (5.58e-2)" "unprognostic (1.38e-7)" "unprognostic (2.29e-1)" "unprognostic (2.60e-3)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (4.73e-2)" "unprognostic (7.25e-11)" "unprognostic (2.01e-1)" "unprognostic (3.15e-1)" "unprognostic (2.60e-2)" "unprognostic (2.70e-2)" 0.1 0.0 0.6 0.1 0.6 0.4 0.1 0.6 0.7 0.0 0.5 0.2 0.0 0.1 0.1 4.7 0.1 0.0 0.3 0.6 0.6 0.0 0.0 0.1 0.0 0.6 0.7 0.1 5.5 0.0 0.1 0.0 0.7 1.1 0.0 0.0 2.4 0.0 732.0 0.6 0.1 0.1 0.6 0.3 0.2 0.2 0.7 0.2 0.2 60.3 0.0 0.0 0.0 0.6 0.3 0.0 0.7 0.6 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.2 0.2 0.5 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 1.3 0.8 0.5 0.1 4.1 0.1 0.6 0.5 0.3 0.5 0.0 0.3 0.6 10.5 8.8 0.0 0.1 0.5 0.5 2.7 0.1 0.0 0.1 0.1 0.1 2.1 0.2 0.7 0.4 2.4 0.0 0.8 0.2 0.1 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 0.7 0.6 0.6 0.6 0.7 0.7 0.6 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 MYLPF "HUMMLC2B, MRLC2, MYL11" ENSG00000180209 "Myosin light chain, phosphorylatable, fast skeletal muscle" Q96A32 16 30370934-30377991 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 108 "skeletal muscle: 19905.3;tongue: 5921.7" "Cell type enriched" "Detected in many" 29 "Skeletal myocytes: 654.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 73 "plasmacytoid DC: 19.6" "Lineage enriched" "Detected in single" 73 "dendritic cells: 19.6" "Group enriched" "Detected in some" 18 "BEWO: 75.4;HSkMC: 166.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039262, HPA055059" Enhanced NA NA 1000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 37: Myocytes - Muscle contraction" "HPA039262: AB_2676418, HPA055059: AB_2732591" "unprognostic (8.81e-3)" "unprognostic (7.55e-3)" "unprognostic (1.05e-2)" "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.37e-3)" "unprognostic (8.26e-4)" "unprognostic (1.28e-1)" "unprognostic (1.16e-2)" "unprognostic (5.52e-2)" "unprognostic (4.14e-4)" "unprognostic (1.84e-1)" "unprognostic (3.88e-1)" "unprognostic (7.07e-3)" "unprognostic (1.44e-2)" 2.0 0.5 0.1 0.2 0.0 0.6 3.3 0.3 0.3 0.3 0.0 1.0 0.0 0.5 0.1 69.9 0.0 0.0 1.7 0.1 0.0 0.4 1.2 0.9 0.3 0.1 0.1 0.7 1.3 0.0 0.5 1.2 0.1 44.7 0.1 0.1 119.3 0.1 19905.3 2.7 0.7 0.2 0.0 0.5 0.7 4.8 0.0 10.0 2.0 5921.7 0.6 0.1 0.8 0.3 0.0 0.2 0.0 0.4 0.0 0.0 75.4 0.1 0.0 0.1 0.0 3.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.2 166.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.2 0.3 0.7 0.4 0.1 0.2 0.0 3.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 6.6 1.2 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 19.6 0.0 0.2 0.1 0.0 0.3 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 1.6 3.2 2.3 0.3 2.5 0.9 1.7 8.3 0.6 1.1 8.6 7.2 1.9 4.3 5.0 7.3 0.0 15.9 13.2 2.2 0.0 0.8 14.9 3.0 3.8 3.0 3.6 0.4 0.4 0.9 16.5 2.4 1.1 6.2 8.8 0.7 5.3 1.3 4.2 0.0 0.5 2.9 2.0 4.7 11.5 22.4 1.2 5.3 1.8 1.0 3.1 1.6 19.6 1.0 1.2 0.4 5.7 0.4 2.9 1.5 1.1 4.2 3.8 1.9 0.0 654.1 5.9 4.7 1.7 1.2 1.1 6.6 4.8 0.4 2.2 2.7 MYOD1 "bHLHc1, MYF3, MYOD, PUM" ENSG00000129152 "Myogenic differentiation 1" P15172 11 17719571-17722136 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 36.1" "Group enriched" "Detected in some" 9 "Skeletal myocytes: 10.0;Spermatogonia: 3.8" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 461.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA055436, HPA078647" Enhanced Nucleoplasm NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "HPA055436: , HPA078647: " "unprognostic (1.07e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 461.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYOG "bHLHc3, MYF4" ENSG00000122180 Myogenin P15173 1 203083129-203086012 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "skeletal muscle: 101.0;tongue: 46.7" "Cell type enriched" "Detected in single" 36 "Skeletal myocytes: 11.0" "Group enriched" "Detected in some" 6 "head and neck cancer: 3.9;testis cancer: 1.7" "Region enriched" "Detected in single" 5 "cerebellum: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 222 "HSkMC: 29.6;RH-30: 57.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA028336 Supported Nucleoplasm NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "HPA028336: AB_2672562" "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (2.22e-1)" "unprognostic (2.79e-9)" "unprognostic (3.96e-1)" "unprognostic (2.56e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 2.2 0.0 0.2 4.1 0.0 101.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.6 0.0 46.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 57.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.0 0.4 0.2 2.5 0.4 0.5 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MYOZ1 "CS-2, FATZ, MYOZ" ENSG00000177791 "Myozenin 1" Q9NP98 10 73631612-73641474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 82 "skeletal muscle: 7134.0;tongue: 3308.1" "Cell type enriched" "Detected in some" 11 "Skeletal myocytes: 144.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "BEWO: 44.6" "Region enriched" "Detected in single" 17 "olfactory bulb: 3.9" "Low region specificity" "Detected in all" "HPA037848, HPA038437" Enhanced NA NA 71000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 37: Myocytes - Muscle contraction" "HPA037848: AB_10670156, HPA038437: AB_2676009" "unprognostic (4.55e-2)" "unprognostic (2.23e-1)" "unprognostic (4.90e-2)" "unprognostic (3.91e-2)" "unprognostic (1.14e-1)" "unprognostic (5.08e-2)" "unprognostic (2.76e-2)" "unprognostic (1.22e-4)" "unprognostic (1.18e-1)" "unprognostic (9.25e-2)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (5.14e-2)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" "unprognostic (7.17e-2)" "unprognostic (1.09e-1)" 3.0 0.7 2.9 0.2 3.1 0.0 2.6 2.8 3.9 1.4 2.6 0.7 0.0 1.0 23.2 63.9 1.5 1.4 45.2 2.6 3.4 2.9 0.6 5.0 0.4 3.0 2.8 1.8 0.6 0.2 2.7 2.2 3.0 22.1 0.3 1.1 36.9 3.4 7134.0 2.1 0.5 0.9 2.9 1.6 0.6 2.1 3.0 0.9 4.4 3308.1 0.4 0.9 1.6 3.0 0.0 0.0 0.3 0.0 0.0 0.0 44.6 0.3 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.2 7.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.1 2.8 3.9 2.6 3.4 3.0 2.8 3.0 2.9 3.0 3.0 0.2 0.0 0.0 0.3 0.0 0.3 1.6 0.3 0.6 2.7 1.0 1.9 9.3 0.0 1.3 5.5 0.0 0.4 0.0 0.0 7.9 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 0.2 2.5 1.5 0.0 0.0 0.0 0.9 0.0 0.0 6.3 0.0 0.1 0.0 2.0 0.0 0.8 1.2 0.9 0.7 0.0 0.0 0.0 6.1 0.0 0.5 0.1 0.0 0.0 7.5 0.0 0.3 0.0 0.4 0.1 0.6 13.1 144.4 11.6 0.4 2.2 0.1 0.3 0.1 0.6 3.0 0.0 0.3 NEB "NEB177D, NEM2" ENSG00000183091 Nebulin P20929 2 151485336-151734487 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 69 "skeletal muscle: 9300.2;tongue: 2495.6" "Cell type enriched" "Detected in many" 8 "Skeletal myocytes: 662.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 8.8;RH-30: 34.3;U-266/70: 12.8" "Group enriched" "Detected in some" 6 "cerebellum: 6.5;olfactory bulb: 4.0" "Region enriched" "Detected in some" 6 "cerebellum: 11.8" HPA016601 Enhanced NA NA 120000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "HPA016601: AB_1854361" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (2.13e-2)" "unprognostic (2.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-3)" "unprognostic (2.54e-2)" "unprognostic (1.45e-1)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-13)" "unprognostic (6.80e-2)" "unprognostic (2.22e-2)" "unprognostic (4.07e-3)" "unprognostic (4.06e-2)" 2.3 6.4 2.2 0.7 5.0 1.3 2.9 4.0 2.6 0.5 1.4 1.3 1.1 0.6 1.6 16.2 0.5 12.7 40.7 2.2 5.4 3.3 4.9 2.3 1.3 2.9 2.9 0.9 2.0 0.1 2.6 0.8 2.4 22.1 0.1 3.5 85.9 0.2 9300.2 9.3 1.8 0.2 2.0 3.0 1.1 1.7 2.9 1.1 13.0 2495.6 0.8 0.4 1.2 2.9 0.5 0.5 0.8 0.7 0.1 0.1 2.3 0.4 0.0 0.0 0.0 6.1 0.7 1.7 1.2 0.1 0.2 1.2 0.1 0.0 0.0 0.8 0.9 0.6 1.1 2.0 0.0 1.1 1.5 5.0 0.3 0.1 0.0 0.3 0.8 0.5 1.2 8.8 0.5 0.7 0.6 1.1 1.4 3.0 1.0 1.6 34.3 0.2 0.1 1.2 2.0 0.3 0.3 0.4 0.2 1.3 0.9 1.1 0.8 0.9 1.2 0.1 1.2 12.8 2.0 0.4 0.2 0.8 1.5 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.2 5.0 4.0 2.6 2.2 5.4 2.9 2.9 2.4 2.0 2.9 2.9 0.3 0.0 1.1 14.0 2.0 0.8 1.2 0.2 2.8 2.4 0.5 0.4 82.6 18.6 0.7 0.0 0.0 0.5 1.2 0.0 0.0 0.5 7.6 1.4 1.5 2.1 1.8 0.0 13.1 0.0 0.4 10.6 2.0 2.5 1.3 2.2 0.7 2.4 0.7 3.3 9.2 0.0 4.1 1.3 0.7 7.6 0.6 2.7 0.0 7.5 0.2 0.4 0.0 6.0 5.2 0.1 0.0 0.0 2.0 1.1 0.3 0.4 0.1 1.7 0.0 662.8 1.9 1.4 1.6 0.2 1.3 0.8 1.1 1.5 0.0 0.2 NFIC "CTF, CTF5, NF-I, NFI" ENSG00000141905 "Nuclear factor I C" P08651 19 3314403-3469217 "Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 293.6" "Cell type enhanced" "Detected in all" "Hepatocytes: 394.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 168.4;U-2197: 164.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004300, CAB004674, HPA052625" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Nucleoli fibrillar center" "CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889" "unprognostic (2.59e-1)" "unprognostic (5.07e-3)" "unprognostic (2.11e-1)" "prognostic favorable (1.52e-6)" "unprognostic (8.38e-2)" "unprognostic (1.71e-3)" "unprognostic (1.14e-1)" "unprognostic (3.04e-1)" "unprognostic (9.66e-2)" "unprognostic (1.73e-1)" "unprognostic (6.81e-2)" "unprognostic (3.16e-2)" "unprognostic (2.03e-2)" "unprognostic (2.54e-1)" "unprognostic (9.65e-2)" "unprognostic (2.85e-2)" "unprognostic (1.80e-3)" 42.9 51.0 18.8 18.0 28.4 9.3 38.5 27.2 46.4 50.5 14.1 58.9 9.2 53.6 10.1 32.5 44.7 16.3 62.6 15.5 17.1 21.2 56.8 34.7 6.3 40.0 33.6 52.3 68.7 29.5 29.2 7.5 39.4 39.2 7.7 10.5 45.3 33.1 293.6 42.0 22.9 28.8 31.4 20.1 43.1 13.1 35.7 7.8 33.7 63.1 5.7 46.3 36.3 30.0 63.5 92.8 1.1 53.7 47.9 41.2 5.6 55.6 30.3 36.9 25.7 2.3 20.8 0.5 19.2 51.1 26.4 30.1 15.4 37.8 15.6 44.6 13.7 11.6 75.1 19.2 37.2 19.0 22.8 34.8 25.9 50.2 19.8 24.3 34.9 3.6 32.8 55.3 28.1 45.7 11.1 4.0 3.0 2.8 37.8 28.1 34.0 23.1 14.7 13.3 12.6 32.1 168.4 16.4 17.0 0.8 48.7 14.1 49.5 61.7 56.2 164.1 76.3 1.9 2.5 0.5 83.9 38.6 91.8 1.5 4.1 1.8 2.3 4.0 1.9 1.5 2.2 2.2 3.1 1.6 1.5 1.5 8.7 5.9 0.9 1.2 0.8 3.0 18.8 28.4 27.2 46.4 15.5 17.1 40.0 33.6 39.4 31.4 35.7 30.0 96.4 80.1 82.6 40.8 18.9 100.1 136.5 85.5 174.8 189.5 117.1 101.2 124.8 270.2 50.0 92.0 58.4 9.7 12.4 25.6 52.8 146.5 32.0 77.7 156.3 101.9 47.9 31.1 42.2 190.8 5.9 174.6 80.5 140.1 26.0 85.5 112.5 394.2 55.9 80.8 34.4 41.9 63.1 146.1 50.2 22.0 252.5 58.2 46.2 46.9 56.8 151.1 11.3 21.1 44.5 113.8 32.0 253.2 20.8 175.1 27.0 59.4 67.7 65.4 72.3 285.7 110.8 14.6 39.2 124.7 97.7 8.5 26.1 62.3 59.3 101.2 NT5C1A "CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201" ENSG00000116981 "5'-nucleotidase, cytosolic IA" Q9BXI3 1 39659121-39672038 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 72.4;tongue: 28.6" "Cell type enhanced" "Detected in single" "Inhibitory neurons: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "SH-SY5Y: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050283, HPA054158" Supported NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA050283: AB_2681072, HPA054158: AB_2682402" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (6.19e-1)" "unprognostic (1.51e-3)" "unprognostic (7.19e-2)" "unprognostic (2.87e-1)" "unprognostic (3.34e-1)" "unprognostic (1.32e-1)" "unprognostic (3.29e-2)" "unprognostic (1.81e-2)" 0.2 2.6 1.4 0.1 0.8 0.0 0.0 4.8 5.4 0.2 0.0 0.0 0.0 0.1 0.1 3.0 0.2 0.0 11.4 0.7 1.6 0.4 0.0 0.0 0.0 3.0 3.1 0.1 3.9 0.0 0.0 0.0 2.0 0.5 0.0 0.1 0.1 0.1 72.4 0.0 0.1 0.1 1.4 0.0 0.1 0.2 2.2 0.1 0.0 28.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 17.8 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 4.8 5.4 0.7 1.6 3.0 3.1 2.0 1.4 2.2 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NT5C3A "cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1" ENSG00000122643 "5'-nucleotidase, cytosolic IIIA" Q9H0P0 7 33014114-33062797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.4" "Cell type enhanced" "Detected in all" "Distal enterocytes: 191.0;Paneth cells: 186.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010520, HPA010630, HPA029058" Uncertain Supported "Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 10000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 51: Myeloid cells - Hemostasis" "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380" "unprognostic (7.50e-2)" "unprognostic (3.10e-1)" "unprognostic (1.14e-1)" "unprognostic (2.69e-2)" "unprognostic (1.22e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (3.25e-2)" "unprognostic (3.12e-2)" "unprognostic (2.82e-3)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (9.37e-2)" "unprognostic (2.05e-1)" "unprognostic (2.12e-3)" "unprognostic (3.43e-3)" 12.4 14.3 11.4 26.1 11.4 32.6 21.3 15.2 15.6 12.6 10.8 51.9 40.0 16.9 14.3 18.6 15.9 23.4 16.6 11.5 11.5 22.4 11.8 17.6 30.8 11.1 11.8 13.4 21.4 9.7 7.5 16.3 11.5 12.3 51.0 20.4 9.7 10.0 87.4 28.7 37.3 13.2 12.7 22.9 27.0 9.5 12.0 22.5 17.1 51.0 45.8 23.8 14.4 13.1 42.2 27.6 25.2 29.6 21.2 16.1 20.3 44.8 30.5 29.2 38.9 19.9 115.1 100.4 27.7 29.6 48.3 63.8 28.3 30.8 40.4 16.2 36.2 54.7 36.5 28.7 23.3 55.6 36.9 21.7 23.8 35.9 63.0 16.4 22.2 33.2 43.3 24.8 37.3 29.9 25.0 87.8 27.8 47.1 31.2 25.9 22.9 60.0 87.8 39.8 28.1 37.0 31.1 52.4 66.6 24.5 35.2 33.5 19.8 25.1 20.9 42.6 55.7 50.6 69.0 54.8 20.6 34.9 42.5 112.5 25.9 82.5 26.6 32.7 30.6 64.0 34.2 30.8 22.1 63.6 34.5 29.1 103.8 28.2 39.2 20.6 56.2 37.9 11.4 11.4 15.2 15.6 11.5 11.5 11.1 11.8 11.5 12.7 12.0 13.1 39.1 22.4 13.7 30.7 85.1 46.8 40.9 85.3 47.8 23.9 22.6 18.9 16.9 32.9 40.4 16.5 41.7 36.9 42.5 191.0 29.4 34.4 5.7 40.9 21.0 40.8 119.6 127.1 45.3 79.0 31.6 35.2 42.8 21.4 17.7 38.3 30.0 18.9 25.0 1.7 49.4 98.9 40.7 31.2 23.5 5.0 33.8 111.4 26.6 29.0 37.0 23.4 55.6 48.2 52.4 48.3 186.6 22.2 43.8 45.7 91.8 84.8 53.7 27.1 13.1 30.7 24.9 46.4 24.0 35.5 38.9 28.3 53.7 23.3 71.0 65.9 OBSCN "ARHGEF30, KIAA1556, KIAA1639, UNC89" ENSG00000154358 "Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF" Q5VST9 1 228208044-228378876 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 481.3" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 155.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 10.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA021186, HPA065801" Enhanced Approved "Plasma membrane,Cytosol" NA NA 4500000 "Cluster 7: Monocytes - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane, Cytosol" "HPA021186: AB_1854761, HPA065801: " "unprognostic (8.47e-3)" "unprognostic (1.56e-1)" "unprognostic (9.99e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (5.30e-3)" "unprognostic (6.36e-2)" "unprognostic (4.54e-3)" "unprognostic (1.82e-1)" "unprognostic (8.81e-2)" "unprognostic (1.93e-2)" "unprognostic (3.38e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-2)" 3.5 2.5 2.4 1.4 18.4 1.6 3.7 10.4 4.4 8.1 18.1 5.2 0.7 3.7 1.8 4.6 5.1 1.1 78.5 0.9 2.7 6.6 1.3 8.9 2.1 4.3 2.7 8.6 5.4 1.1 13.6 0.9 2.4 9.9 0.5 0.8 9.4 1.7 481.3 4.7 5.4 0.5 1.0 9.3 5.2 1.9 6.3 4.9 7.5 112.8 1.3 3.2 7.4 0.1 1.7 2.8 3.6 3.7 0.2 0.2 4.6 1.6 0.7 1.7 1.4 2.1 1.3 3.2 5.4 0.7 0.7 2.1 1.3 2.2 0.3 2.0 3.4 1.7 10.5 0.1 1.2 2.4 2.2 1.4 0.6 0.4 0.5 5.1 0.5 7.0 3.2 0.0 0.3 1.8 3.3 3.5 4.9 0.6 2.1 4.4 0.0 1.9 1.8 1.4 1.7 6.3 0.6 3.9 1.0 0.8 3.4 4.0 1.0 0.0 5.1 0.3 0.5 2.5 0.5 4.7 0.0 0.8 2.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 2.4 18.4 10.4 4.4 0.9 2.7 4.3 2.7 2.4 1.0 6.3 0.1 1.5 0.0 5.5 1.6 2.4 2.2 6.6 7.7 23.9 4.2 7.3 11.9 155.8 4.3 4.5 5.5 10.4 0.1 1.9 0.7 11.7 3.6 4.9 3.9 3.7 3.1 0.0 3.0 3.9 0.5 0.5 5.7 3.1 11.3 7.0 1.8 1.4 0.5 0.1 0.0 5.3 2.7 4.1 0.3 1.0 4.5 3.1 1.1 1.8 5.6 0.5 7.9 4.1 1.5 1.7 0.8 1.1 4.5 1.5 3.8 0.6 4.1 1.3 3.2 0.0 22.9 6.1 1.0 4.1 9.4 1.7 1.2 5.4 6.2 1.2 3.6 OPTN "FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP" ENSG00000123240 Optineurin Q96CV9 10 13099449-13138308 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "skeletal muscle: 879.4;tongue: 394.5" "Cell type enhanced" "Detected in all" "Late spermatids: 933.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003279, HPA003360, CAB019303" Approved Enhanced Cytosol NA NA 370000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528" "unprognostic (2.84e-2)" "unprognostic (3.37e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-3)" "unprognostic (5.58e-2)" "unprognostic (3.74e-2)" "unprognostic (5.15e-3)" "unprognostic (3.14e-2)" "unprognostic (2.68e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-2)" "unprognostic (6.14e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (7.62e-2)" "unprognostic (5.67e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" 92.7 90.4 45.7 35.8 53.5 50.1 64.0 45.9 55.9 52.3 36.8 55.4 63.2 39.7 21.9 61.8 37.7 41.6 105.7 54.9 49.2 72.3 73.8 58.9 45.7 48.0 53.9 92.1 35.4 33.1 33.8 57.5 52.9 34.1 57.2 48.8 46.3 41.4 879.4 77.9 69.6 43.4 44.3 57.3 56.1 72.8 45.4 30.1 27.1 394.5 37.6 43.8 56.3 49.0 83.3 23.1 12.8 17.8 171.4 175.6 15.2 97.6 110.7 72.1 119.0 41.1 108.1 0.7 37.6 134.3 113.2 75.6 17.3 93.5 54.8 192.9 9.2 17.2 32.1 22.0 175.4 0.6 59.5 94.6 72.6 69.2 71.8 177.9 62.4 23.8 21.5 123.7 98.7 17.6 8.3 2.3 5.2 22.4 10.3 1.4 25.5 8.5 87.9 57.6 2.8 13.6 84.9 25.0 64.3 49.9 54.6 11.4 171.6 58.8 28.9 81.0 27.5 63.3 23.5 0.6 88.3 14.3 11.4 47.9 2.5 0.3 56.1 1.5 43.3 18.0 71.2 65.8 0.5 11.7 28.0 34.5 1.7 51.2 3.8 5.2 109.6 30.2 45.7 53.5 45.9 55.9 54.9 49.2 48.0 53.9 52.9 44.3 45.4 49.0 68.2 67.3 29.4 18.6 25.9 74.4 46.6 104.5 67.2 38.7 30.5 32.9 237.7 68.6 81.3 31.3 18.8 112.8 89.8 199.8 33.2 135.5 281.9 36.0 38.6 82.4 42.6 126.5 48.9 114.0 39.8 91.6 88.7 37.4 70.8 92.8 47.8 30.9 31.6 90.9 26.6 106.4 65.1 15.1 26.0 933.6 95.7 14.5 90.7 25.3 36.6 36.4 119.4 13.6 28.1 166.3 186.9 103.4 86.3 92.3 209.9 162.4 73.7 103.4 111.7 63.1 106.6 102.0 13.7 58.1 77.9 75.4 107.5 166.3 44.1 75.0 PCNT "KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4" ENSG00000160299 Pericentrin O95613 21 46324141-46445769 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 239.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 4.6;granulocytes: 6.0;T-cells: 8.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016820, HPA019887, HPA032101" Uncertain Supported "Centriolar satellite,Centrosome,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 37: Myocytes - Muscle contraction" Centrosome "Centriolar satellite, Cytosol" "HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151" "unprognostic (9.07e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (1.30e-2)" "unprognostic (5.35e-2)" "unprognostic (3.40e-3)" "unprognostic (1.27e-2)" "unprognostic (2.59e-1)" "unprognostic (9.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.59e-3)" "unprognostic (3.86e-2)" "unprognostic (1.95e-2)" "unprognostic (5.83e-2)" "unprognostic (2.90e-1)" "unprognostic (3.36e-1)" "unprognostic (5.86e-2)" 9.7 11.1 7.6 5.9 10.5 17.7 8.9 4.2 11.9 8.6 5.3 10.7 4.1 8.2 4.3 11.7 8.5 3.6 28.3 6.0 5.4 7.7 10.9 8.2 8.2 9.0 3.9 9.6 7.8 4.3 20.3 3.5 9.5 8.2 4.3 4.6 9.7 4.2 239.2 12.3 10.1 4.4 2.6 11.5 9.5 25.6 4.7 12.5 8.4 52.0 5.5 9.6 9.2 7.4 15.4 11.6 18.0 11.1 8.9 8.8 11.3 11.6 8.0 11.3 10.0 14.2 9.7 15.2 7.3 13.4 15.3 10.8 14.6 9.9 7.8 44.9 20.4 40.2 24.1 11.3 3.1 20.6 16.1 4.8 7.5 15.2 7.6 5.5 8.8 15.8 20.9 22.4 15.8 25.4 20.6 21.3 18.0 13.9 8.0 25.3 7.2 13.5 8.7 16.3 22.1 9.8 25.4 15.7 8.0 4.4 14.8 16.0 12.1 20.4 10.2 11.7 18.9 19.3 17.2 16.4 12.6 19.9 11.1 6.0 0.6 1.2 1.5 0.5 4.6 0.3 0.7 4.8 2.0 0.1 0.5 8.8 0.4 0.4 1.0 4.6 0.8 2.0 7.6 10.5 4.2 11.9 6.0 5.4 9.0 3.9 9.5 2.6 4.7 7.4 10.5 28.9 32.0 19.9 8.6 8.3 5.7 7.0 13.6 15.0 8.9 8.6 35.7 10.0 15.3 0.0 6.2 6.4 36.7 14.0 0.0 7.1 20.4 17.0 19.9 10.1 15.6 36.2 38.1 7.6 7.4 13.1 25.0 17.8 16.4 25.4 7.1 9.0 23.3 23.5 39.0 11.2 4.1 6.9 5.5 25.6 12.8 12.7 0.0 17.8 14.7 6.8 25.7 10.6 21.9 5.7 5.7 12.0 31.4 4.2 5.7 4.1 13.0 11.1 26.3 61.3 14.2 40.5 39.8 25.0 7.1 6.4 18.8 15.1 10.4 5.1 PDLIM3 ALP ENSG00000154553 "PDZ and LIM domain 3" Q53GG5 4 185500660-185535507 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 4781.7;tongue: 1519.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 228.9;Ductal cells: 332.7;Melanocytes: 124.5;Peritubular cells: 196.0;Skeletal myocytes: 428.3;Smooth muscle cells: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 115.6;RH-30: 26.9;U-266/70: 111.2;U-266/84: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004749 Enhanced Supported Cytosol NA NA 240000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 37: Myocytes - Muscle contraction" Cytosol "HPA004749: AB_1855150" "unprognostic (2.75e-1)" "unprognostic (3.85e-2)" "unprognostic (3.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (9.46e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.97e-7)" "unprognostic (1.64e-3)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.78e-3)" 36.3 11.5 12.7 25.7 13.3 0.0 34.5 16.8 14.8 22.7 10.9 201.2 20.8 235.3 59.1 216.2 97.5 40.1 314.0 12.0 15.7 13.9 7.7 55.2 10.7 19.9 14.2 38.1 18.7 0.8 20.7 18.8 13.8 87.0 32.5 11.2 56.3 148.1 4781.7 12.1 69.0 127.6 17.9 24.5 95.8 8.2 14.6 4.1 32.7 1519.6 26.2 141.1 40.8 14.2 0.0 0.0 0.9 0.0 0.3 0.0 0.8 0.0 0.0 0.3 1.0 1.2 0.4 0.0 0.0 0.0 6.0 0.0 0.0 0.2 0.0 0.0 15.1 0.0 0.8 4.7 13.5 0.0 0.0 8.7 0.0 2.6 0.0 12.3 9.1 0.0 0.0 0.0 115.6 0.0 0.0 0.1 2.4 0.0 1.0 0.0 26.9 0.3 0.0 0.0 17.6 13.3 0.0 0.0 7.3 2.8 0.6 0.0 7.9 0.0 7.6 0.1 7.1 111.2 34.8 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 13.3 16.8 14.8 12.0 15.7 19.9 14.2 13.8 17.9 14.6 14.2 22.4 9.6 6.0 37.2 2.6 8.9 11.4 0.7 12.5 12.1 72.8 105.7 228.9 5.7 2.2 0.0 12.5 2.5 0.6 0.2 0.0 332.7 0.4 1.4 0.8 39.0 3.5 0.0 2.5 16.7 2.7 82.9 1.1 1.1 0.0 1.3 67.5 0.9 1.6 5.0 0.5 0.5 2.0 1.8 11.7 2.6 19.6 2.3 124.5 1.0 3.2 36.4 0.0 6.6 2.6 31.2 0.0 196.0 7.3 12.2 0.0 0.2 3.2 44.3 105.2 428.3 131.4 4.0 12.6 2.4 7.1 12.2 2.5 2.4 0.3 3.9 PGM1 ENSG00000079739 "Phosphoglucomutase 1" P36871 1 63593411-63660245 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Congenital disorder of glycosylation, Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 1559.1;tongue: 788.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 238.4;Extravillous trophoblasts: 185.9;Hepatocytes: 214.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004666, HPA024190, HPA024637, HPA046329" Enhanced Supported Cytosol NA NA 21000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol "CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625" "unprognostic (2.50e-1)" "unprognostic (2.26e-3)" "unprognostic (1.74e-2)" "unprognostic (5.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.28e-2)" "unprognostic (1.86e-3)" "unprognostic (2.42e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.74e-5)" "unprognostic (7.07e-2)" "unprognostic (1.55e-2)" "unprognostic (6.58e-3)" "unprognostic (1.37e-1)" "unprognostic (2.46e-1)" "unprognostic (9.74e-3)" 113.7 70.8 31.6 20.7 34.7 21.5 57.4 34.3 38.4 33.9 53.1 58.9 60.8 22.9 19.2 49.3 17.0 30.3 178.9 31.4 34.0 52.2 279.8 42.6 14.7 44.7 34.1 51.0 112.2 65.3 31.8 26.9 32.7 46.6 49.9 22.6 41.8 49.7 1559.1 30.6 55.1 41.4 31.9 14.7 30.6 11.1 36.5 14.3 27.5 788.0 19.4 38.4 22.1 30.2 113.4 47.0 17.3 57.0 111.0 81.4 138.6 45.7 61.8 48.9 79.0 38.8 51.3 35.8 93.2 71.2 107.4 26.5 24.0 96.3 55.9 44.0 32.1 75.3 72.6 40.3 91.6 66.8 4.3 103.4 60.7 57.1 88.5 129.8 29.6 36.3 0.1 46.3 78.8 6.9 19.6 36.7 78.3 3.4 73.9 26.8 80.0 11.8 70.0 35.3 10.4 66.7 100.0 103.0 157.4 78.6 32.4 25.2 3.1 71.6 36.0 64.0 39.4 29.1 45.5 57.8 117.0 58.0 31.5 46.0 33.2 49.2 40.5 22.4 32.7 22.4 23.5 31.0 48.4 11.8 21.0 24.7 38.7 43.9 21.2 13.9 20.4 35.4 31.6 34.7 34.3 38.4 31.4 34.0 44.7 34.1 32.7 31.9 36.5 30.2 8.4 93.0 29.4 48.3 16.9 17.8 29.0 58.8 47.8 9.2 33.8 21.8 139.2 48.6 24.2 16.5 10.4 76.6 14.2 81.8 88.0 55.9 32.0 8.2 12.1 12.7 13.1 5.7 17.9 238.4 185.9 37.0 27.0 13.5 5.1 134.3 15.0 214.4 24.6 0.0 26.3 47.5 20.3 17.0 10.8 8.5 22.1 13.5 26.6 4.7 32.8 75.8 29.9 32.2 9.8 70.5 31.6 38.0 40.4 29.2 90.2 74.8 17.0 11.4 13.1 53.4 25.5 5.6 10.1 57.3 18.2 58.8 19.0 20.2 81.5 19.0 PGPEP1L ENSG00000183571 "Pyroglutamyl-peptidase I like" A6NFU8 15 98968229-99007792 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 30.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.1;Distal tubular cells: 1.9;Early spermatids: 3.8;Excitatory neurons: 3.8;Inhibitory neurons: 3.3;Late spermatids: 1.7;Skeletal myocytes: 2.1;Spermatocytes: 2.7;Spermatogonia: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA041781 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "HPA041781: AB_10795642" "unprognostic (2.48e-1)" "unprognostic (2.82e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-3)" "unprognostic (7.18e-2)" "unprognostic (3.99e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (9.78e-2)" "unprognostic (1.58e-1)" "unprognostic (4.53e-3)" "unprognostic (1.86e-1)" "unprognostic (2.62e-1)" "unprognostic (2.00e-2)" "unprognostic (1.65e-1)" 0.2 0.1 0.7 0.2 0.9 0.1 0.4 0.0 1.1 0.2 0.0 0.5 0.2 0.2 0.0 0.8 0.1 0.5 3.8 0.5 0.4 0.4 0.0 0.2 0.3 0.2 0.3 0.1 0.5 0.0 0.1 0.2 0.1 0.5 0.0 0.1 0.6 0.5 30.9 0.1 0.1 0.1 0.0 0.0 0.2 2.0 0.4 0.1 0.1 7.5 0.0 0.3 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 1.1 0.5 0.4 0.2 0.3 0.1 0.0 0.4 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 3.8 0.1 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.9 2.7 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PPDPFL C8orf22 ENSG00000168333 "Pancreatic progenitor cell differentiation and proliferation factor like" Q8WWR9 8 49054311-49076093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 948.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "glioma: 0.7;renal cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "HEL: 1.3" HPA060329 Uncertain NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 50: Fibroblasts - ECM organization" "HPA060329: AB_2684255" "unprognostic (6.33e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.06e-10)" 2.6 0.1 0.2 0.0 0.6 0.0 1.1 0.6 0.5 0.0 0.2 0.2 0.0 0.0 0.0 2.4 0.1 0.0 1.6 0.3 1.4 0.0 0.1 0.1 0.0 1.0 0.2 0.1 0.1 0.0 0.3 0.0 1.1 2.3 0.0 0.3 9.8 0.2 948.1 1.7 0.2 0.0 0.5 0.0 0.1 0.2 0.4 0.0 0.3 112.8 0.0 0.3 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.6 0.5 0.3 1.4 1.0 0.2 1.1 0.5 0.4 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R27 "DYSFIP1, toonin" ENSG00000182676 "Protein phosphatase 1 regulatory subunit 27" Q86WC6 17 81833492-81835050 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "skeletal muscle: 1205.9" "Group enriched" "Detected in some" 14 "Early spermatids: 56.5;Skeletal myocytes: 108.8" "Cancer enriched" "Detected in single" 10 "head and neck cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "HL-60: 206.4;THP-1: 385.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA042227, HPA048632" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 43: THP-1 - Innate immune response" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane, Cytosol" "HPA042227: , HPA048632: AB_2680469" "unprognostic (3.35e-2)" "unprognostic (1.12e-4)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-1)" "unprognostic (1.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.21e-2)" "unprognostic (7.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.98e-6)" "unprognostic (7.97e-2)" "unprognostic (1.21e-1)" "unprognostic (2.19e-3)" "unprognostic (1.30e-1)" 0.3 0.9 0.0 0.0 0.1 1.3 0.4 0.2 0.3 0.4 0.0 0.2 0.0 0.1 0.0 1.2 0.1 0.0 0.5 0.1 0.0 0.2 0.7 0.2 0.0 0.1 0.0 0.2 0.4 0.0 11.8 0.0 0.1 1.8 0.0 0.0 5.8 0.0 1205.9 2.1 0.2 0.0 0.0 0.2 0.1 0.5 0.1 0.1 0.4 47.6 0.0 0.1 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 206.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 1.4 0.2 0.0 0.0 385.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 1.3 0.0 0.0 0.0 0.3 0.0 0.3 0.1 1.2 2.9 1.3 2.4 0.6 0.0 0.2 0.0 0.0 3.0 0.3 1.6 0.0 0.0 56.5 0.9 0.7 0.9 1.2 0.0 0.0 0.5 2.7 0.6 0.0 1.5 0.0 0.7 1.1 1.2 0.6 0.0 0.0 1.1 0.0 0.0 0.4 5.7 0.9 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.3 4.7 0.2 0.2 0.2 0.0 108.8 0.5 1.7 0.6 1.2 0.1 1.4 0.2 0.2 1.6 0.5 PRAMEF9 ENSG00000204505 "PRAME family member 9" 1 13171848-13179459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 52 "skeletal muscle: 33.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 33: Striated muscle - Muscle contraction" 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 33.3 0.3 0.1 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.3 0.1 0.6 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.2 0.8 0.2 0.0 0.5 0.1 0.0 0.5 0.0 0.3 0.4 0.2 0.0 0.5 0.2 0.0 0.1 0.2 0.2 0.2 0.4 0.4 0.1 0.0 0.5 0.2 0.2 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRKAG3 ENSG00000115592 "Protein kinase AMP-activated non-catalytic subunit gamma 3" Q9UGI9 2 218822383-218832086 "FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "skeletal muscle: 70.4;tongue: 17.9" "Cell type enhanced" "Detected in single" "Skeletal myocytes: 3.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (3.51e-1)" "unprognostic (4.41e-3)" "unprognostic (2.05e-1)" "unprognostic (1.53e-1)" "unprognostic (2.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.86e-3)" "unprognostic (7.74e-2)" "unprognostic (3.44e-2)" "unprognostic (5.85e-2)" "unprognostic (3.27e-1)" "unprognostic (9.04e-2)" "unprognostic (9.95e-2)" "unprognostic (1.49e-1)" "unprognostic (2.97e-1)" "unprognostic (7.69e-2)" 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.8 0.0 70.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 17.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PYGM GSD5 ENSG00000068976 "Glycogen phosphorylase, muscle associated" P11217 11 64746389-64759974 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 65 "skeletal muscle: 8468.3;tongue: 3594.2" "Cell type enhanced" "Detected in many" "Astrocytes: 29.7;Cardiomyocytes: 47.5;Late spermatids: 49.2;Peritubular cells: 44.0;Skeletal myocytes: 64.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 8.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.1" "Cell line enhanced" "Detected in some" "HSkMC: 3.7;NB-4: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056003 Enhanced NA NA 10000000 "Cluster 10: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" "HPA056003: AB_2683006" "unprognostic (3.33e-1)" "unprognostic (6.03e-3)" "unprognostic (3.87e-4)" "unprognostic (1.95e-3)" "unprognostic (8.71e-2)" "unprognostic (1.09e-2)" "unprognostic (1.25e-3)" "unprognostic (2.92e-1)" "unprognostic (3.88e-1)" "unprognostic (3.08e-2)" "unprognostic (1.12e-1)" "unprognostic (2.64e-1)" "unprognostic (6.33e-6)" "unprognostic (3.37e-3)" "unprognostic (1.81e-1)" "unprognostic (1.62e-2)" "unprognostic (5.68e-2)" 15.2 3.0 35.4 2.1 30.1 1.2 7.7 55.5 29.4 5.8 15.5 25.5 1.5 10.4 6.4 92.2 14.6 3.8 70.8 26.8 26.1 2.4 1.2 2.7 2.2 48.8 30.4 4.0 1.6 0.3 1.7 1.4 39.6 25.6 3.6 2.9 50.0 26.3 8468.3 4.2 7.0 14.7 44.9 3.3 6.9 6.7 47.3 1.3 5.2 3594.2 1.2 16.7 5.2 38.1 0.1 0.0 0.7 0.1 0.5 0.7 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.6 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.6 0.1 0.3 0.2 0.0 0.3 0.4 0.1 3.7 0.2 0.2 0.1 0.0 0.0 1.1 0.7 0.6 0.0 1.1 0.7 2.2 0.7 0.1 0.1 0.4 0.7 0.1 0.0 0.1 0.2 0.0 0.2 0.3 0.4 0.4 0.3 0.4 0.3 0.0 0.4 0.1 0.0 1.0 1.4 0.4 0.0 0.1 0.0 8.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.1 0.0 1.1 0.0 0.1 0.1 1.3 0.0 0.2 0.2 0.1 35.4 30.1 55.5 29.4 26.8 26.1 48.8 30.4 39.6 44.9 47.3 38.1 2.4 0.0 2.3 29.7 3.0 0.8 0.6 0.2 5.2 3.5 2.9 4.7 47.5 0.0 0.8 0.0 4.2 0.6 1.9 1.0 0.0 0.1 11.7 1.6 5.2 2.0 0.0 0.0 0.2 0.0 0.2 5.1 1.1 4.0 0.0 0.8 1.8 0.0 0.5 0.0 0.2 0.9 0.0 0.6 1.3 49.2 16.4 2.3 0.0 1.0 0.5 9.9 4.1 0.5 0.4 0.3 0.2 44.0 0.3 1.3 0.6 0.0 0.1 1.3 6.6 64.3 12.8 1.2 0.9 2.5 0.6 0.1 2.9 0.9 1.1 0.3 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 984.0;tongue: 447.9" "Cell type enhanced" "Detected in all" "Erythroid cells: 901.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Supported Nucleoplasm,Cytosol NA NA 3400000 "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm Cytosol "HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516" "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 79.2 63.4 77.8 49.4 79.8 85.8 71.0 78.1 95.7 59.2 71.0 91.6 48.4 65.0 31.2 70.0 64.1 38.2 132.4 80.5 79.8 54.1 70.4 66.4 55.9 80.5 76.7 56.2 76.7 66.1 47.7 55.5 80.1 57.5 35.8 24.5 68.0 52.5 984.0 72.6 52.8 54.8 77.0 54.5 66.4 48.7 79.4 53.0 54.9 447.9 44.0 78.5 57.1 82.0 138.0 52.6 55.7 57.4 91.5 104.1 94.7 66.1 130.2 152.6 137.2 59.8 95.3 117.3 150.0 99.4 104.4 102.7 78.0 137.7 55.9 170.0 109.8 47.2 57.3 58.3 181.7 102.1 130.7 107.9 199.6 110.1 208.9 89.7 105.4 188.0 124.1 102.1 138.2 139.8 126.6 124.2 76.5 124.6 135.6 65.4 59.4 189.6 118.9 53.8 104.3 81.8 75.4 129.1 145.8 40.2 100.4 173.7 82.5 214.9 57.4 263.3 203.9 148.2 133.8 86.0 177.9 193.3 183.2 31.3 76.3 64.9 81.1 102.4 87.3 77.5 66.8 69.1 68.3 73.5 63.3 73.4 9.2 79.1 105.3 86.0 82.0 69.1 77.8 79.8 78.1 95.7 80.5 79.8 80.5 76.7 80.1 77.0 79.4 82.0 120.2 86.6 56.2 11.8 127.6 120.4 176.8 165.2 122.3 51.7 110.3 121.3 59.5 108.7 108.4 55.2 20.9 212.0 99.6 95.7 166.3 179.5 193.1 74.3 76.9 120.4 87.3 901.4 22.0 191.0 240.1 101.4 101.9 74.1 111.5 77.7 86.4 96.2 175.3 52.2 22.9 138.5 136.3 88.3 170.3 44.1 118.4 119.6 142.3 12.2 182.5 73.9 94.7 15.6 25.8 184.1 119.0 114.0 159.0 351.3 139.9 163.3 91.1 56.1 111.7 138.3 129.3 263.6 179.6 153.3 146.5 244.8 113.0 117.8 154.8 211.1 RAPSN "CMS1D, CMS1E, RNF205" ENSG00000165917 "Receptor associated protein of the synapse" Q13702 11 47437764-47449143 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "skeletal muscle: 88.9;tongue: 33.1" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 63.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 238.7" "Low region specificity" "Detected in some" HPA039475 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Centrosome, Cytosol" "HPA039475: AB_10794196" "unprognostic (5.37e-2)" "unprognostic (1.02e-1)" "unprognostic (7.34e-2)" "unprognostic (4.58e-2)" "unprognostic (2.95e-2)" "unprognostic (1.44e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-3)" "unprognostic (1.35e-1)" "unprognostic (5.38e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.64e-4)" "unprognostic (3.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.48e-2)" 0.3 1.5 0.5 0.2 0.5 0.3 0.2 0.3 1.2 0.2 0.9 0.8 0.1 0.0 0.1 1.2 0.1 0.1 2.6 0.5 0.5 0.3 0.5 0.4 0.2 0.3 0.5 0.0 0.2 0.0 0.1 2.1 0.5 0.7 0.0 0.1 1.3 0.0 88.9 0.5 0.5 0.1 0.4 0.6 0.2 0.3 0.6 0.1 0.2 33.1 0.1 0.1 0.1 0.5 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.2 0.7 0.1 0.2 1.2 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 59.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 238.7 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.3 0.1 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 1.2 0.5 0.5 0.3 0.5 0.5 0.4 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 2.7 0.3 0.1 0.2 0.0 0.0 0.1 0.2 0.1 1.0 0.0 0.5 0.0 0.2 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.3 0.3 13.8 0.0 0.5 0.0 0.0 0.6 1.3 0.0 0.5 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.0 1.1 0.0 0.0 63.8 0.5 0.0 0.4 0.0 0.0 0.3 0.4 0.1 0.2 0.1 RASA4 "CAPRI, GAPL, KIAA0538" ENSG00000105808 "RAS p21 protein activator 4" O43374 7 102573807-102616756 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 254.9;tongue: 88.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 73.9;Enteroendocrine cells: 71.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 48.9" HPA043010 Uncertain Approved "Vesicles,Cell Junctions" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 56: Bipolar cells - Visual perception" Vesicles "Cell Junctions" "HPA043010: AB_2678267" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (8.93e-3)" "unprognostic (1.69e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (3.44e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (4.62e-3)" "unprognostic (4.19e-2)" "unprognostic (4.81e-2)" "unprognostic (8.87e-3)" "unprognostic (2.47e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" 38.9 17.5 22.9 10.8 18.8 6.0 31.2 22.7 23.0 37.4 3.6 29.8 10.9 37.7 4.7 10.8 28.4 6.3 14.5 22.5 22.8 29.2 2.6 22.1 13.8 21.5 25.9 25.2 12.3 12.8 24.2 13.0 17.3 23.4 4.0 13.3 12.9 18.0 254.9 17.3 21.6 7.5 17.2 16.8 16.1 5.4 22.7 4.8 17.3 88.6 7.1 26.0 29.0 16.3 1.1 1.5 14.1 2.6 1.8 5.8 0.6 16.3 7.6 4.3 4.9 6.1 3.1 9.9 11.9 24.0 0.3 12.7 0.6 0.1 1.7 1.7 2.4 3.2 4.1 1.0 2.1 2.0 4.4 6.4 1.4 1.4 0.4 18.7 2.7 6.5 5.9 17.0 1.4 4.0 8.6 7.1 1.0 6.6 7.3 17.5 2.9 16.5 0.4 5.0 12.7 25.3 2.3 2.3 1.9 7.5 1.1 5.7 3.0 48.9 22.3 4.9 4.1 28.9 18.5 7.7 4.3 4.5 5.9 0.4 7.9 0.2 1.3 8.6 3.0 3.2 2.4 1.8 10.9 2.9 2.5 1.5 1.8 1.4 1.1 9.2 3.3 3.8 22.9 18.8 22.7 23.0 22.5 22.8 21.5 25.9 17.3 17.2 22.7 16.3 26.8 12.8 10.9 15.0 8.3 3.8 4.5 1.3 0.6 73.9 2.0 3.0 1.1 2.8 5.2 3.7 16.7 0.2 7.2 5.9 13.7 1.1 0.4 3.3 13.0 24.9 71.8 5.7 5.6 0.7 0.2 5.0 3.1 2.9 1.3 13.6 3.3 1.4 6.0 28.6 6.6 11.8 0.0 11.6 22.8 0.3 8.4 13.3 1.8 4.7 14.2 9.4 6.2 5.5 1.4 1.7 2.8 7.9 4.0 2.9 19.9 8.4 6.2 11.7 13.1 21.3 10.0 3.4 3.3 1.3 3.4 0.4 6.4 5.6 2.9 4.1 RASA4B ENSG00000170667 "RAS p21 protein activator 4B" C9J798 7 102479976-102517777 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 130.9" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Bipolar cells: 3.3;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.2;intermediate monocyte: 2.0;myeloid DC: 3.3;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 6 "dendritic cells: 3.3;monocytes: 2.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 15.1;U-138 MG: 17.0;U-2 OS: 14.9" "Low region specificity" "Detected in all" HPA043010 Uncertain Approved "Vesicles,Cell Junctions" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" Vesicles "Cell Junctions" "HPA043010: AB_2678267" "unprognostic (1.05e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-2)" "unprognostic (1.55e-1)" "unprognostic (2.10e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" "unprognostic (2.31e-1)" "unprognostic (5.44e-4)" "unprognostic (1.18e-2)" "unprognostic (3.77e-2)" "unprognostic (4.37e-3)" "unprognostic (1.10e-1)" 14.0 5.8 6.5 4.2 6.1 2.2 10.8 6.3 7.9 13.3 3.0 11.9 6.4 16.5 1.3 2.8 9.7 3.7 4.7 6.2 8.0 6.4 0.8 6.0 4.7 7.8 8.3 9.6 2.4 5.2 5.8 4.9 6.7 8.1 1.8 5.3 4.5 7.6 130.9 5.5 7.8 3.8 6.6 5.9 4.9 2.1 7.6 1.9 3.8 19.2 2.8 9.5 9.5 7.5 0.2 1.4 3.7 0.5 1.3 2.9 0.2 6.8 4.4 2.2 3.6 0.5 1.1 3.4 7.3 8.6 0.7 9.1 0.0 0.0 1.1 0.5 1.6 0.5 2.7 0.8 1.2 0.3 0.5 2.9 0.8 0.1 0.2 10.4 0.9 1.7 0.9 9.8 0.7 3.0 2.9 1.9 0.3 1.7 1.9 2.8 1.5 4.6 0.1 0.9 3.1 15.1 1.0 0.5 0.5 3.0 1.0 2.0 2.0 17.0 14.9 1.8 0.6 3.5 2.9 2.4 2.3 0.9 2.8 0.0 2.2 0.0 0.3 2.0 0.2 0.1 0.3 0.1 3.3 0.2 0.3 0.4 0.3 0.0 0.4 2.1 0.3 1.2 6.5 6.1 6.3 7.9 6.2 8.0 7.8 8.3 6.7 6.6 7.6 7.5 0.6 0.0 0.6 2.9 1.1 0.4 0.2 0.0 1.2 3.3 0.1 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.9 0.1 0.0 0.1 0.3 1.8 2.4 0.4 0.5 0.2 0.0 0.3 5.6 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.8 1.3 0.0 0.6 0.9 0.0 0.3 1.0 0.0 1.0 0.6 0.6 0.0 1.5 0.0 0.1 0.0 0.0 2.5 0.2 1.3 0.3 0.1 0.6 0.0 0.5 0.8 0.3 0.0 0.3 1.1 0.1 1.6 0.3 0.0 0.2 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridine synthase D4" Q96CM3 11 126202096-126211692 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 135.5;tongue: 75.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria Nucleoplasm "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favorable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 14.8 12.7 10.2 9.8 10.4 10.6 14.0 10.5 11.2 13.8 10.7 12.1 10.4 12.6 7.7 15.1 12.9 8.1 27.2 10.5 10.4 11.8 20.5 9.4 13.8 10.2 10.2 18.3 26.8 7.8 8.8 6.8 10.5 11.5 10.1 6.1 14.4 7.0 135.5 17.1 12.1 9.2 10.6 14.4 20.0 8.8 10.5 13.2 10.1 75.2 15.5 12.4 13.4 10.5 15.6 14.0 17.0 19.7 24.5 34.3 12.5 16.2 22.7 16.6 15.1 46.4 27.3 35.7 16.8 14.1 23.7 25.1 40.3 25.8 17.3 32.4 23.9 84.1 15.0 40.5 18.3 42.5 17.1 29.8 35.0 18.4 22.9 24.8 33.4 28.8 51.8 25.1 20.2 13.5 26.6 46.3 18.4 49.3 29.1 31.0 25.2 33.3 25.7 19.8 29.3 20.5 21.5 29.7 16.7 17.0 46.2 21.9 20.9 18.6 13.3 15.4 19.9 10.1 12.4 30.7 8.8 47.2 19.7 1.6 12.7 1.4 15.9 11.7 19.6 14.4 18.0 14.3 16.3 14.5 20.4 16.8 0.9 14.3 14.0 7.0 18.1 13.3 10.2 10.4 10.5 11.2 10.5 10.4 10.2 10.2 10.5 10.6 10.5 10.5 10.0 3.2 8.4 6.8 15.3 27.5 20.4 13.2 17.1 9.9 13.1 9.1 35.4 12.8 7.4 7.3 8.4 14.0 12.3 7.2 9.8 12.3 1.8 6.7 7.1 11.9 15.5 6.7 7.0 19.6 17.1 10.2 10.7 7.4 5.7 15.2 13.6 11.3 13.3 11.8 8.4 10.7 2.0 15.9 8.7 2.3 9.6 8.6 10.6 8.4 21.0 5.3 14.4 6.6 7.8 13.5 7.4 8.6 12.4 17.4 15.6 14.5 7.0 8.2 6.6 15.6 9.9 10.3 16.7 13.2 24.0 13.3 13.1 18.3 18.8 14.7 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433691-38587564 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 1618.9" "Cell type enhanced" "Detected in many" "Astrocytes: 29.4;Basal squamous epithelial cells: 22.8;Microglial cells: 49.6;Muller glia cells: 50.6;Skeletal myocytes: 41.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.8;myeloid DC: 2.9;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 8 "dendritic cells: 2.9;monocytes: 3.8" "Cell line enhanced" "Detected in some" "A549: 7.7;HaCaT: 18.9;hTCEpi: 7.6;RH-30: 15.3;SiHa: 30.7;U-2 OS: 12.4" "Low region specificity" "Detected in single" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" NA NA 46000 "Cluster 51: Monocytes - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 37: Myocytes - Muscle contraction" "Golgi apparatus, Vesicles" Cytosol "HPA056416: AB_2683121" "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 1.4 2.4 10.3 1.6 8.0 0.3 2.1 8.5 9.3 2.1 1.0 1.2 0.5 0.7 1.3 17.2 1.7 1.1 0.9 7.5 20.5 1.9 0.4 2.6 2.1 8.6 9.7 0.9 0.4 1.9 1.5 1.8 7.7 3.8 0.3 10.6 14.0 1.4 1618.9 13.3 1.3 0.8 2.6 1.7 1.0 8.9 22.6 1.5 1.2 286.6 2.6 1.0 3.3 6.1 0.0 7.7 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.4 0.5 6.3 0.0 0.0 18.9 0.2 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.6 1.7 7.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.5 1.0 0.0 0.0 15.3 1.5 0.8 0.0 0.0 1.5 30.7 0.0 0.0 0.6 0.7 5.9 0.0 0.0 12.4 0.3 0.0 0.4 1.4 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.2 1.8 0.2 0.2 0.1 0.3 2.9 0.3 0.0 0.0 0.0 0.0 3.8 0.0 0.4 0.3 10.3 8.0 8.5 9.3 7.5 20.5 8.6 9.7 7.7 2.6 22.6 6.1 0.3 0.0 1.1 29.4 1.4 11.3 3.8 6.6 22.8 8.9 0.5 7.9 3.6 0.0 1.1 0.0 2.1 0.2 1.2 0.0 5.9 0.1 6.7 0.2 0.9 1.0 0.0 0.4 10.2 0.0 0.4 0.9 0.0 0.5 0.0 0.3 0.7 0.0 8.8 1.7 17.2 0.0 2.0 2.9 15.2 5.9 3.1 6.2 0.0 49.6 1.3 50.6 0.0 13.6 2.0 0.0 0.0 1.9 0.9 0.8 0.0 0.2 0.4 1.8 0.0 41.7 1.2 6.3 7.4 7.5 4.7 0.3 2.6 0.4 0.0 0.7 SCN4A "HYKPP, HYPP, Nav1.4, SkM1" ENSG00000007314 "Sodium voltage-gated channel alpha subunit 4" P35499 17 63938554-63972918 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Congenital myasthenic syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 137.4;tongue: 54.0" "Cell type enriched" "Detected in some" 6 "Adipocytes: 46.4" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "REH: 15.0;RH-30: 45.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA053992 Approved "Nucleoplasm,Centriolar satellite" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Centriolar satellite" "HPA053992: AB_2797249" "unprognostic (2.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.57e-2)" "unprognostic (1.78e-3)" "unprognostic (2.80e-2)" "unprognostic (1.63e-2)" "unprognostic (3.87e-4)" "unprognostic (3.84e-3)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (3.15e-2)" "unprognostic (2.70e-2)" "unprognostic (4.38e-3)" "unprognostic (3.46e-1)" "unprognostic (4.15e-1)" "unprognostic (6.45e-2)" 17.9 0.7 0.0 0.2 0.1 0.0 16.0 0.3 0.1 0.1 0.0 1.1 0.0 0.1 0.0 1.1 0.2 0.3 0.8 0.0 0.0 0.7 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.7 1.5 0.1 0.0 0.5 0.1 0.0 1.8 0.0 137.4 0.7 0.3 0.0 0.0 0.8 0.5 1.7 0.0 0.2 4.3 54.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 15.0 45.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.8 1.4 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 1.1 2.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 4.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.1 5.9 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 322.9;tongue: 96.9" "Cell type enhanced" "Detected in many" "Adipocytes: 12.9;Cardiomyocytes: 19.1;Cone photoreceptor cells: 20.9;Inhibitory neurons: 13.7;Skeletal myocytes: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 14.1;HUVEC TERT2: 24.8;TIME: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1500000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favorable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 8.8 2.8 7.7 1.8 6.7 1.2 7.9 21.9 9.4 12.0 1.0 7.6 13.7 10.5 1.4 5.5 10.7 3.7 38.8 7.9 5.4 12.1 12.4 5.1 1.7 5.0 5.0 14.8 3.6 2.1 13.4 1.9 4.9 8.3 1.8 5.2 8.5 2.3 322.9 8.9 10.8 6.2 2.2 3.0 5.4 32.2 7.3 2.2 4.7 96.9 0.9 8.4 8.8 5.3 0.9 1.0 14.1 5.4 5.8 1.9 1.3 1.0 0.5 0.9 1.3 0.3 0.6 0.7 4.0 3.3 2.0 1.4 1.3 0.5 0.8 1.3 4.2 7.7 0.7 1.2 0.8 0.1 2.7 3.3 1.7 1.2 0.6 2.8 24.8 4.1 0.7 0.7 2.3 0.5 1.3 1.0 6.3 0.2 1.7 9.0 3.1 0.3 0.5 0.4 7.1 9.3 1.3 0.6 1.2 3.5 1.6 1.3 11.8 2.3 3.3 3.5 0.6 5.9 1.2 6.1 0.6 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 6.7 21.9 9.4 7.9 5.4 5.0 5.0 4.9 2.2 7.3 5.3 12.9 0.0 2.8 3.9 1.0 1.7 0.8 0.3 0.6 5.7 1.9 3.0 19.1 1.5 0.8 0.0 20.9 0.2 0.6 0.1 0.0 0.3 0.6 0.4 2.8 10.2 0.0 0.8 6.7 0.4 0.6 4.4 0.5 0.4 0.0 9.9 6.8 5.3 0.4 6.7 13.7 0.3 0.0 2.5 0.7 3.1 5.6 0.5 1.8 4.7 0.4 1.9 1.0 5.5 1.5 0.4 0.0 2.6 1.9 0.5 3.3 2.9 0.3 7.5 0.0 12.0 2.9 3.3 1.2 0.5 1.0 0.1 0.8 0.5 0.8 0.5 SH3BGR 21-GARP ENSG00000185437 "SH3 domain binding glutamate rich protein" P55822 21 39445855-39515506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "skeletal muscle: 1268.3;tongue: 578.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 180.2;Distal tubular cells: 46.9;Early spermatids: 151.2" "Cancer enhanced" "Detected in all" "glioma: 21.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 101.0" "Low region specificity" "Detected in all" CAB003685 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane, Cytosol" "CAB003685: AB_425682" "unprognostic (3.41e-2)" "unprognostic (1.26e-1)" "unprognostic (5.84e-3)" "unprognostic (1.68e-3)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (3.89e-2)" "unprognostic (9.78e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-3)" "unprognostic (3.59e-2)" "unprognostic (4.75e-1)" "unprognostic (5.98e-3)" "unprognostic (7.16e-2)" "unprognostic (4.60e-2)" "unprognostic (1.68e-2)" "unprognostic (2.06e-2)" 8.9 24.0 41.8 3.6 44.9 2.0 11.2 42.0 72.4 10.8 37.3 39.4 6.6 12.3 28.5 20.3 8.1 9.5 154.1 43.7 43.0 13.2 11.8 5.4 2.0 43.8 40.8 6.0 11.0 10.7 25.6 2.1 44.4 25.1 7.0 14.7 14.2 21.2 1268.3 4.8 8.5 11.0 41.0 3.3 16.9 20.1 42.4 3.2 16.3 578.1 2.1 20.8 8.1 50.5 2.0 2.9 3.7 4.2 5.5 9.2 1.0 2.7 0.6 1.9 1.5 1.6 3.9 6.6 8.9 10.9 14.5 0.3 1.2 3.1 2.9 3.9 7.6 7.6 0.9 3.1 15.1 2.8 1.3 7.6 13.5 7.0 12.1 3.4 1.8 13.9 5.0 7.7 7.8 9.4 3.7 4.2 3.2 6.2 6.2 6.5 13.1 4.5 8.3 1.8 10.0 4.0 5.8 4.9 5.4 2.3 19.8 0.5 1.6 5.0 0.6 3.1 7.9 26.3 5.7 6.7 101.0 5.0 6.9 0.0 0.2 0.0 0.2 0.9 0.9 1.4 0.4 0.9 0.9 0.6 1.6 1.2 0.2 1.2 0.9 3.7 0.1 0.4 41.8 44.9 42.0 72.4 43.7 43.0 43.8 40.8 44.4 41.0 42.4 50.5 2.4 3.2 3.9 15.3 1.4 2.7 12.8 5.9 1.8 2.1 11.4 25.0 180.2 5.7 4.4 5.5 4.2 3.7 3.2 2.3 46.9 5.1 151.2 11.3 5.0 3.1 1.2 0.8 6.4 21.3 1.7 5.6 3.6 10.6 4.5 5.3 2.2 9.2 2.4 5.0 6.5 1.7 4.1 1.6 2.0 35.4 2.1 1.5 12.4 5.6 1.2 21.2 0.0 3.0 14.6 4.8 3.2 5.7 1.0 3.3 2.3 14.4 6.7 6.2 6.6 22.7 16.9 32.4 23.6 1.1 1.7 1.9 1.4 4.7 2.7 4.6 SLN "MGC12301, MGC125854, MGC125855" ENSG00000170290 Sarcolipin O00631 11 107707378-107719693 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 8190.2;tongue: 3399.6" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 730.3;Muller glia cells: 462.5;Skeletal myocytes: 225.1" "Group enriched" "Detected in many" 5 "glioma: 21.6;head and neck cancer: 22.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HSkMC: 2.5;Karpas-707: 1.2;PC-3: 1.1;SuSa: 2.5;U-2 OS: 1.1" CAB011628 Approved Microtubules NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" Microtubules "CAB011628: AB_2195046" "unprognostic (6.85e-2)" "unprognostic (6.18e-8)" "unprognostic (2.60e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-3)" "unprognostic (4.12e-3)" "unprognostic (5.28e-3)" "unprognostic (1.31e-2)" "unprognostic (2.76e-1)" "unprognostic (6.35e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.52e-9)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "unprognostic (5.09e-4)" "unprognostic (3.77e-2)" 5.1 8.3 2.8 0.0 3.4 0.0 2.1 3.9 7.8 0.2 1.3 4.7 0.3 0.2 0.8 149.2 0.7 0.3 975.1 2.4 1.4 2.6 0.7 6.4 0.2 1.5 2.3 0.6 1.8 0.2 0.7 1.3 2.3 37.0 0.1 60.7 59.4 0.3 8190.2 4.4 1.5 1.4 1.3 0.3 0.8 1.3 1.4 2.7 2.0 3399.6 0.9 0.4 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.4 3.9 7.8 2.4 1.4 1.5 2.3 2.3 1.3 1.4 2.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 2.4 0.0 0.0 730.3 0.0 0.0 0.0 2.1 1.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 10.5 0.0 0.0 0.3 0.4 1.9 42.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.0 0.0 1.1 8.8 0.0 1.0 0.0 0.0 0.0 462.5 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.0 0.4 0.0 19.9 0.0 225.1 40.5 0.1 0.0 0.0 1.4 5.7 1.0 0.0 0.0 0.1 SMTNL1 CHASM ENSG00000214872 "Smoothelin like 1" A8MU46 11 57542641-57550274 "Predicted intracellular proteins" "Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 51 "skeletal muscle: 711.3;tongue: 192.9" "Cell type enriched" "Detected in some" 5 "Skeletal myocytes: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.6;U-266/84: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (1.35e-2)" "unprognostic (3.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.79e-3)" "unprognostic (3.09e-1)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (8.41e-2)" "unprognostic (1.41e-1)" "unprognostic (3.53e-3)" "unprognostic (4.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.04e-6)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (4.49e-1)" "unprognostic (1.44e-2)" 0.4 0.2 0.7 0.9 0.1 2.3 0.4 0.2 0.3 0.4 0.0 0.2 0.3 0.3 0.0 8.8 0.5 0.3 0.3 0.2 0.2 0.2 0.8 0.9 0.8 2.5 0.6 0.5 0.1 0.0 0.5 0.1 0.5 1.6 0.0 0.6 6.1 0.0 711.3 0.3 0.5 0.0 1.3 1.1 0.2 0.5 0.9 0.0 0.4 192.9 0.0 0.2 0.4 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.1 0.7 0.3 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.6 1.0 0.0 0.1 0.4 0.0 0.6 0.3 0.7 0.4 0.4 0.4 0.2 0.3 0.5 0.2 0.3 0.6 0.4 1.1 0.2 0.5 0.2 0.2 0.1 0.7 0.1 0.2 0.3 0.2 0.2 2.5 0.6 0.5 1.3 0.9 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMTNL2 FLJ42461 ENSG00000188176 "Smoothelin like 2" Q2TAL5 17 4583999-4608319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 500.8;tongue: 136.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 8.7;Collecting duct cells: 9.2;Distal tubular cells: 33.2;Proximal tubular cells: 35.4;Sertoli cells: 26.3;Skeletal myocytes: 8.2" "Cancer enhanced" "Detected in many" "renal cancer: 10.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "CACO-2: 49.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA025706 Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Nuclear speckles" "HPA025706: AB_1848935" "unprognostic (8.62e-2)" "unprognostic (5.40e-2)" "unprognostic (7.13e-2)" "unprognostic (2.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-2)" "unprognostic (4.89e-3)" "unprognostic (2.73e-1)" "unprognostic (3.73e-3)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (5.89e-2)" "prognostic favorable (1.28e-4)" "unprognostic (3.43e-2)" "unprognostic (1.01e-1)" "unprognostic (1.56e-3)" "unprognostic (2.22e-1)" 8.3 0.1 0.9 1.5 1.1 0.0 2.5 0.8 1.6 3.4 1.0 1.2 0.2 3.9 2.3 8.0 7.2 2.1 18.2 2.5 0.7 31.8 0.2 4.7 0.2 0.9 1.0 6.7 0.6 1.1 2.3 4.9 1.0 5.0 0.5 0.1 6.1 0.9 500.8 1.5 1.2 2.5 0.7 0.8 1.0 1.3 1.0 0.2 1.4 136.2 0.1 4.5 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.4 0.0 0.8 0.0 2.7 0.0 0.6 0.0 2.9 0.0 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.3 3.2 0.0 0.0 0.0 0.1 5.4 0.0 11.4 0.0 0.0 0.0 0.0 10.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.8 1.6 2.5 0.7 0.9 1.0 1.0 0.7 1.0 0.8 0.3 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 8.7 0.0 0.6 9.2 0.0 0.8 0.0 0.0 33.2 0.1 0.1 1.8 1.3 1.3 0.0 0.0 0.1 0.0 1.5 6.1 0.0 2.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.6 0.3 1.8 1.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 26.3 8.2 7.6 0.0 0.5 0.1 0.0 0.5 0.3 0.1 0.2 0.3 SNAI3 "SMUC, Zfp293, ZNF293" ENSG00000185669 "Snail family transcriptional repressor 3" Q3KNW1 16 88677688-88686507 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 31.3" "Cell type enhanced" "Detected in some" "dendritic cells: 19.7;granulocytes: 9.5;Kupffer cells: 14.6;Langerhans cells: 9.3;Macrophages: 9.4;NK-cells: 17.5;Plasma cells: 14.0;T-cells: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "NB-4: 18.2;RPMI-8226: 28.6" "Region enhanced" "Detected in single" "basal ganglia: 1.5" "Not detected" "Not detected" HPA071127 Approved Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA071127: AB_2686346" "unprognostic (1.03e-2)" "prognostic favorable (1.39e-4)" "unprognostic (2.20e-2)" "unprognostic (6.19e-4)" "unprognostic (3.05e-1)" "unprognostic (2.85e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (3.24e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.58e-4)" "unprognostic (9.09e-2)" "unprognostic (1.62e-1)" "unprognostic (8.46e-2)" "unprognostic (6.57e-2)" "unprognostic (1.11e-1)" "unprognostic (7.47e-2)" 0.7 0.5 1.5 2.4 2.4 1.8 0.4 0.0 3.3 0.6 0.0 1.2 1.5 0.6 0.3 0.6 0.8 1.0 2.4 1.9 0.0 0.7 0.8 2.2 3.9 2.1 0.0 0.5 1.7 1.5 0.7 0.1 3.7 0.8 0.3 0.3 1.2 0.2 31.3 0.6 3.7 0.2 0.0 6.9 3.3 0.9 0.0 0.8 0.9 7.3 2.6 1.4 0.5 0.0 0.3 0.9 0.3 1.3 0.0 0.0 0.6 0.3 0.0 0.0 0.1 3.5 0.3 2.3 0.5 0.0 0.8 0.8 0.3 0.2 0.0 0.4 1.2 1.1 0.1 1.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.1 0.0 1.5 2.1 4.3 0.0 3.2 0.2 18.2 0.4 0.3 0.4 3.9 0.3 28.6 0.0 0.4 1.7 0.2 0.7 0.0 0.2 0.4 1.2 2.2 0.3 0.1 1.0 0.2 0.0 0.7 4.2 4.0 0.3 4.9 0.5 5.2 14.1 48.5 10.2 5.3 18.8 7.8 16.7 9.8 16.7 6.1 10.0 6.4 30.9 1.1 1.5 11.9 21.4 10.9 1.5 2.4 0.0 3.3 1.9 0.0 2.1 0.0 3.7 0.0 0.0 0.0 0.3 3.2 0.0 2.0 8.5 0.5 0.1 0.4 0.0 0.2 0.4 0.5 2.0 0.0 0.7 0.0 0.0 0.0 19.7 0.0 1.9 0.1 0.0 0.6 0.0 0.4 0.0 0.4 6.4 0.4 0.5 0.2 0.5 0.1 9.5 0.0 0.4 0.1 6.9 0.0 3.7 0.1 2.0 14.6 9.3 0.3 0.0 9.4 5.4 0.0 5.3 0.1 17.5 1.0 1.9 0.1 1.1 0.4 14.0 0.1 0.0 0.2 1.0 0.9 0.0 0.7 0.4 0.0 1.5 0.2 0.3 0.1 14.0 0.0 0.3 0.1 STAC3 MGC2793 ENSG00000185482 "SH3 and cysteine rich domain 3" Q96MF2 12 57243453-57251188 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 40 "skeletal muscle: 2315.3;tongue: 1169.0" "Cell type enriched" "Detected in many" 7 "Skeletal myocytes: 287.7" "Cancer enhanced" "Detected in all" "head and neck cancer: 11.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 5.8" "Group enriched" "Detected in many" 6 "dendritic cells: 3.6;monocytes: 5.8" "Cell line enriched" "Detected in many" 23 "RH-30: 2282.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA039285, HPA039527" Enhanced Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm Cytosol "HPA039285: AB_2676427, HPA039527: AB_10673424" "unprognostic (6.16e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (5.25e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (9.12e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (4.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.09e-1)" "unprognostic (1.14e-3)" 2.7 2.0 2.7 7.3 2.5 17.8 2.1 4.6 5.3 1.4 2.3 2.6 2.0 0.8 2.8 31.2 1.7 2.3 1.5 2.6 2.3 1.8 4.4 6.5 8.9 2.7 2.6 1.0 1.4 2.6 2.1 2.9 2.7 23.0 3.0 3.2 43.9 1.1 2315.3 3.4 2.6 2.5 2.1 9.1 1.7 11.9 2.6 4.1 2.1 1169.0 7.4 2.4 1.3 3.1 0.6 0.8 2.1 4.0 1.3 2.2 0.8 0.5 0.5 0.5 0.7 0.5 1.9 55.0 1.1 1.2 0.0 1.0 0.9 1.1 0.2 1.4 1.0 27.9 0.3 0.6 0.5 17.2 97.1 10.0 1.6 0.4 0.6 1.3 0.9 6.1 2.9 2.2 7.5 5.4 1.6 36.3 0.1 0.8 1.0 13.0 2282.0 2.6 1.3 1.2 1.4 1.1 1.6 1.5 0.3 0.3 0.9 48.4 1.0 0.5 0.4 1.6 0.4 2.2 1.2 9.6 1.1 32.9 0.7 0.0 4.4 0.3 0.0 5.8 0.0 0.7 0.0 0.2 3.6 0.3 0.0 0.1 0.2 0.0 2.9 1.0 0.2 1.4 2.7 2.5 4.6 5.3 2.6 2.3 2.7 2.6 2.7 2.1 2.6 3.1 0.4 0.0 0.6 1.3 1.9 1.5 0.4 1.1 0.6 7.5 1.2 1.4 0.3 1.5 0.4 0.0 2.1 1.0 2.8 0.9 0.0 0.8 13.5 1.1 0.6 0.7 2.4 0.4 3.0 1.0 0.7 0.8 1.1 0.9 5.7 1.5 1.8 1.3 39.9 1.7 2.4 1.2 4.1 37.3 16.3 8.9 1.2 24.1 0.0 0.0 26.3 1.5 0.0 1.5 1.2 0.9 1.0 0.7 0.5 1.0 1.6 0.7 2.3 2.5 0.0 287.7 1.0 3.4 1.4 0.6 0.3 1.4 1.6 0.8 1.2 0.4 STK25 "SOK1, YSK1" ENSG00000115694 "Serine/threonine kinase 25" O00506 2 241492670-241509730 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 489.9;tongue: 213.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047147 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA047147: AB_10966137" "unprognostic (1.75e-1)" "unprognostic (8.29e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (3.42e-2)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (3.91e-8)" "unprognostic (6.16e-2)" "unprognostic (7.15e-3)" "unprognostic (1.11e-1)" "unprognostic (2.58e-3)" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-1)" "unprognostic (3.19e-1)" "unprognostic (4.58e-1)" 53.2 50.6 48.2 37.1 48.9 47.0 52.8 35.8 56.7 59.8 27.8 59.8 36.2 62.9 24.0 62.6 60.5 32.9 69.1 50.4 47.1 56.5 50.0 49.6 36.7 37.5 40.9 59.4 70.3 45.9 65.3 38.7 43.3 55.4 30.5 28.9 48.7 40.2 489.9 53.1 50.5 42.1 30.7 61.6 58.7 48.7 46.4 38.5 71.9 213.8 31.8 60.8 56.7 41.2 75.2 46.9 91.1 114.0 109.9 75.9 140.1 122.3 81.8 90.9 103.4 52.3 64.4 28.5 33.7 163.9 82.3 62.9 130.2 132.9 109.9 107.0 136.4 79.7 98.3 136.6 99.3 48.7 59.0 110.1 93.9 88.3 70.3 111.1 208.7 102.6 125.2 24.6 168.8 78.6 73.0 75.9 127.9 69.5 66.3 121.1 116.2 42.6 79.5 62.4 152.8 70.2 59.4 44.2 77.0 102.7 35.7 85.2 245.7 68.2 83.0 79.1 88.3 50.3 12.1 48.8 66.0 39.6 79.1 17.0 16.3 12.9 17.3 15.5 16.3 15.9 15.9 18.5 15.0 16.9 12.3 11.8 5.8 24.6 19.7 11.8 23.3 12.6 48.2 48.9 35.8 56.7 50.4 47.1 37.5 40.9 43.3 30.7 46.4 41.2 43.6 22.4 41.4 23.2 19.7 25.5 29.0 29.7 19.9 48.7 33.2 39.4 36.3 42.9 24.0 25.8 27.1 82.7 19.8 35.2 27.4 46.0 13.8 18.5 28.4 52.7 35.4 48.6 29.8 34.2 80.7 35.1 36.7 25.4 25.4 40.8 45.7 21.5 45.1 32.0 26.1 40.0 20.3 27.3 25.7 14.4 32.6 20.8 19.6 21.5 47.0 58.9 18.6 16.1 27.5 36.9 74.5 39.9 15.8 37.1 43.4 46.1 16.2 41.1 46.0 41.7 35.3 90.2 54.7 31.7 30.4 52.4 25.4 53.2 44.9 29.9 STRIT1 DWORF ENSG00000240045 "Small transmembrane regulator of ion transport 1" P0DN84 3 155290227-155293683 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 79 "skeletal muscle: 1711.3;tongue: 698.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.1;prostate cancer: 1.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Not detected" "Not detected" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (6.77e-4)" "unprognostic (1.60e-2)" "unprognostic (6.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.82e-3)" "unprognostic (1.33e-2)" 0.6 0.1 3.5 0.2 15.2 0.2 0.5 4.5 3.5 0.0 2.8 0.2 6.3 0.2 0.5 14.1 0.1 0.4 5.5 3.3 2.8 5.9 0.3 0.2 0.3 3.1 4.1 0.1 0.3 0.1 0.1 0.1 4.2 12.1 0.2 0.3 8.7 0.1 1711.3 2.2 3.6 0.0 1.7 0.2 0.2 0.2 7.5 0.0 0.4 698.4 0.1 0.0 0.1 5.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 15.2 4.5 3.5 3.3 2.8 3.1 4.1 4.2 1.7 7.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYPL2 Mg29 ENSG00000143028 "Synaptophysin like 2" Q5VXT5 1 109466546-109482134 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "skeletal muscle: 363.5;tongue: 175.3" "Cell type enhanced" "Detected in some" "Astrocytes: 5.5;Cardiomyocytes: 10.6;Collecting duct cells: 3.7;Hepatocytes: 4.8;Late spermatids: 11.1;Proximal tubular cells: 5.1;Skeletal myocytes: 4.8" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 31.6;ASC TERT1: 13.2;BJ: 14.1;BJ hTERT+: 44.1;fHDF/TERT166: 23.1;HAP1: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076657 Approved "Plasma membrane,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" Cytosol "Plasma membrane" "HPA076657: " "unprognostic (1.82e-2)" "unprognostic (1.81e-1)" "unprognostic (2.90e-4)" "unprognostic (6.63e-2)" "unprognostic (1.35e-1)" "unprognostic (9.36e-3)" "unprognostic (2.84e-2)" "unprognostic (2.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "prognostic favorable (3.05e-4)" "unprognostic (2.54e-3)" "unprognostic (3.40e-1)" "unprognostic (9.46e-3)" "unprognostic (6.39e-4)" 2.8 11.7 1.5 0.6 1.5 0.0 1.5 1.3 2.4 4.0 4.0 6.2 0.5 6.6 4.5 4.6 1.4 0.9 19.9 1.6 1.3 9.6 9.5 1.3 0.5 1.4 1.3 3.0 5.1 5.8 1.1 3.2 1.2 3.1 1.0 0.4 4.2 6.0 363.5 0.7 1.6 6.0 1.0 1.1 3.2 9.3 1.6 0.1 8.0 175.3 0.3 4.1 2.4 1.3 0.0 0.1 0.1 1.8 31.6 13.2 0.0 14.1 44.1 4.3 1.6 0.0 0.1 0.0 0.0 23.1 0.5 0.0 11.8 0.0 0.9 0.0 5.1 0.0 0.4 0.2 0.6 0.0 1.1 1.2 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.1 0.1 0.0 1.4 3.3 2.3 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 1.3 2.4 1.6 1.3 1.4 1.3 1.2 1.0 1.6 1.3 0.2 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 10.6 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.2 2.8 0.0 0.1 0.4 0.0 0.0 0.3 1.3 0.0 1.0 0.0 0.0 0.0 0.9 0.0 4.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 1.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.1 0.0 5.1 0.0 0.0 0.0 4.8 2.6 0.4 1.4 0.0 0.0 0.1 0.2 0.4 0.0 0.0 TAL2 bHLHa19 ENSG00000186051 "TAL bHLH transcription factor 2" Q16559 9 105662457-105663124 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 13.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Distal tubular cells: 7.9;Enteroendocrine cells: 3.5;Muller glia cells: 2.7;Proximal tubular cells: 2.3" "Group enriched" "Detected in some" 4 "renal cancer: 1.6;testis cancer: 0.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 6.9;naive B-cell: 7.3" "Lineage enriched" "Detected in many" 4 "B-cells: 7.3" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;HAP1: 2.9;K-562: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA030886 Uncertain Approved Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA030886: AB_10601596" "unprognostic (3.89e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "unprognostic (5.54e-2)" "unprognostic (2.24e-1)" "unprognostic (9.06e-2)" "unprognostic (4.98e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-3)" "unprognostic (2.63e-1)" "unprognostic (7.00e-4)" "unprognostic (2.84e-2)" "prognostic favorable (2.69e-4)" "unprognostic (2.70e-2)" "unprognostic (1.24e-1)" "unprognostic (1.29e-1)" "unprognostic (7.39e-2)" 0.1 0.2 0.4 0.1 0.5 0.0 0.1 0.3 0.9 0.2 1.3 0.1 0.0 0.1 0.6 0.1 0.2 0.0 0.2 0.5 0.5 3.0 0.2 0.1 0.2 0.5 0.6 0.3 0.1 0.0 0.4 0.1 0.6 0.1 0.1 0.5 0.1 0.1 13.7 0.1 0.1 0.0 0.4 0.2 0.1 0.3 0.4 0.1 0.1 2.4 0.3 0.1 0.1 0.7 0.0 0.4 1.5 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.2 2.1 0.1 0.0 0.1 0.0 0.4 0.0 2.9 0.0 0.1 0.4 0.3 0.7 0.0 0.0 0.1 0.3 1.1 0.1 0.3 0.1 0.1 0.1 0.0 0.5 8.2 0.2 0.2 0.2 0.5 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.7 0.7 0.1 0.1 0.1 0.0 0.2 1.3 0.3 0.2 0.4 0.4 0.6 0.6 1.2 0.0 0.1 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.1 0.4 0.5 0.3 0.9 0.5 0.5 0.5 0.6 0.6 0.4 0.4 0.7 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.4 0.1 0.2 0.0 0.0 0.0 4.2 0.0 0.1 0.0 7.9 0.1 0.1 0.0 0.2 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.0 0.0 2.3 0.0 1.0 0.0 0.8 0.1 0.6 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TBX1 "CATCH22, VCF" ENSG00000184058 "T-box transcription factor 1" O43435 22 19756703-19783593 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 61.5;tongue: 36.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 181.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 24.6;K-562: 121.6;NB-4: 28.6;TIME: 40.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029330 Approved "Nuclear bodies,Cytoplasmic bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear bodies, Cytoplasmic bodies" "HPA029330: AB_2673002" "unprognostic (2.54e-1)" "unprognostic (4.28e-3)" "unprognostic (7.53e-3)" "unprognostic (1.59e-1)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (2.53e-1)" "unprognostic (5.48e-2)" "unprognostic (1.18e-1)" "unprognostic (4.42e-2)" "unprognostic (2.25e-2)" "unprognostic (8.30e-3)" "unprognostic (9.14e-2)" "unprognostic (4.44e-1)" "unprognostic (8.31e-2)" "prognostic favorable (8.90e-4)" 4.0 0.6 0.5 1.0 0.7 0.1 8.0 0.6 0.8 7.4 0.8 1.8 0.7 2.6 0.2 3.0 7.7 0.4 0.8 0.2 0.2 0.4 0.4 4.3 2.9 0.6 0.2 2.2 0.3 7.6 0.7 0.1 0.5 5.2 0.3 0.0 8.1 0.5 61.5 10.6 3.0 0.6 0.0 0.6 1.2 16.8 0.9 0.0 11.2 36.5 1.2 2.7 7.1 1.0 15.3 1.4 0.2 10.7 0.0 0.0 2.1 0.2 0.0 0.0 0.0 1.1 0.1 0.3 0.3 0.3 1.5 0.8 12.0 10.4 0.0 0.6 24.6 0.2 2.9 0.0 0.0 0.1 0.1 0.1 0.1 2.4 0.0 0.0 0.0 0.5 121.6 0.0 7.7 2.8 0.3 28.6 1.7 0.0 16.8 0.3 10.6 0.1 0.0 0.0 1.5 0.4 0.0 0.2 0.0 3.1 5.1 7.7 40.0 0.1 0.4 0.2 0.2 0.3 0.5 0.1 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.6 0.8 0.2 0.2 0.6 0.2 0.5 0.0 0.9 1.0 11.4 0.0 2.8 0.0 0.3 2.4 1.6 3.3 0.0 0.6 1.1 0.9 2.4 0.0 1.6 0.0 0.0 0.2 0.6 0.1 0.0 0.0 43.3 0.2 0.1 7.5 0.0 0.0 0.3 0.2 1.7 1.5 0.0 0.2 2.5 0.1 2.5 0.0 2.0 0.0 0.9 1.0 6.1 1.3 3.6 181.9 2.5 1.0 0.0 0.0 0.1 0.3 2.1 0.0 0.0 0.1 0.0 2.2 0.0 1.0 0.1 0.0 2.3 0.1 0.0 1.1 0.8 1.9 12.8 0.3 2.4 0.1 0.7 0.0 0.2 2.0 TMEM38A "MGC3169, TRIC-A" ENSG00000072954 "Transmembrane protein 38A" Q9H6F2 19 16661139-16690023 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "skeletal muscle: 581.3;tongue: 260.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.7;Cone photoreceptor cells: 85.5;Excitatory neurons: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 36.9;eosinophil: 12.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 36.9" "Cell line enhanced" "Detected in many" "Daudi: 16.1;OE19: 15.2;U-266/70: 15.6;U-698: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048100, HPA050463" Enhanced Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "HPA048100: , HPA050463: AB_2681137" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-1)" "unprognostic (2.99e-1)" "unprognostic (3.49e-1)" "prognostic favorable (2.78e-5)" "unprognostic (2.94e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.99e-10)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (4.50e-3)" "unprognostic (1.96e-2)" 2.1 4.1 10.5 1.3 15.4 5.8 2.3 13.3 15.9 1.9 52.4 2.9 1.9 1.3 18.0 9.2 3.4 0.9 26.1 10.8 16.1 5.7 7.6 4.5 1.5 10.7 14.3 2.4 2.1 4.4 7.4 0.6 11.2 7.0 2.7 10.0 9.3 5.0 581.3 1.8 2.0 1.4 10.2 1.6 14.7 3.9 16.0 2.9 2.5 260.0 2.3 1.7 1.3 11.3 4.1 0.8 1.0 6.1 3.3 0.3 0.5 1.4 0.8 0.9 1.9 1.3 5.8 16.1 2.4 0.3 5.3 3.3 8.1 1.7 0.9 1.1 2.4 0.0 2.5 1.3 0.9 0.1 0.2 1.4 6.2 1.1 0.7 4.6 0.4 2.9 0.1 1.5 0.6 6.3 0.2 1.7 1.5 15.2 9.4 8.5 1.4 4.4 5.8 3.0 9.9 6.9 4.4 0.5 2.1 0.5 3.0 1.3 0.0 1.2 2.8 3.7 0.7 15.6 12.2 27.1 1.4 9.6 1.2 36.9 4.2 12.3 0.0 1.6 0.0 4.6 0.5 0.1 0.4 6.0 0.1 0.1 2.4 3.5 1.0 0.8 0.8 1.0 10.5 15.4 13.3 15.9 10.8 16.1 10.7 14.3 11.2 10.2 16.0 11.3 2.8 3.2 1.5 18.3 2.3 1.1 3.5 6.7 3.4 30.7 3.9 2.2 25.9 1.5 3.0 0.0 85.5 0.1 0.6 1.7 1.9 3.6 0.1 1.4 0.6 4.5 4.2 0.0 31.0 2.5 0.1 3.0 17.3 1.4 0.0 2.2 9.7 9.2 0.4 13.5 24.0 7.6 14.2 4.3 1.2 0.9 10.5 0.9 3.6 3.7 0.9 13.9 0.0 7.5 3.1 10.8 1.1 22.6 2.9 3.4 0.4 1.2 1.8 9.5 0.0 25.4 3.9 0.9 1.3 3.3 0.3 0.1 0.6 2.1 2.7 1.3 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 100.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 78.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Approved Supported Nucleoplasm,Mitochondria NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: AB_2671101" "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 18.1 18.2 9.2 9.8 9.7 10.4 11.3 10.5 12.3 8.0 9.5 12.6 5.8 8.9 10.6 9.3 11.3 8.9 19.3 10.3 10.2 12.0 24.4 9.0 10.1 9.6 9.1 10.5 25.0 8.3 7.6 10.3 10.1 7.4 9.7 6.1 9.9 5.9 100.7 7.7 9.5 9.1 9.5 9.6 17.8 9.8 9.5 11.0 6.0 20.5 10.3 11.3 7.4 10.1 21.2 16.4 13.1 13.8 14.9 12.7 13.6 17.6 15.8 19.4 15.3 15.8 11.9 28.4 15.0 12.0 16.4 19.1 24.9 16.8 21.4 18.9 17.5 28.3 10.0 21.2 14.7 15.5 14.5 11.8 15.3 12.2 6.4 7.3 16.4 14.2 22.0 13.5 20.5 15.9 35.8 29.6 12.3 26.6 20.6 25.4 12.8 24.2 20.5 20.0 29.7 13.1 11.0 78.0 23.3 10.2 16.0 14.1 10.6 11.1 13.7 20.7 16.9 19.9 18.7 28.1 16.4 12.1 12.5 6.3 9.1 6.7 8.0 10.2 9.1 17.7 9.0 9.3 9.6 10.9 10.3 9.6 6.7 5.8 7.9 11.0 7.9 12.0 9.2 9.7 10.5 12.3 10.3 10.2 9.6 9.1 10.1 9.5 9.5 10.1 136.2 16.0 30.1 5.5 37.1 67.3 43.7 54.8 24.5 23.9 26.2 22.2 46.3 14.3 35.7 22.0 8.4 71.2 48.1 69.0 66.5 36.6 20.3 40.8 26.2 96.4 13.8 26.5 12.8 63.5 59.6 50.2 17.3 17.1 39.9 17.0 28.5 50.3 132.4 10.1 11.4 31.7 42.7 70.0 74.5 12.1 29.8 73.2 40.9 5.6 38.9 23.1 22.6 3.5 8.1 43.6 37.9 29.0 68.6 42.1 28.8 75.4 58.7 17.5 39.5 61.9 40.8 70.6 29.5 21.5 59.7 70.3 39.8 52.6 34.1 26.2 TMOD4 Sk-Tmod ENSG00000163157 "Tropomodulin 4" Q9NZQ9 1 151169986-151176284 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 68 "skeletal muscle: 1225.0;tongue: 534.1" "Cell type enhanced" "Detected in single" "Astrocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 8.6;U-266/84: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA028203 Enhanced NA NA "Cluster 24: B-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 24: NB-4 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "HPA028203: AB_10600830" 0.9 0.9 1.6 2.9 1.6 2.3 1.6 1.5 2.5 0.8 2.2 2.0 1.0 2.0 2.5 12.9 1.8 2.2 0.7 1.7 1.4 0.8 0.2 2.4 5.8 1.5 1.7 1.7 0.4 0.6 0.1 1.3 1.5 10.1 2.4 1.0 8.1 1.8 1225.0 4.1 2.0 1.5 1.4 3.5 1.7 1.4 1.5 2.7 0.5 534.1 7.1 1.2 0.2 1.4 0.9 1.5 2.1 0.5 1.3 0.2 1.8 0.8 0.3 0.8 0.1 0.7 0.8 1.2 0.9 1.2 0.4 0.7 1.5 0.4 0.3 2.9 4.4 2.1 3.4 0.0 0.6 1.9 5.0 0.2 0.6 0.9 2.5 2.4 0.6 4.5 1.2 2.8 0.4 2.4 0.8 8.6 1.3 0.6 2.3 3.6 0.8 0.4 0.3 1.2 1.7 1.4 0.4 0.0 0.2 0.5 0.7 4.0 0.5 0.1 1.0 1.7 1.0 3.4 6.4 1.0 0.6 4.3 0.6 0.0 0.1 0.1 0.5 0.0 0.2 0.4 0.5 0.1 0.0 0.4 0.4 0.9 0.0 0.0 0.1 0.3 0.4 0.2 1.6 1.6 1.5 2.5 1.7 1.4 1.5 1.7 1.5 1.4 1.5 1.4 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 TNNC2 "CFAP85, FAP85" ENSG00000101470 "Troponin C2, fast skeletal type" P02585 20 45823214-45833745 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 109 "skeletal muscle: 30416.4;tongue: 8088.6" "Group enriched" "Detected in many" 4 "Proximal enterocytes: 338.7;Skeletal myocytes: 1165.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.2;head and neck cancer: 22.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Hep G2: 10.0;HSkMC: 14.8;SCLC-21H: 11.3" "Region enriched" "Detected in some" 5 "olfactory bulb: 6.1" "Low region specificity" "Detected in some" "HPA043174, HPA058481" Enhanced Approved Nucleoplasm,Vesicles No NA 560000 "Cluster 19: B-cells - Humoral immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm Vesicles "HPA043174: AB_10806380, HPA058481: AB_2683729" "unprognostic (1.13e-1)" "unprognostic (7.25e-2)" "unprognostic (3.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-5)" "unprognostic (1.80e-2)" "unprognostic (5.72e-3)" "unprognostic (3.12e-3)" "unprognostic (2.19e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (9.03e-3)" "unprognostic (7.15e-3)" "unprognostic (4.79e-1)" "unprognostic (5.23e-2)" "unprognostic (1.13e-1)" 6.6 5.5 4.8 0.4 5.7 1.1 8.3 5.2 6.9 2.2 4.4 5.3 2.5 4.2 1.0 128.5 3.0 2.2 4.0 4.8 4.5 1.7 2.5 3.2 0.5 4.4 4.5 6.5 2.2 1.2 3.1 0.2 4.5 44.3 2.2 1.3 176.3 1.3 30416.4 10.1 7.8 1.0 4.1 1.8 2.4 4.6 4.8 6.7 5.1 8088.6 0.7 2.5 3.0 5.5 0.1 0.0 0.2 0.4 1.6 1.0 1.7 0.1 0.4 0.0 0.1 0.2 1.1 0.4 1.1 1.0 0.4 0.4 0.0 0.4 0.0 0.0 0.3 0.0 1.0 10.0 0.4 0.3 0.2 14.8 0.2 0.1 0.7 0.3 0.0 1.2 0.1 0.5 0.2 1.2 0.7 0.1 0.0 0.4 0.6 0.3 0.6 0.2 0.4 0.1 11.3 0.5 1.6 0.1 0.4 0.5 1.3 0.4 0.5 0.2 0.3 0.9 0.2 1.5 0.4 0.2 1.4 0.1 0.2 0.0 0.6 1.3 0.1 1.1 0.6 5.3 1.3 0.2 0.3 4.6 0.0 0.3 2.0 0.3 0.8 0.8 3.9 8.7 4.8 5.7 5.2 6.9 4.8 4.5 4.4 4.5 4.5 4.1 4.8 5.5 0.9 3.2 0.6 0.3 3.1 0.8 0.5 2.0 0.0 4.2 3.1 1.7 0.5 2.8 3.6 3.7 0.0 2.4 0.5 171.7 3.9 1.5 6.9 37.1 1.0 3.8 22.9 0.0 1.9 5.1 0.4 7.2 0.5 2.3 0.0 13.9 0.0 1.1 0.3 0.0 0.7 108.2 14.2 0.3 1.1 47.0 1.2 22.4 0.0 0.0 2.1 1.4 1.0 0.0 0.6 3.3 92.9 3.0 0.5 0.7 338.7 1.0 4.3 2.4 0.0 1165.3 9.5 2.5 5.5 0.1 8.4 0.1 4.7 7.2 37.0 0.7 TNNI1 ENSG00000159173 "Troponin I1, slow skeletal type" P19237 1 201403768-201429866 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 40 "skeletal muscle: 12562.8;tongue: 3158.3" "Group enriched" "Detected in some" 17 "Cardiomyocytes: 74.7;Skeletal myocytes: 176.2" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.6;prostate cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RH-30: 491.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028190 Approved Uncertain Nucleoplasm,Nucleoli NA NA 74000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm Nucleoli "HPA028190: AB_10600831" "unprognostic (2.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.91e-1)" "unprognostic (5.39e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (1.93e-2)" "unprognostic (2.37e-1)" "unprognostic (4.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-2)" "unprognostic (1.05e-2)" "unprognostic (2.59e-2)" "unprognostic (3.52e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" 1.3 0.4 0.0 0.1 0.0 0.1 1.6 0.1 0.1 0.3 0.0 0.9 2.1 1.2 0.4 194.2 0.4 1.2 97.4 0.0 0.2 10.8 1.9 1.1 0.3 0.1 0.0 0.5 1.5 0.0 0.3 0.1 0.1 85.8 0.0 0.0 56.6 0.0 12562.8 2.1 2.5 0.1 0.0 0.3 1.3 0.5 0.1 1.6 1.4 3158.3 0.4 0.2 1.5 0.1 0.9 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.3 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.6 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 491.6 0.9 0.0 0.8 0.3 0.0 0.1 0.1 0.1 4.9 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.9 74.7 0.0 0.0 0.0 0.0 0.4 0.0 0.7 5.9 0.0 3.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.5 3.6 0.0 1.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 176.2 2.2 0.0 0.2 0.0 0.0 0.5 1.0 0.0 0.9 0.1 TNNI2 "AMCD2B, DA2B, FSSV" ENSG00000130598 "Troponin I2, fast skeletal type" P48788 11 1838981-1841680 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 25 "skeletal muscle: 7969.8;tongue: 2622.3" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 449.4;Skeletal myocytes: 598.7" "Group enriched" "Detected in many" 10 "cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 86.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 35.7;hTCEpi: 101.2" "Region enriched" "Detected in single" 6 "olfactory bulb: 5.1" "Not detected" "Not detected" "CAB018697, HPA055938" Enhanced Approved "Plasma membrane,Intermediate filaments" NA NA 110000 "Cluster 52: Eosinophils - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane" "Intermediate filaments" "CAB018697: AB_628400, HPA055938: AB_2682976" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (9.99e-3)" "unprognostic (1.01e-1)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-3)" "unprognostic (5.62e-2)" "unprognostic (1.77e-1)" "unprognostic (2.79e-2)" 3.0 1.8 0.3 1.1 0.3 6.1 7.9 0.3 0.6 1.0 0.4 1.2 0.3 0.8 0.3 66.9 0.9 5.6 1.7 0.3 0.4 0.7 1.6 7.8 1.6 0.4 0.4 0.7 8.8 0.0 0.9 3.0 0.4 14.0 0.2 0.0 216.1 3.2 7969.8 55.2 2.7 0.2 0.4 5.8 1.1 0.7 0.5 1.9 2.8 2622.3 1.0 27.4 3.2 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 35.7 1.0 0.2 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 8.1 101.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 3.1 0.0 0.1 1.2 2.4 0.0 1.0 0.0 1.0 0.0 0.7 0.0 0.0 12.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 13.8 5.8 53.3 0.1 12.5 0.1 3.8 0.0 0.0 8.0 4.8 0.0 0.0 39.7 0.4 17.6 86.4 0.0 2.5 0.3 0.3 0.3 0.6 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.6 1.2 3.2 4.4 0.0 9.1 25.1 2.6 1.8 15.4 0.0 0.5 23.7 5.6 21.5 3.0 0.0 0.0 33.8 15.7 0.1 0.0 1.4 0.0 1.4 0.2 2.0 0.0 0.0 0.0 0.6 449.4 2.4 1.1 0.1 10.8 0.4 0.4 0.3 39.6 0.0 0.0 0.0 2.0 18.8 10.7 0.0 0.3 25.9 0.0 0.0 16.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 4.2 0.1 0.0 0.2 13.2 0.0 0.0 598.7 2.4 0.0 0.6 2.7 6.5 87.2 1.9 4.3 0.0 0.9 TNNT3 "AMCD2B, DA2B, DKFZp779M2348, FSSV" ENSG00000130595 "Troponin T3, fast skeletal type" P45378 11 1919703-1938706 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 43 "skeletal muscle: 13906.8;tongue: 4507.7" "Cell type enriched" "Detected in many" 4 "Skeletal myocytes: 542.6" "Group enriched" "Detected in many" 9 "head and neck cancer: 28.8;urothelial cancer: 19.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 17 "basophil: 5.3" "Lineage enriched" "Detected in single" 17 "granulocytes: 5.3" "Cell line enriched" "Detected in some" 21 "HSkMC: 24.0" "Region enhanced" "Detected in some" "olfactory bulb: 5.1" "Low region specificity" "Detected in single" "CAB002451, HPA037810, HPA056909" Enhanced NA NA 470000 "Cluster 34: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" "CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273" "unprognostic (1.01e-2)" "prognostic favorable (7.37e-4)" "unprognostic (2.17e-2)" "unprognostic (2.30e-3)" "unprognostic (1.23e-2)" "unprognostic (1.29e-2)" "unprognostic (4.53e-3)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (4.29e-3)" "unprognostic (3.53e-2)" "unprognostic (4.34e-1)" "unprognostic (1.42e-5)" "unprognostic (2.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.79e-2)" "unprognostic (2.90e-2)" 31.2 2.4 0.2 1.4 0.4 1.5 20.0 0.1 0.4 16.3 0.1 5.8 0.2 6.6 2.8 62.5 14.4 1.9 185.3 0.2 0.1 0.8 1.4 3.7 1.4 0.1 0.1 1.7 2.2 0.3 2.5 41.3 0.1 20.7 0.5 0.0 216.0 3.1 13906.8 8.8 3.0 1.3 0.1 2.8 3.3 5.2 0.1 5.4 7.6 4507.7 2.0 20.3 12.0 0.2 0.0 0.0 0.0 0.0 0.5 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 33.1 0.0 1.9 0.0 0.8 2.9 3.9 5.9 2.2 0.0 0.4 0.3 17.8 0.0 10.1 0.0 0.0 24.5 1.5 0.0 0.0 0.1 0.3 2.4 0.3 33.9 0.0 0.0 0.1 0.0 6.7 42.0 0.0 0.1 0.0 3.0 0.0 0.0 2.7 0.0 0.0 0.0 6.1 0.0 2.3 2.5 110.9 2.2 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 94.8 0.3 0.2 0.0 0.0 42.5 0.0 0.0 542.6 11.2 0.1 0.6 2.9 3.4 18.3 2.0 0.7 0.0 17.1 TRIM63 "IRF, MURF-1, RNF28, SMRZ" ENSG00000158022 "Tripartite motif containing 63" Q969Q1 1 26051301-26068436 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Muscle protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 1935.8" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 272.2" "Cancer enriched" "Detected in some" 10 "melanoma: 31.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "ASC diff: 16.1;SK-MEL-30: 55.7" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 5.1" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (1.10e-1)" "unprognostic (4.80e-4)" "unprognostic (1.45e-2)" "unprognostic (7.52e-3)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (1.01e-1)" "unprognostic (2.16e-2)" "unprognostic (5.90e-2)" "unprognostic (1.33e-2)" "unprognostic (2.32e-1)" "unprognostic (5.58e-2)" 1.2 0.2 0.0 0.0 0.1 0.0 0.8 0.0 0.1 1.5 0.0 0.7 0.3 8.8 0.3 7.1 0.6 2.7 243.0 0.0 0.0 1.5 0.4 1.3 0.0 0.1 0.1 0.2 0.8 0.0 0.2 4.0 0.0 1.5 0.2 0.1 9.6 0.4 1935.8 4.2 0.8 3.5 0.0 0.2 0.8 0.2 0.2 0.3 0.5 387.6 0.2 8.9 1.1 0.1 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.4 0.0 272.2 5.7 0.0 1.8 0.0 0.5 0.0 0.0 1.9 1.8 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 8.1 0.0 0.1 10.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 12.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 3.3 29.7 0.0 0.0 0.0 34.7 1.4 0.0 0.0 0.0 0.1 1.6 6.1 0.0 0.1 0.1 TRIM7 "GNIP, RNF90" ENSG00000146054 "Tripartite motif containing 7" Q9C029 5 181193924-181205293 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 193.3;tongue: 51.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 17.8;Cardiomyocytes: 40.1;Squamous epithelial cells: 39.6;Suprabasal keratinocytes: 28.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 16.4;HDLM-2: 35.0;PC-3: 18.8;TIME: 16.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039213 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 37: Myocytes - Muscle contraction" Vesicles "Nucleoplasm, Cytosol" "HPA039213: AB_10795173" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (5.20e-2)" "unprognostic (1.10e-2)" "unprognostic (6.85e-2)" "unprognostic (1.80e-2)" "unprognostic (3.89e-4)" "unprognostic (3.45e-2)" "unprognostic (3.72e-1)" "unprognostic (1.64e-1)" "unprognostic (3.48e-2)" "unprognostic (1.97e-1)" "unprognostic (7.16e-3)" "unprognostic (1.26e-1)" "unprognostic (3.90e-2)" "unprognostic (6.17e-2)" "unprognostic (1.15e-2)" 2.1 1.5 1.2 0.4 1.0 0.4 2.1 10.5 3.0 5.5 0.4 1.9 0.3 1.3 3.1 27.0 2.2 0.2 8.5 0.9 1.7 3.9 0.6 2.6 0.4 3.1 2.9 1.5 4.8 2.7 5.5 0.3 2.8 2.8 0.5 1.6 7.3 0.6 193.3 28.7 1.3 0.6 1.3 1.4 2.2 1.3 2.0 0.4 6.3 51.0 2.1 2.2 9.5 1.3 9.0 4.4 0.1 0.5 0.7 0.8 0.2 1.9 0.0 0.7 1.8 0.4 12.0 0.6 6.1 2.6 3.7 16.4 4.8 13.8 0.2 35.0 1.8 0.9 12.2 0.2 2.2 0.0 2.0 0.1 10.5 0.4 6.7 2.7 3.9 1.6 0.5 2.0 0.4 1.3 0.5 0.3 0.0 14.5 18.8 0.4 6.0 1.4 4.9 0.0 0.4 1.1 4.2 0.2 6.5 0.2 1.0 0.4 16.0 0.2 3.4 0.6 6.3 2.8 0.4 1.0 0.5 0.7 1.5 0.0 1.7 0.0 0.4 0.7 0.7 0.1 0.4 0.4 0.3 0.2 0.7 0.5 0.0 0.1 0.5 0.2 0.9 0.3 1.2 1.0 10.5 3.0 0.9 1.7 3.1 2.9 2.8 1.3 2.0 1.3 7.3 0.0 1.1 0.0 1.0 17.8 4.3 11.1 12.0 6.2 0.8 1.5 40.1 0.0 6.3 3.7 0.0 0.1 0.8 5.9 5.9 0.7 0.9 0.2 0.3 4.6 0.0 0.0 1.3 2.4 0.7 4.8 11.2 0.7 0.0 0.1 5.7 0.4 1.1 0.0 3.9 3.3 2.0 6.0 2.8 0.0 0.9 2.9 1.8 0.0 5.7 0.6 1.0 2.0 0.1 5.0 6.5 1.5 0.1 2.5 0.0 1.5 2.9 2.9 13.1 17.3 5.8 1.5 0.4 39.6 28.4 0.0 1.4 0.1 3.4 5.3 TRIM72 MG53 ENSG00000177238 "Tripartite motif containing 72" Q6ZMU5 16 31214091-31231537 "Predicted intracellular proteins, Transporters" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 151.8;tongue: 43.0" "Cell type enriched" "Detected in many" 5 "Skeletal myocytes: 45.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 0.9" "Region enriched" "Detected in many" 7 "cerebellum: 9.3" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 7.2;LHCN-M2: 12.6;RH-30: 29.7;U-266/70: 17.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054909 Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Vesicles Nucleoplasm "HPA054909: AB_2682639" "unprognostic (2.61e-1)" "unprognostic (3.21e-3)" "unprognostic (5.07e-2)" "unprognostic (9.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.13e-1)" "unprognostic (2.01e-3)" "unprognostic (2.80e-1)" "unprognostic (6.57e-2)" "unprognostic (4.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.49e-2)" "unprognostic (2.24e-10)" "unprognostic (7.70e-2)" "unprognostic (6.72e-2)" "unprognostic (4.15e-1)" "unprognostic (4.30e-4)" 0.2 0.2 0.9 0.2 0.8 0.8 0.2 9.3 1.0 0.1 0.5 0.2 0.2 0.2 0.3 1.0 0.1 0.2 0.8 0.7 0.4 0.1 0.1 0.2 0.3 1.0 0.5 0.2 0.3 0.1 0.0 0.2 1.3 1.9 0.1 0.8 2.5 0.1 151.8 0.5 0.2 0.1 0.1 0.3 0.3 0.3 0.5 0.1 0.2 43.0 0.2 0.1 0.0 1.2 0.1 0.1 0.2 0.4 0.2 0.1 0.3 0.3 0.1 0.0 0.0 0.2 0.4 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.3 0.1 0.2 0.7 0.2 0.2 7.2 0.3 1.2 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.8 12.6 0.1 0.1 0.5 0.2 0.2 0.2 0.3 29.7 4.1 0.0 0.2 2.6 0.2 0.1 0.3 0.1 0.3 0.2 2.6 0.1 0.2 0.2 0.2 0.1 17.9 1.7 0.2 0.2 0.4 0.2 1.9 0.3 0.5 0.3 0.3 0.3 0.4 0.3 0.2 0.3 0.6 0.4 0.3 1.5 0.6 0.4 0.6 0.2 0.1 0.9 0.8 9.3 1.0 0.7 0.4 1.0 0.5 1.3 0.1 0.5 1.2 4.7 3.2 3.8 0.0 0.8 0.1 3.1 0.0 0.0 1.0 3.1 8.0 3.0 0.0 2.5 0.0 2.1 0.3 2.4 0.0 0.0 0.0 0.3 1.5 4.7 1.5 0.0 0.0 0.2 0.0 0.3 2.5 0.0 4.0 1.3 0.8 0.4 0.0 0.2 0.0 0.1 0.2 0.0 1.2 0.3 0.0 0.0 3.1 0.0 0.0 0.6 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.1 0.1 0.0 0.9 0.0 45.6 2.2 0.1 0.2 0.8 0.3 0.1 2.2 1.2 0.9 1.5 USP19 "KIAA0891, ZMYND9" ENSG00000172046 "Ubiquitin specific peptidase 19" O94966 3 49108046-49120938 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" "unprognostic (3.23e-2)" "unprognostic (2.12e-1)" "unprognostic (5.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-2)" "unprognostic (3.90e-3)" "unprognostic (2.99e-2)" "unprognostic (3.00e-3)" "unprognostic (2.69e-1)" "unprognostic (3.65e-2)" "unprognostic (2.31e-2)" "unprognostic (1.26e-1)" "prognostic favorable (7.05e-9)" "unprognostic (2.99e-1)" "unprognostic (2.11e-1)" "unprognostic (1.72e-3)" "unprognostic (7.54e-2)" 20.3 25.5 16.4 19.4 18.7 26.8 19.6 19.0 18.6 21.9 24.4 26.2 22.4 24.3 19.1 19.7 24.3 15.5 26.8 17.4 16.8 18.9 18.6 17.7 21.5 19.0 17.5 22.8 21.2 31.0 17.5 16.5 17.9 19.4 15.9 14.3 29.6 24.4 75.6 26.5 21.9 18.9 16.7 22.9 21.6 20.8 18.4 27.4 23.6 45.0 16.8 23.3 19.6 19.5 20.2 26.3 28.6 42.1 36.8 24.1 38.7 23.1 26.1 35.1 28.7 28.7 27.3 41.6 22.2 24.4 36.2 24.1 40.3 29.1 16.0 32.7 32.1 42.5 56.4 22.8 36.1 45.7 40.5 33.8 22.7 36.9 24.1 25.9 24.2 33.8 30.8 28.4 18.9 23.9 42.6 43.0 58.2 27.4 44.1 19.4 24.3 45.7 22.3 37.4 16.5 51.4 33.3 38.1 34.9 26.1 26.0 55.4 21.8 24.5 30.5 36.7 33.7 77.7 97.1 38.0 32.8 34.3 32.6 9.7 3.7 5.3 4.5 3.6 4.2 2.8 3.7 5.2 4.6 2.9 3.3 3.9 7.5 2.9 4.4 1.9 2.7 4.3 16.4 18.7 19.0 18.6 17.4 16.8 19.0 17.5 17.9 16.7 18.4 19.5 7.8 12.8 14.5 10.4 7.2 6.2 3.8 8.5 8.6 12.7 8.7 7.4 13.1 5.7 9.9 7.3 18.8 9.6 9.2 17.1 5.9 7.7 3.6 14.8 8.7 7.6 9.1 10.3 8.4 7.8 5.3 7.7 14.3 9.5 2.5 8.1 7.9 13.6 9.0 13.5 8.0 11.6 10.2 8.7 4.7 4.9 13.1 6.8 3.6 2.8 6.5 8.7 3.1 8.0 7.7 11.5 13.9 12.4 7.4 4.2 16.3 7.7 14.9 11.4 13.1 12.3 11.1 16.2 13.2 9.1 5.4 13.5 8.0 9.8 13.4 3.1 VGLL2 ENSG00000170162 "Vestigial like family member 2" Q8N8G2 6 117265558-117273565 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 129.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.2;Hofbauer cells: 1.5;Skeletal myocytes: 7.7;Spermatogonia: 1.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Region enhanced" "Detected in some" "thalamus: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RH-30: 13.8;U-2 OS: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (3.02e-2)" "unprognostic (3.09e-2)" "unprognostic (1.75e-1)" "unprognostic (4.92e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.5 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.1 0.8 0.6 0.0 0.0 0.7 0.2 129.4 0.2 0.0 0.0 0.3 0.0 0.0 0.4 2.3 0.0 0.0 30.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 1.7 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.0 0.7 0.6 0.8 0.3 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 YBX3 "CSDA, CSDA1, dbpA, ZONAB" ENSG00000060138 "Y-box binding protein 3" P16989 12 10699089-10723323 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "skeletal muscle: 4915.7;tongue: 1635.6" "Cell type enhanced" "Detected in many" "Early spermatids: 1418.1;Prostatic glandular cells: 1553.4;Skeletal myocytes: 1316.7;Urothelial cells: 1339.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034838 Approved Supported Cytosol NA NA 230000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA034838: AB_10670980" "unprognostic (1.93e-2)" "unprognostic (6.20e-2)" "unprognostic (3.56e-1)" "unprognostic (3.61e-2)" "unprognostic (4.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-1)" "unprognostic (2.41e-1)" "unprognostic (3.23e-3)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.17e-13)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.44e-1)" 250.4 96.7 17.6 77.5 17.6 151.1 200.2 18.8 25.5 152.1 28.4 249.1 37.5 136.8 47.3 271.0 166.7 65.0 469.9 16.5 22.3 194.1 53.8 209.5 32.9 25.4 22.4 134.6 291.0 18.6 84.1 72.5 23.9 177.1 58.8 82.8 218.1 67.5 4915.7 358.1 99.0 100.9 20.9 79.5 149.7 265.7 22.2 36.7 136.1 1635.6 54.6 225.4 204.8 19.7 117.2 90.3 41.4 136.1 165.7 310.7 307.4 173.4 142.7 138.7 132.0 160.4 259.5 109.3 57.7 130.3 96.5 215.5 173.3 338.1 124.6 1.2 325.2 91.3 123.6 108.4 198.3 171.7 10.4 343.3 452.3 124.2 414.6 148.9 313.6 152.3 123.1 0.4 154.7 112.6 137.8 141.9 435.5 103.7 76.9 76.9 192.6 127.4 192.6 150.0 52.2 0.3 129.1 130.9 174.1 288.0 37.1 133.9 221.3 94.5 282.6 108.4 201.5 0.5 38.1 13.4 133.1 0.2 104.8 0.0 4.2 0.0 0.6 4.2 0.0 1.6 0.0 1.5 3.2 6.5 0.0 1.6 0.8 0.8 2.4 0.1 0.1 1.0 17.6 17.6 18.8 25.5 16.5 22.3 25.4 22.4 23.9 20.9 22.2 19.7 680.9 150.6 164.4 14.0 192.8 764.9 1226.9 212.9 552.7 36.1 288.8 292.7 497.7 105.8 177.8 145.3 89.6 145.7 39.2 94.3 133.1 125.3 1418.1 563.0 402.1 563.1 67.6 1081.5 2.4 143.3 84.3 484.8 119.8 551.3 63.3 291.0 235.6 23.1 97.7 16.8 1.0 139.5 120.1 223.2 494.7 470.2 264.7 292.2 259.7 21.5 83.9 67.2 2.1 4.5 0.1 122.0 76.3 223.8 80.6 1553.4 43.9 240.4 240.4 365.4 124.9 1316.7 643.1 594.6 158.4 638.6 1050.5 125.7 72.5 70.8 157.4 1339.7 YIPF7 "FinGER9, FLJ39576" ENSG00000177752 "Yip1 domain family member 7" Q8N8F6 4 44622065-44678556 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 84.9;tongue: 27.9" "Cell type enhanced" "Detected in some" "Astrocytes: 1.6;Cardiomyocytes: 1.5;Early spermatids: 1.5;Excitatory neurons: 4.8;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.0;Skeletal myocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA030642 Uncertain NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "HPA030642: AB_10601027" "unprognostic (9.41e-4)" "unprognostic (2.27e-1)" "unprognostic (2.90e-2)" "unprognostic (2.24e-1)" "unprognostic (2.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.46e-2)" "unprognostic (9.81e-2)" "unprognostic (2.32e-2)" "unprognostic (3.05e-2)" "unprognostic (1.52e-2)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.98e-2)" 0.0 0.1 1.0 0.0 1.0 0.0 0.1 5.4 1.3 0.1 0.2 0.1 0.1 0.1 0.2 0.6 0.1 0.0 0.8 1.0 1.2 0.1 0.0 0.0 0.1 0.8 1.1 0.2 0.3 0.0 0.2 0.0 1.0 0.3 0.0 0.3 0.3 0.2 84.9 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.9 0.0 0.1 27.9 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 1.0 5.4 1.3 1.0 1.2 0.8 1.1 1.0 0.9 0.9 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.1 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ZNF703 "FLJ14299, NLZ1, ZEPPO1, ZNF503L, Zpo1" ENSG00000183779 "Zinc finger protein 703" Q9H7S9 8 37695782-37700019 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 108.4" "Cell type enriched" "Detected in many" 4 "Syncytiotrophoblasts: 434.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "intermediate monocyte: 3.3;non-classical monocyte: 4.3" "Lineage enriched" "Detected in single" 12 "monocytes: 4.3" "Cell line enhanced" "Detected in many" "HEK 293: 156.8;OE19: 61.2;SK-MEL-30: 60.0;T-47d: 52.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023930, CAB068249" Supported NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "CAB068249: AB_2665667, HPA023930: AB_1859425" "unprognostic (4.64e-2)" "unprognostic (3.15e-2)" "unprognostic (7.01e-3)" "unprognostic (1.71e-3)" "unprognostic (2.54e-1)" "unprognostic (1.42e-1)" "unprognostic (6.93e-2)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-1)" "unprognostic (9.63e-2)" "prognostic unfavorable (2.70e-7)" "unprognostic (5.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.01e-1)" "unprognostic (2.23e-1)" 24.6 14.4 16.6 7.6 15.0 1.9 27.4 10.7 16.9 39.9 9.8 46.9 15.1 27.8 12.7 18.2 33.2 6.2 18.8 14.2 10.3 8.1 4.2 10.7 4.1 21.8 17.9 19.6 8.7 1.9 5.9 12.1 16.4 21.7 12.6 0.4 18.3 8.7 108.4 57.4 25.9 11.6 15.0 18.9 22.8 2.9 14.7 2.8 10.6 33.3 2.9 36.8 28.7 10.7 3.2 6.6 0.8 5.2 15.1 7.9 5.2 29.1 13.6 8.8 7.4 27.2 36.0 0.0 7.2 18.4 4.0 17.2 3.0 4.4 6.8 0.8 156.8 0.0 9.5 17.5 14.9 0.0 3.0 26.6 8.2 9.1 3.7 19.0 7.8 0.3 0.4 0.0 14.1 27.4 0.1 0.8 2.6 61.2 11.6 2.7 4.7 3.7 2.7 14.2 2.9 0.2 5.4 4.6 60.0 6.2 52.6 3.1 23.1 10.3 23.7 16.1 12.3 1.9 0.1 0.2 9.1 3.2 6.7 0.0 0.4 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 16.6 15.0 10.7 16.9 14.2 10.3 21.8 17.9 16.4 15.0 14.7 10.7 11.9 6.4 0.0 14.7 15.3 48.2 13.2 28.9 103.0 3.7 39.3 27.8 9.1 2.8 14.5 5.5 0.0 41.4 7.7 52.0 3.9 7.1 0.4 30.8 37.0 9.5 79.6 0.0 1.5 2.5 37.2 36.0 14.8 20.3 0.0 5.8 2.5 2.2 36.2 0.0 2.8 95.4 10.2 23.6 31.9 0.7 31.4 31.2 33.8 11.2 7.9 9.3 0.0 0.0 0.6 3.7 56.9 15.8 1.9 9.7 35.4 2.8 7.7 0.9 52.6 54.9 66.4 0.0 0.6 99.7 74.6 434.1 6.0 6.1 92.6 10.7